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Abstract 
The work described in this thesis covers two projects: 
a) The development of a supported sixteen residue peptidyl model 
incorporating the 'reactive triad' serine, histidine and aspartic acid, found within 
serine protease enzymes. The methodology was designed to allow rapid 
screening of a combinatorial library of simple peptides containing the reactive 
triad, some of which were anticipated to show synthetic esterase activity. It is 
envisaged that this could be undertaken by observing selective cleavage of a 
highly coloured red azo dye tethered through the ester under investigation to the 
peptide via a glycol linker. One peptidyl system has been synthesised and 
investigated to allow the development of the methodology and it was found that 
intramolecular hydrolysis could be observed when glycol linkers of optimal 
length were utilised under favourable conditions. 
b) Vancomycin was modified with extended glycol chains containing a 
terminal double bond to allow covalent dimerisation via cross coupling 
metathesis. Binding of the vancomycin monomers and dimers to an N-acetyl-L- 
Lys-D-Ala-D-Ser peptide model has been demonstrated via electrospray 
ionisation mass spectrometry by Professor Albert Heck at Utrecht, Holland and 
in-vivo studies are ongoing to elucidate if enhanced vancomycin activity towards 
vancomycin resistant bacteria can be observed. 
iii 
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Introduction 
I Introduction 
1.1 Enzymes 
1. LI History 
For many thousands of years since the time of ancient Egypt, mankind has been 
using biological enzymes in the fermentation process. An example of this was 
brewing beer. I Ever since, our ancestors have tried to rationalise the 'invisible 
or vital force' responsible for converting a sweet and sticky mash into a palatable 
liquid bearing the gift of euphoria. An excellent historical account of the rational 
and heated debates that lead to the elucidation of the 'vital force' being attributed 
to enzymes, has been provided by Dressler and Potter. I 
Figure 1.1. Stick representation of the senne protease, elastase. 2 
It was not until the 19'h century that scientists addressed the question of whether 
the entity responsible was a living species or a chemical substance. In 1897 
Eduard Buchner observed that extracts of yeast, containing no living cells, were 
able to carry out the fermentation of sugar to alcohol and carbon dioxide. He 
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proposed that a species called 'zymase' found in yeast cells was responsible for 
fermentation. In 1926 James Sumner crystallised the enzyme urease from Jack 
Beans and proved beyond doubt that biological catalysis was carried out by a 
chemical substance. His investigations showed the crystalline urease structure 
was overwhelmingly protein and attributed this to being the enzyme. However, 
he was met with much scepticism whereby other investigators argued the 
enzymes were not necessarily the protein but other small molecules trapped 
within the crystal structure. Finally, about ten years later, Sumner's conclusions 
gained full acceptance through further work and elaborate experiments 
conducted by Moses Kunitz and John Northrop and the remarkable catalytic 
force of enzymes was credited to chemical molecules called proteins. 
1.1.2 Structure 
Enzymes are large polypeptide molecules (with the exception of ribosomes 
which contain a mixture of ribonucleic acid and protein)3 whose molecular 
weight varies from 5,000 to 5,000,000 Da with typical values in the range of 
20,000-100,000 Da. As can be seen above, an enzyme's overall geometrical 
structure is complex. However, this can be simplified into four main 
substructures: primary, secondary, tertiary and quaternary. 
a) A polypeptide chain consists of a series of cc-amino acid building blocks 
joined together via amide bonds to form a linear sequence. This is the primary 
structure of the polypeptide (Figure 1.1). 
2 
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b) There are at least three common stable forms of secondary structure 
commonly observed in proteins: the a-helix, the P-sheet and the P-tum, which 
are all controlled by hydrogen bonding interactions available. Hydrogen 
bonding between the carbonyl oxygen of one amide linkage and the N-H of the 
linkage four residues ahead of the chain within a single polypeptide gives rise to 
an oc-helix (Figure 1.2). This results in all the amino acid side chains pointing 
outwards from the pitch of the helix. The P-sheet is a structure formed by two or 
more linear polypeptide strands, held together by a series of interstrand hydrogen 
bonds. There are two types of P-sheet structures: parallel P-sheets, in which the 
peptide strands both proceed in the same amino-to-carboxyl direction; and 
antiparallel, in which the peptide strands proceed in opposite directions. The 0- 
turn is a structure often fornied at the end of a P-sheet which leads to a 180' turn 
in the direction of the peptide chain. 
se(ondary 
0 
N 
&, 0, ý 
0 *1. 
O., sle,. a, y 
Figure 1.2. The four basic structures of enzymes. 4 
c) The three-dimensional structure of protein sub-units, known as the tertiary 
structure, arises from combining elements of secondary structure to form one or 
several compact globular units called domains. The packing of secondary 
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structural units usually involves burying hydrophobic amino acid side chains on 
the inside of the protein and positioning hydrophilic amino acid side chains on 
the surface. 
d) Frequently, proteins consist of a number of domains where a particular - 
domain has a specific function, such as binding a substrate or cofactor. Larger 
proteins often consist of more than one tertiary structure, which fit together to 
form the active quaternary structure. 5 
The process which produces the secondary, tertiary and the unique overall stable 
and active geometry of an enzyme, is referred to as folding. The sequence of 
amino acids in the polypeptide chain is all-important for this to occur and 
contains all the information needed. In living organisms the amino acid 
sequence is controlled by the nucleotide sequence of the corresponding gene, i. e. 
the piece of deoxyribonucleic acid (DNA) which encodes for that particular 
protein in that particular organism and when the polypeptide sequence is formed 
inside cells by ribosomes, the polypeptide chain folds spontaneously. This is 
remarkable when one considers how many possible conformations are available. 
In 1968 the biophysicist Cyrus Levinthal considered a polypeptide chain of 150 
residues. Assuming the shortest possible time for the polypeptide to convert 
from one conformation to another was one picosecond and simplifying the 
argument by only allowing three possible conformations for each peptide group. 
The polypeptide would have 3150 possible conformations to process, which 
would take 1048 years. Remarkably, the actual folding time can be between 0.1 
and 1000 seconds. 4 It was also shown by Anfinsen and his colleagues at the 
National Institutes of Health, that it was possible to refold a particular digestive 
4 
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enzyme after it had been severely denatured. They subjected the denatured 
enzyme to near physiological conditions of pI-L salt concentration and 
temperature and within hours the polypeptide chain refolded, regaining full 
biological activity. This indeed indicates the polypeptide sequence was capable 
of containing all the information required to induce folding into an 
architecturally complex and biologically active geometry. 
1.1.3 Selectivity and Catalysis 
Enzymes are almost always proteins (the exception being ribosomes) but not all 
proteins are enzymes, the difference being that enzymes possess catalytic 
activity. The part of the enzyme's tertiary structure that is responsible for the 
activity is called the 'active site' and the function of enzymes is to catalyse 
biochemical reactions where parameters under consideration are speed, 
selectivity and specificity. 
With regard to speed, enzymes are capable of catalysing reactions at rates well in 
excess of a million-fold faster than the uncatalysed reaction. Ratios of K. tlK.,. t 
can be as large as 106ý. 1014 . An 
illustration of this is shown in Figure 1.3 where 
glycoside hydrolysis is considered. In this instance, the rate of intramolecular 
acid-catalysed glycoside hydrolysis is 10' fold faster than acid-catalysed 
glycoside hydrolysis. However, the enzyme-catalysed glycoside hydrolysis is 
even faster than acid-catalysed glycoside hydrolysis, by 107 fold. 
An example of an extremely efficient enzyme is acetylcholinerase, which has a 
turnover number of 25,000 reactions catalysed per second, meaning that it 
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cleaves an acetylcholine molecule in just 40 millionths of a second. This is 
incredibly fast and the reaction involved begins to be controlled by the rate at 
which a substrate can diffuse onto the enzyme's active site, and the product can 
diffuse away into solution; the so called diffusion-limit. 
OH 
+H Acid-catalysed kb,, = 1.9 X 10-6 S-1 H vo 0 Ph hydrolysis inO. IMHCI 
OH 
OH (*r,. 
10 
0H Intramolecular k,, i = 1.4 x 10-3S-1 
00 hydrolysis 
OH I 
Enzyme 
%6 OH cq---ý-O 
0-galactosidase k,,, t = 40 s-1 
H%-ý:; ýýOPHh hydrolysis 0 
OH 
Figure 1.3. Comparing the rates of glycoside hydrolysis via acid, intramolecular 
and enzymatic mechanisms. 
As fast as the substrate can diffuse onto the active site it is processed by the 
enzyme before the next molecule of substrate appears. The cfficiency of 
acetylcholine is truly remarkable and not necessary surprisingly, for it is 
involved in the propagation of nerve impulses at synaptic junctions: a process for 
which the utmost speed is needed. 
Enzymes are also highly selective in the reactions that they catalyse and they 
need to be. Typically a biological cell may contain several hundred different 
chemical compounds, however the enzyme is required to selectively process only 
one of these and specifically carry out only one reaction pathway upon this. 
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1.1.4 Transition State Stabilisation 
A crucial property of a catalyst is its ability to reduce the activation energy of a 
reaction through stabilisation of its transition state. Enzymes do the same 
although the situation is somewhat more complicated since there are usually 
several transition states in an enzymatic transformation. Another aspect is the 
enzymes ability to bind to the substrate. This can be viewed as aiding the 
reaction by holding the substrate in the enzyme's 'active site', encouraging the 
formation of the transition state to occur, before the substrate diffuses away 
again. However, it is not actually advantageous for the enzyme to bind its 
substrate too tightly. Tim Bugg has rationalised this in an interesting manner, 3 
by examining the free energy curves for a hypothetical enzyme-catalysed 
reaction proceeding via a single rate determining transition state, shown in 
Figure 1.4. 
Assuming it was possible to alter the enzyme E in a manner that it bound the 
substrate S or the transition state more tightly, and in each case the starting free 
energy of (E + S) was the same. In the presence of high substrate concentrations 
the enzyme would in practice be fully saturated, so the activation energy for the 
reaction would be governed by the energy difference between the ES complex 
and the transition state. In Fig. 1.4b the enzyme is able to bind both the substrate 
and the transition state more tightly (and hence lower their free energy equally). 
This, however, leads to no change in the activation energy, and hence no change 
in the rate acceleration. In Fig. 1.4c the enzyme binds only the substrate more 
tightly which generates a 'thermodynamic pit' for the ES complex and hence 
increases the activation energy, so the reaction is slower. However, if, as in Fig. 
7 
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1.4d the enzyme can selectively bind the transition state, then it can reduce the 
activation energy and hence increase the reaction rate. 
(b) Enzyme binds S& TS more tightly 
E E 
(c) Enzyme binds S more tightly (d) Enzyme binds TS more tightly 
t 
E 
ES 
E 
Figure 1.4. Transition state stabilisation and substrate binding. 
The conclusion of this analysis is that in order to achieve optimal catalysis, 
enzymes are required to selectively bind the transition state, rather than the 
substrate and it can be clearly seen it is not advantageous for enzymes to bind 
their substrates too tightly. 
8 
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1.1.5 Enzyme Mmics 
For an excellent source of information discussing enzyme mechanisms, models 
and mimics please refer to Anthony Kirby's review. 6 The following is a brief 
description to discuss some of the properties an enzyme mimic requires to be 
justified, followed by a very brief description of some systems that have been 
investigated. 
Enzyme mimics catalyse reactions by mechanisms that are demonstrably 
enzyme-like. The minimum requirement is that the reactions concerned should 
involve an initial binding interaction between the substrate and the catalyst. This 
gives rise to Michaelis-Menten kinetics and the reactivity is measured in terms of 
the familiar parameters k,,. t and Km. Real enzymes are more than just highly 
evolved catalysts: they also recognise and respond to molecules other than their 
specific substrate and product, as part of the control mechanism of the cell. The 
evolution of artificial enzymes is at a more primitive stage, with efficient 
catalysis the primary objective. Systems are known that model various other 
functions, such as potential control mechanisms. However, to be useful as an 
industrial catalyst, for example, an artificial enzyme does not need sophisticated 
built-in feedback control or high substrate specificity 
A major problem encountered by enzyme mimics studied to date has proven to 
be product inhibition where the transition state has been stabilised but so too has 
the product. This inevitably leads to product inhibition and a loss of product 
turnover. The following are some examples of enzyme mimic systems. 
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1.1.5.1 Cyclodextrins 
Cyclodextrins consist of a hydrophobic cavity lined with CH groups and 
glycosidic oxygen atoms, and carry an array of hydroxyl groups on both rims 
(Scheme 1.1). The full structural formula 1 can be represented in the simpler 
form 2, often showing only the single functional group of interest 3. 
Hio 
t 60 
HHO HO 0 ou, 
HOA. 
OH 
OH 
HO 
OH 
2 
7 O]F" 
HOPH 
3 
HO 
Scheme 1.1. Schematic representation of cyclodextrins. 
As can be seen the structure is slightly more open on the side of the secondary 
OH groups. This, plus some steric hindrance by the primary 6-CH20H groups 
on the other face, makes the face more accessible to hydrophobic guests which 
can bind in the cavity if they are of the right size. 6 
Urunodified cyclodextrins are themselves good functional enzyme mimics 
(Scheme 1.2) where their secondary OH groups, with pKa values in the range 
12-12.5, can be efficiently involved in nucleophilic attack towards, for example, 
nitrophenyl esters. The nucleophilic reaction is inefficient forp-substituted 
benzene derivatives 4 due to the ester group being held in the central axis of the 
cyclodextrin upon tight binding of the substrate. This holds the ester group too 
10 
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far from the secondary OH groups, however, if general base catalysis begins to 
compete, a true catalytic system is realised. i. e. The catalytic group is unchanged 
and immediately available for further reaction. The nucleophilic mechanism on 
the other hand, which is favoured for aryl acetates with substituents, in the meta 
position 5 of the aromatic ring, gives the acylated cyclodextrin 6 as the initial 
product. However, quite often the intermediate ester is more stable than the 
original substrate and the subsequent hydrolysis becomes rate limiting. Product 
inhibition in not over come as the product is still bound. The problem is 
typically resolved by using an excess of cyclodextrin but then the observed 
'catalysis' does not involve turnover. 
-"Ölý- OR 
0 
11ýk 
07 
45 
OH 
Scheme 1.2. Unmodified cyclodextrins. 
Cyclodextrin catalysis can be improved by modifying the OH functional groups, 
for example with imidazole. 7 The substrate can also be modified through the 
-use of ferrocene to efficiently bind the cavity. 8-10 Another interesting approach 
to improving the cyclodextrin system is to form dimers through a covalent 
linkage 7 which is itself included in the catalytic cycle (Scheme 1.3). The Cu+ 
complex is an efficient catalyst for the hydrolysis of the adamantanyl ester which 
was problematic for the cyclodextrin monomer because the ester was bound in 
11 
Introduction 
the wrong orientation. This time the system achieves turnover because the 
bifunctional binding of the substrate is sufficiently stronger than the two halves 
produced upon the intramolecular ester cleavage, so that product inhibition is 
avoided. 
7 
Scheme 1.3. Cyclodextrin dimer tethered together via a covalent linkage. 
1.1.5.2 Synthetic Hosts 
The previous section was concerned with the use of a model to effect the 
cleavage of a particular bond. Another area of interest is designing systems 
which will a) bring two substrates into close proximity which allows them to 
react with each other (and would ideally catalyse this reaction too), b) bind 
single substrates and then react with them. 
a) An example of a synthetic host behaving as a matchmaker is that of the 
porphyrin host 8 (Scheme 1.4). The porphyrin trimer binds symmetrical di- and 
tri-pyridyl systems very strongly and the substituted monomeric pyridines well 
enough to accelerate the Diels-Alder reaction between suitable guests when they 
are bound inside the cavity. The binding also controls the stereochernistry of the 
12 
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reaction well enough to reverse the normal kinetic selectivity, so that the exo 
adduct is produced up to 1000 times faster than the corresponding endo isomer. 
Unfortunately the product also binds strongly, eliminating turnover and hence 
catalysis. 
Scheme 1.4. Porphyrin synthetic host 8. 
b) An example of a synthetic host used to form a new covalent bond after first 
binding and reacting with the substrate itself is 9 (Scheme 1.5). Devised by 
Koga el al., II (which is a simpler dithiol that can be used to synthesise peptide 
bonds)] 2 this was based on earlier work which had shown that crown ethers bind 
the ammonium group of amino acid derivatives, and that bound activated esters 
will acylate groups like SH attached to the crown. Loading 9 With first one and 
then a second (x-amino acid (as thioesters) allows intramolecular aminolysis and 
the formation of the dipeptide, as the thioester. 
13 
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COOH 
OMe 
ý10---) 
SH 
0 
0 
SH 0 
COOH 
9 
Scheme 1.5. A synthetic host which can be used to synthesise dipeptides. 
1.1.5.3 Catalytic Antibodies 
Catalytic antibodies 13 or abzymes are currently the most successful enzyme 
mimics, though they too fall far short of enzymes in terms of catalytic efficiency. 
They are proteins raised in a biological system specifically against transition 
state analogues (haptens) for the reaction of interest. Consequently, the 
problems of design and synthesis involve in principle only small molecules on a 
scale familiar to the organic chemist. Under the right conditions the immune 
system responds to the transition state analogue by producing vast numbers of 
antibodies that recognise and bind to it - literally an exercise in the molecular 
recognition of transition states. The primary limitations are the accuracy of the 
hapten as a model for the transition state and the effectiveness of screening the 
large numbers of antibodies produced for catalysis. 
Though their specificity and potential regio- and enantioselectivities are good, 
current catalytic antibodies are not much more efficient than other enzyme 
mimics. They have proved quite good at catalysing certain reactions, like the 
hydrolysis ofp-nitrophenyl esters and have been reported to catalyse the 
14 
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hydrolysis of benzyl 14 and other alkyl esters. 15 Catalysis of the hydrolysis of 
activated esters is rather reliably obtained with suitable, usually phosphonate 
haptens which model the structure of the tetrahedral transition states involved. 
Again this methodology can suffer product inhibition where by the product binds 
to the antibody after formation and thus inhibits turnover. A strategy against this 
is to design the reaction so that the product structure is distinctly geometrically 
different from its transition state (Scheme 1.6). 
cl 0 0, "P 
Cl 
S02+ NEt ---- 
S, cl 
0 -S02 
4t 
cl cl 
cl 00 
10 
cl 0 
Ns 
cl 
NEt 0 COOH 
D 
C, cl 
Cl 00 
12 13 
Scheme 1.6. An approach of using a hapten to generate a catalytic antibody. 
Thus Hilvert's antibody catalysing the Diels-Alder reaction of 
tetrachlorothiophene dioxide 10 and N-ethylmaleimide achieves turnover 
because the initial adduct 11 rapidly loses S02 to give the bicyclic product 12.16 
Catalysis results simply from productive binding. The hapten 13 is a reasonable 
transition state analogue but geometrically very different from the final product. 
15 
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1.1.6 Serine Proteases 
Serine proteases are a class defined by the presence of a uniquely reactive serine 
side chain. 5,17 They hydrolyse the same type of substrate, namely polypeptide 
chains of proteins, however, different members of the family preferentially 
cleave polypeptide chains at sites adjacent to different amino acid residues. This 
is illustrated by considering the enzymes chymotrypsin, trypsin and elastase who 
have very similar three dimensional structures but different specificity (Figure 
1.5). Chymotrypsin preferentially cleaves adjacent to bulky aromatic side 
chains, trypsin to positively charged side chains and elastase to small uncharged 
side chains. 
0, , 
) 
!II ýý F1 
I 
Figure 1.5. All of the above four examples have very similar structures except 
subtilisin. They are all highly efficient serine protease enzymes. 
16 
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Subtilisin is another serine protease and despite having a completely different 
three dimensional structure to the examples above, its active site is remarkably 
similar. Interestingly, much of our understanding of basic enzymology comes 
from studies on the senne proteases, notably on chymotrypsin and trypsin, 
because of their ready isolation in large quantities from pancreases from 
slaughter houses. However, subtilisin been pushed to the fore of investigation 
owing to its lack of disulfide crosslinks, meaning its handling is far easier, and 
its commercial use in soap powders has meant it has been readily available. It is 
obtainable in high yields from E. coli allowing production on the ton scale. 
As mentioned above serine proteases are a class defined by the presence of a 
uniquely reactive serine side chain. The unique reactivity comes from the 
interaction of the side chains of three groups, aspartic acid, histidine and serine 
commonly referred to as the 'charge relay system' or 'reactive triad' 17 (Scheme 
1.7). 
1 
", %ä 
R 
Co 
-%' 2 
Or 
30 -01 (>ýi- (1 peptide sequence containing the peptide sequence containing the 
triad of three functional groups tri ad of three functional groups 
commonlv found in svnthetic esterases] commoniv found in svnthetic esi 
Scheme 1.7. Aspartic acid's interaction with histidine, whose subsequent 
interaction with serine, creates a serine residue which is highly nucleophilic. 
OH2 
17 
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For subtilisin these refer to the units 32,64 and 221 respectively (Figure 1.6). 
They are held in a favourable spatial configuration and orientation by the rest of 
the enzyme's massive structural architecture, resulting in the activation and 
increase in nucleophilic strength of the serine hydroxy side chain by the negative 
charge on the carboxylate via the histidine. Hydrolysis of the serine substrate 
ester bond by water regenerates the enzyme and the hydrolysed substrate. 
Figure 1.6. Subtilisin with its reactive triad of aspartic acid-32, histidine-64 and 
senne-22 1, indicated. 
A recent detailed discussion of the reactive triad's discovery and elucidation can 
be found in chapter sixteen of Alan Fersht's latest excellent text. 5 The 
importance of the oxyanion binding site with regard to the stabilisation of the 
carbonyl-tetrahedral intermediate is mentioned and the controversy around 
whether the reactive triad operates as described above or whether the mechanism 
is justified via a low-barrier hydrogen bond. 
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1.1.7 Synthetic Esterases 
An interesting paper was published in 1993 by Atassi and Manshouri 18 who 
claimed that an artificial enzyme system did attain catalytic efficiency that 
rivalled that of natural enzymes. 'Pepzymes' consisting of small 29 residue 
peptides, one of which had been designed by surface-simulation synthesis to 
mimic the active site of (x-chymotrypsin and cyclised by a disulfide bond, was 
reported to hydrolyse the simple trypsin substrate N-tosyl-L-arginine methyl 
ester with catalytic efficiencies comparable to a-chymotrypsin. Not surprisingly, 
this claim generated a great deal of scepticism and excitement, and was later 
challenged by other groups. 19,20 The specific reasons as to why this was no 
surprise, were summarised by Matthews et al. 20 and the review of Anthony 
Kirby has explained the difficulties involved in designing and realising artificial 
enzymes. 
In view of these difficulties we wished to design a model to probe whether small 
linear peptides incorporating the 'reactive triad' of serine proteases could be used 
to hydrolyse ester bonds. The design is shown in Scheme 1.8. 
Polymer Combinatorial 
Linker series of a-amino support 
)-GE)d 
acid residues 
Combinatorial. I --Z 
series of (x-aimno 
[-CASPARTIC 
du A acid resi ues ACID 
SERINE 
Combinatorial 
series of cc-amino 
acid residues 
I 
Combinatorial 
series of ce-amino 
acid residues 
IRSTIDINE 
Scheme 1.8. The reactive triad incorporated within small linear peptides. 
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The peptides, bound on a suitable polymer support, could be synthesised so that 
each of the main components of the reactive triad would be present and 
combinatorially spaced apart with a range of other naturally occurring amino 
acids. This would create a combinatorial library with a large range of potentially 
active protein sequences. Hopefully a particular sequence would hold its 
reactive triad in the just the correct spatial configuration and orientation 
necessary to yield an effective synthetic serine esterase. 
Several problems are immediately evident in designing such a system even if a 
particular sequence were to show the activity desired. One of which includes the 
elucidation of active sequences. This was taken into consideration by deciding 
to rely on intramolecular cleavage of the ester concerned, whereby one side of 
the ester would be tethered to the terminal end of the peptide and the other 
covalently linked to a dye [such as the highly active red azo dye, disperse red], 
(Scheme 1.9). 
acid 
Polyme KINLIM VI 
Ifighly 
Potentially active protein seq 11 1c colored support in ga dye 
I 
Upon hydrolysis of the ester bond, the 
highly coloured dye would be lost 
Scheme 1.9. Should a peptide sequence show activity, then the ester would be 
cleaved via intramolecular hydrolysis, and the highly coloured dye would be 
released. 
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This method is again shown in Scheme 1.10. Under the combinatorial 
conditions, each individual bead would be loaded with only one particular 
peptide sequence. The peptides would be tethered to the ester through a linker, 
the ester would be covalently linked to the dye and all the sequences available 
would be represented several times throughout the bead mixture. Therefore, 
upon analysing a mixture of the coloured beads under various conditions, a 
sequence showing activity would cleave its ester bond via intramolecular 
hydrolysis, giving a distinct colour loss. The most active sequences would then 
be indicated by the beads showing the least amount of colour within the bead 
mixture. 
I )\ 
Sequence X is inactive and no 
colourloss is observed 
D% 
I )N C- 
Sequence Y is highly active and 
total colourloss is observed 
Scheme 1.10. Within the bead mixture a single bead would only support one 
particular sequence. Only active sequences would show colour loss. 
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In this situation a labile linker would need to be incorporated between the 
support and peptide sequence. The decoloured beads could then be hand picked 
from the bulk, their peptides cleaved from the support and the sequences 
deduced by Edman Degradation and mass spectrometry. - 
1.1.8 Summary of The Results Presented in This Thesis 
Using this visual technique we envisaged it would be possible to analyse a large 
number of peptide systems very quickly. This would be highly desirable when 
changing parameters such as peptide length and incorporating the use of 
synthetically designed amino acids alongside the twenty naturally occurring 
amino acids, which would potentially create a large variety of peptide libraries. 
If particular peptides did prove to be active then, having ascertained their 
sequences, it would then be necessary to synthesise them on a larger scale in 
order to establish, for example, if they were exerting catalysis, which functional 
groups of the peptides were responsible, how substrate specific they were and 
whether they would be capable of catalysing other reactions. 
In order to develop the methodology needed to synthesise such a system, we 
initially used a model utilising only one peptide sequence (Figure 1.7). This was 
chosen from literature precedent'21 and the entirety of the research performed to 
date, has been on this. The peptide of choice was a modified version of the 
sixteen unit sequence, Lys-Ala-Ala-Ala-Glu-His-Lys-Ala-Ala-His-Glu-Leu-Glu- 
Asp-Pro-Asp-NH. Jacqueline Barton previously developed a system where the 
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above peptide was covalently linked to a rhodium intercalator, which had been 
shown to bind DNA. The peptide had been designed to have a high degree of a- 
helicity within its structure by incorporating a glutamate - lysine salt bridge and 
use of space filling alanines. The two histidines were assumed to create a zinc 
co-ordination site on one side of the cc-helix and Jacqueline Barton proposed the 
rhodium intercalator would bring the peptide into close proximity to the DNA 
and effect its hydrolysis in the presence of zinc. Indeed, successful hydrolysis 
was observed. We decided to use the same peptide sequence but change one of 
the histidine residues to create the reactive triad within a similar geometrical 
environment. This gave the new sequence, Lys-Ala-Ala-Ala-Glu-Ser-Lys-Ala- 
Ala-His-Glu-Leu-Glu-Asp-Pro-Asp-NE. 
The peptide was synthesised by conventional manual solid-phase methods using 
an Fmoc strategy on Tentagel resin, 10% of which, not shown in the figure 
below, was loaded with an acid labile Rink linker. The linker was incorporated 
to allow partial cleavage of the peptide and any subsequent derivatives during 
the acidic deprotection stage of the peptide, giving an opportunity for analysis by 
mass spectrometry. The synthesis of the peptide is discussed in more detail in 
the next chapter. 
Another potential problem that could be envisaged for the system below was that 
the ester group, being hydrolysed intramolecularly, needs to reach the active 
serine residue. To overcome this a variety of different lengthed glycol linkers 
tethering the ester to the peptide were incorporated. Two different ester groups 
were also initially used to allow even more flexibility and as can be seen the 
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highly red coloured azo dye, disperse red, was covalently linked to the other side 
of the ester. This gave ten individual systems which we could subject to various 
pH ranges, co-solvents, and additives to allow the optimum hydrolysis conditions 
to be evaluated. 
An important property of enzymes is their ability to induce a high level of 
enantioselective control. Once our system was successfully synthesised and a 
variety of conditions to effect hydrolysis had been examined, we found that only 
one of the two esters (n = 2) afforded reasonable hydrolysis and the optimum 
linker length was five glycol units long. Using these parameters we decided to 
investigate if our system was capable of inducing any enantioselective control. 
This was undertaken by incorporating a racemic chiral centre on the carbon alpha 
to the ester carbonyl to give the system shown in Figure 1.8. Subsequent 
cleavage of the ester group and analysis via chiral BPLC was envisaged to 
clearly indicate if any enantioselective control was afforded during the 
hydrolysis. UnfortunatelY, the addition of the methyl group alpha to the ester's 
carbonyl eliminated any hydrolysis previously observed in all conditions except 
one, where the amount of material released was too low for analysis via chiral 
IHPLC. We rationalised the lack of the new systems activity could have been due 
to the methyl group providing too much steric hindrance near the ester, 
preventing nucleophilic attack at its carbonyl. The extra steric hindrance might 
have also altered the geometry of the peptide as it came closer to effect the 
hydrolysis, causing it to become deactivated. 
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Although the addition of the chiral centre did remove most of the activity 
previously experienced, we had been able to show these systems were capable of 
showing hydrolysis where the linker length and choice of ester were important. 
A brief investigation was also undertaken to examine if the peptide was capable 
of intermolecular hydrolysis of ap-nitrophenyl ester. Indeed, under the correct 
conditions hydrolysis was found to occur only in the presence of the supported 
peptide and this is discussed in more detail in the next chapter. 
The methodology to build the above systems has now been developed and we 
envisage improvements can be made to enhance their capability. This will be 
necessary because although hydrolysis of the ester and subsequent release of dye 
was observed, it was never possible to observe a bead losing all of its colour 
(unless harsh conditions such as basic hydrolysis were used, which were unlikely 
to involve the reactive triad). Areas of development would include the polymer 
support. Initially tentagel was used because it had desirable swelling properties 
and was readily available. However, a support such as PEGA gel might be more 
suitable as it has a higher degree of permeability towards macromolecules, such 
as peptides. Other areas would also include screening the ester to find if the 
structure can be modified to increase the hydrolysis observed, and further 
investigation undertaken to deduce if the serine residue was directly involved in 
the intermolecular hydrolysis of the p-nitrophenyl ester. 
Once the initial methodology has been optimised, then the screening of similar 
peptides and eventually a variety of peptide libraries, can be undertaken. 
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1.2 Vancomycin 
1.2.1 Antibiotics 
The observation that the mould of Penicillium notatum killed cultures of the 
bacterium Staphylococcus aureus, by Alexander Fleming in 1929, is well known 
and documented in general biological texts. 22 Fleming eventually grew'the' 
fungus in a liquid medium and, after separating the fluid from the cells, 
discovered that the cell free liquid was an inhibitor of many bacterial species. 
He called the active ingredient penicillin and this marked the discovery of 
antibiotics (substances produced by microorganisms that can kill or prevent the 
growth of other microorganisms). About ten years later Howard Florey and 
Ernst Chain successfully isolated and purified penicillin, and after being 
launched as a product in the early 1940s, it was soon saving lives from diseases 
such as pneumonia. 
However, antibiotic resistance has developed. Resistance can take several forms 
where bacteria can alter the drug's target, prevent the drug from reaching the 
target by mechanisms such as efflux pumps or destroy or modify the drug so that 
it cannot bind to its target. This can occur when bacteria genetically mutate or 
acquire resistance genes from other bacteria, which can trade genetic material on 
pieces of DNA called plasmids. Misuse of antibiotics has generally contributed 
to the increase in resistance where for example antibiotics are prescribed for viral 
infections even though they do not kill viruses, or patients often fail to take all 
the antibiotic that has been prescribed. In these instances the most susceptible 
bacteria are killed but the more resistant strains survive. With less competition, 
the resistant bacteria have a more favourable environment in which to thrive, a 
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process known as selective pressure. A large amount of the antibiotics produced 
(possibly as much as 50%) are also fed to animals and fish, and sprayed on fruit 
trees. There is concern that antibiotic-resistant infections in humans may arise 
through foodborne illnesses caused by resistant bacteria or by the migration of 
resistance mechanisms between animal and human pathogens. It was estimated 
in the early 1990s that the unrecognised yearly cost of antibiotic resistance was 
$100 million and recently strains of glycopeptide-intermediate S. aureus (GISA) 
have shown reduced susceptibility towards vancomycin (the antibiotic of last 
resort). Fortunately the GISA strains have currently been susceptible to other 
antibiotics, although methicillin-resistant S. aureus bacteria are a concern due to 
their resistance to all antibiotics other than vancomycin. Encouragingly, a move 
to save essential antibiotics for human use is under way, for Rep. Sherrod Brown 
introduced a bill in the United States House of Representatives in November 
1999 that would prohibit the use of essential antibiotics in livestock "unless there 
is a reasonable certainty of no harm to human health.,, 23 
1.2.2 The Bacterial Peptidoglycan Layer 
A detailed text by Bugg24 provides an excellent review of the bacterial 
peptidoglycan, its biosynthesis and its inhibition. Bacteria generally fall into two 
main classes depending on whether their cell surfaces can be stained with a 
reagent discovered by Gram in 1884, namely Gram-positive and Gram-negative. 
The cell wall of almost all bacterial cells contain a peptidoglycan layer whose 
primary function is to strengthen the cell wall, preventing lysis through turgor 
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pressure which arises from a higher osmotic pressure inside the cell than outside. 
Gram-positive bacterial cell walls contain a thick outer layer of peptidoglycan 
(approximately 20-80 nm) which reacts strongly with Gram's reagent. Grain- 
negative bacterial cell walls are more complicated and possess an outer 
membrane which surrounds a thin peptidoglycan layer (approximately 2-3 nm) 
which limits the staining (Figure 1.9). 
Wall associated 
pfolein - 
Tchýc acd 
L-pote. choic 
ac. d 
Peptidoglycan 
cyloplas-c 
Gram-positive bacteria] cell wall. 
Gram-negative bacterial cell wall. 
Figure 1.9. Gram-positive cell walls have a thick outer layer of peptidoglycan. 
Gram-negative cell walls have a thinner peptidoglycan layer encompassed with 
an outer membrane. 
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The structure of the peptidoglycan consists of three main components: 
disaccharide strands, pentapeptide chains and peptide cross-links (Figure 1.10). 
The glycan strands are generally made up of a P-1,44inked chain of alternating 
N-acetylglucosamine and N-acetylmuramic acid residues, to which pentapeptide 
side chains are attached to the lactyl ether appendage of N-acetylmuramic acid. 
The pentapeptide chain contains D-amino acids that are unique to bacterial 
peptidoglycan. The most common structure is L-Ala-y-D-Glu-X-D-Ala-D-Ala, 
where X is an L-amino acid containing an amino side chain, commonly L-lysine 
or meso-diaminopimelic acid (meso-DAP (m-DAP)). The site where the cross 
linkage occurs is through this amino acid to another peptide strand in mature 
peptidoglycan. Transpeptidation results in the formation of an amide bond 
between the amino group of X with the carbonyl group of position 4 of the 
second peptide chain, and loss of the terminal D-alanine of the second peptide 
chain. 
MurNAc 
/4 MurNAc 
GlcNAc D Glu 
/, 
AI Ia MurNAc 
I GIcIVAC D-Glu a 
m DA 
MurNAc II GIcNAc D-Glu 
D-Ala m-DAP 
Ia MýýAc 
I /Ia 
Mla m-DAP D-Ala Mur7NYAC I GlcXAc D1 
/4 
a D-Ala yu 
GlcNAC yll 
/I 
m-D Dyu GICN. Ac 1 
p JJTU glycan chain 
Aft 
m-D Dfa I 
D-AI: a m-DAP D-Ala I r-=: > peptide cross-link D-Ala 
Figure 1.10. Generalised structure of mature peptidoglycan. 
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This eventually gives rise to the strong peptidoglycan structure, however it 
should be noted that the pentapeptide chain has some unique features, one of 
which is the presence of the D-amino acids which provide an avenue for selective 
inhibition of peptidoglycan. biosynthesis. 
1.2.3 Inhibition 
During growth and division, the cell wall changes shape and size which requires 
the regulation of the peptidoglycan layer through a process which continuously 
breaks it down and rebuilds it. Certain enzymes, called autolysins, restructure or 
reshape the cell wall by breaking bonds in the peptidoglycan layer whilst others 
are responsible for the peptidoglycan biosynthesis. The latter enzymes are 
referred to as penicillin-binding proteins (PBPs) and it is to these proteins that 
penicillin covalently and irreversibly binds. PBPs are responsible for the 
biosynthetic cross-linking between the pentapeptide chains. Therefore, in this 
instance, the P-lactarn antibiotic penicillin kills bacterial cells by inhibiting the 
enzymes which strengthen the peptidoglycan layer, whilst not effecting the 
enzymes which weaken it. The peptidoglycan layer eventually becomes weaker 
through a lack of pentapeptide cross linkage and the cell suffers lysis. 
Vancomycin also kills bacterial cells by restricting the peptidoglycan's ability to 
form the cross-linkages between its pentapeptides. However, instead of 
inhibiting enzymes, vancomycin binds very strongly to the D-Ala-D-Ala portion 
of the pentapeptide and physically blocks the possibility of cross linkage. 
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1.2.4 Vancomycin Structure 
Vancomycin was first isolated in 195625 from Streptomyces orientalis and its 
structure solved 25 years later. 26-29 Its defining feature is a linear heptapeptide 
backbone where the side chains of five amino acids are linked together to hold 
the peptide in a rigid conformation giving a cup-shaped architecture. The cavity 
created by this has a high binding affinity towards D-Ala-D-Ala, which is 
stabilised by a series of five hydrogen bonds (Figure 1.11). 
0=H 0- / 
0 
ýY N 
0 0 
NH2 
Figure 1.11. Left; indication of the hydrogen bonding between N-acyl-L-Lys-D- 
Ala-D-Ala and vancomycin. Right; a theoretical model of this complex. 2 
However, the cavity is also highly guest-specific. For example vancomycin's 
binding affinity to, di-N-acetyl-i, -LYS-D-Ala-D-Ser is a factor of 20 weaker than 
that of di-N-acetyl-L-Lys-D-Ala-D-Ala3O and the binding affinity for N-acyl-D- 
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Ala-r, -Lac compared to N-acyl-D-Ala-D-Ala is a factor of 1000 less. 
31 These 
particular models, along with others, were devised to investigate the binding 
affinities towards pentapeptide variations observed within the peptidoglycan 
layer of resistant bacteria. Strains of bacteria whose pentapeptide have evolved 
from L-Ala-D-GIU-L-LyS-D-Ala-D-Ala to L-Ala-D-GIU-L-Lys-D-Ala-r)-Lac are 
particularly resistant to vancomycin32 (Figure 1.12). 
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Figure 1.12. Modifications within bacteria] peptidoglycan which increase 
vancomycin resistance. 
1.2.5 Modifications to Increase Vancomycin Activity 
Two approaches have been taken to enhance activity of glycopeptide antibiotics 
such as vancomycin or teicoplanin through synthetic modifications and these 
have been reviewed. 33 The first is the modification of sites that do not directly 
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impinge on the binding cavity. These include removal or substitution of sugars, 
the modification of accessible functional groups such as the carboxy group of 
amino acid 7, certain N-terminal modifications and derivation of hydroxy 
groups. In this instance two examples of successful approaches to improved 
antimicrobial activity without direct alteration of the binding site, have been 
reported. These are: a) N-alkyl modifications of the amino sugars of a 
vancomycin-related glycopeptide and b) the modification of the terminal 
carboxyl by amide derivatisation of teicoplanin and related glycopeptides, 
affording improved potency towards both Gram-positive and in some instances 
Gram-negative bacterial activity. 
The second is to modify within the binding regions where a direct effect on 
binding might be expected. 
Another approach, originally developed from a study of non-covalent 
interactions, stemmed from the ability of glycopeptide antibiotics (except 
teicoplanin) to form back-to-back and head-to-tail homodimers. Williams et 
al. 34-36 demonstrated that glycopeptide dimerisation could be highly favourable 
and co-operative with the binding of peptide ligands. It has been proposed this 
could be due to two reasons. 37 The first appears to be motional restriction of the 
glycopeptide. For the monomer, when the amide functional groups of the 
glycopeptide backbone are hydrogen bonded to water, they would probably have 
more motional freedom than when hydrogen bonded to each other as in the 
dimer. The ordering of the amide functional groups should promote ligand 
binding since the magnitude of hydrogen bond fluctuations at the ligand- 
glycopeptide interface would be reduced. Secondly, the ring 6 amino sugar, 
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where present, is proposed to form an ammonium ion-amide carbonyl hydrogen 
bond in the dimer, to residue 2 of the complementary subunit (Figure 1.13). This 
may polarise the NH proton of this residue 2-3 amide linkage so that it forms a 
stronger hydrogen bond to the ligand carboxylate ion in a complex. This implies 
that for the ligand bound dimer, the alkylammonium ion of the amino sugar on 
residue 6 of the antibiotic is able to form an indirect salt bridge to the 
carboxylate anion of the bacterial cell wall analogue, mediated through the 
polarisable amide bond which connects residues 2 and 3 of the antibiotic. 
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Figure 1.13. Hydrogen bonding interactions shown within back-to-back ligand 
bound dimers. 
Vancomycin itself only weakly self-associates in solution, suggesting that 
dimerisation may not play a significant role in its biological action. For this 
reason Griffin and Sundran synthesised covalently linked dimers of vancomycin 
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to examine how their molecular and antibacterial properties would be affected. 38 
Indeed certain dimers were shown to display enhanced in-vitro potency against 
strains of enterococci which exhibited high-level resistance to vancomycin and 
other glycopeptides and these studies were also substantiated with tripeptide 
ligand binding studies. However, these dimers were covalently linked through 
flexible linkers that were too short to allow interactions between the vancomycin 
sub-units in the back-to-back, head-to-tail orientations. Rather the head-to-head 
orientation was favoured. Therefore it was envisaged that different types of 
divalent interactions with ligands in the bacterial wall were occurring. This 
evidence has been an incentive for the development of numerous synthetic 
covalent dimers of vancomycin. For example: 
Whitesides et al. 39 synthesised dimers by covalently linking the carbonyl 
termini of two vancomycins with a rigid p-xylenediamine. A corresponding 
dimeric derivative Of L-Lys-D-Ala-D-Lac was designed and it was shown that 
dimeric vancomycin bound to the L-Lys-D-Ala-D-Lac dimer ligand approximately 
40 times more tightly than vancomycin. The dimeric vancomycin also showed 
comparable activity towards vancomycin-susceptible bacterial strains normally 
achieved with vancomycin but substantially higher activity against vancomycin- 
resistant strains. Whitesides et al 40 have recently shown that a high affinity 
exists between a vancomycin trimer and an analogous trivalent derivative Of D- 
Ala-D-Ala. 
A polymer of vancomycin was synthesised via a ring opening metathesis 
polymerisation and this was shown to exhibit an enhanced of antibacterial 
activity against vancomycin resistant enterocci. 41 
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Williams and Heck42 showed the presence of heterodimers in one-to-one 
mixtures of antibiotics by detection with elecrospray ionisation mass 
spectrometry (ESI-MS) and these were confirmed to exist in aqueous solution 
using NMR spectroscopy. In the instance of a mixture of eremomycin and 
chloroeremomycin, the ion signal due to the heterodimer was the most intense 
observed. However, investigations undertaken to determine the minimum 
inhibitory concentrations (NUCs) of one-to-one mixtures of antibiotics indicated 
that heterodimer formation did not give a significant improvement in biological 
activity relative to the pure antibiotics. 
1.2.6 Screening a Combinatorial Range of Covalently Linked Vancomycin 
Dimers, For Activity via Mass Spectrometry 
In view of the evidence that it was possible to increase vancomycin activity by 
forming covalently linked dimers, we wanted to design a model to investigate the 
effect of combinatorially varying the linkers length towards their activity 
(Scheme 1.11). We envisaged that vancomycin monomers synthetically 
modified at the carboxy group of amino acid 7 with glycol linkers of varying 
lengths attached through an amide bond, bearing a terminal double bond, could 
be combinatorially coupled via Grubbs metathesis (Figure 1.14). 
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As described above, previous studies with vancomycin and vancomycin dimers 
have been shown to bind di and tripeptide models designed to mimic the terminal 
of the pentapeptide found in the peptidoglycan layer of bacteria. Albert Heck 
has designed an ESI-MS technique which is mild enough to analyse the 
vancomycin-tripeptide bound species. 43,44 Shown in Figure 1.15, this could be 
a useful technique for analysing a library of different vancomycin substrates and 
dimers. When the library is submitted to the tripeptide, and no binding occurred 
then a mass spectrum only indicating the presence of the unbound vancomycin 
derivative would be observed. If all the different vancomycin derivatives bound 
to the tripeptide and with an equal affinity, then a second mass spectrum 
indicating the presence of all the vancomycin derivatives and all the 
vancomycin-tripeptide bound species, would be obtained. However, if only one 
vancomycin derivative selectively bound the tripeptide, then that vancomycin 
derivative would be seen to disappear from the mass spectrum, whereas a 
corresponding new peak attributable to that vancomycin-tripeptide species, 
would clearly become present. 
This would allow the quick elucidation of 'likely candidates' from a 
combinatorial library of vancomycin derivatives. To date we have shown the 
vancomycin monomers and homo-dimers from our initial models can be 
analysed by the ESI-MS technique and invitro experiments are currently being 
undertaken to verify these, before the combinatorial library is synthesised. 
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Figure 1.15. A vancomycin derivative's ability to bind the tripeptide model can 
be investigated by analysing its increase in mass. 
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2 Results and Discussion 
2.1 Synthetic Esterase 
2.1.1 Initial Development of The Dye-Linker System 
A major component of the model we wished to develop in order to probe 
whether small linear peptides could be used to hydrolyse ester bonds, was the 
"dye-linkee' system. The refined dye-linker system is shown in Figure 1.7, 
(previous chapter). Initially, however, a simpler dye-linker 14 was chosen to 
allow the synthetic methodology to be firmly established (Scheme 2.1). 
Chiral center A 
HO,,, -., O, o%%ý ýO 
0 
Chiral ýenter B N-, 
N 
Disconnections 14 
CI 
N02 
Scheme 2.1. The original dye-linker 14 was designed to allow the addition of 
chiral centers at positions A and B. 
The original dye-linker 14 contained a short ethoxy-propoxy chain 15 coupled 
through 4-hydroxyl phenyl acetic acid to the highly coloured red azo dye, 
disperse red (Scheme 2.2). The retrosynthetic disconnections employed for the 
synthesis of the original dye-linker are shown in Schemes 2.1 and 2.2. Two 
positions of interest were A and B, where chiral centers could be introduced at a 
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later stage to allow the investigation of potential enantioselective control 
delivered by active synthetic esterases. It was envisaged that a chiral center at 
position A could be introduced whilst synthesising the ethoxy-propoxy chain 15 
via asymmetric hydroboration, and oxidative work up of various analogues (R' 
alkyl, aryl, halide). A chiral center at position B could be introduced via 
asymmetric analogues of methyl 4-hydroxyphenyl acetate (R = alkyl, aryl, 
halide). 
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methyl 4-hydroxyphenyl acetate, R=H 
Nk 
N Ar 
cl 
disperse red 13 
N02 
Rl I 
HO,,, o---,, 0 ýýýOH ==* protection"eoN"*O'ý00"%%%, 
^R1 
Rl =H, 15 
ON.,. ý A protection'*ý OH + Br'ooN'Oýý'ýRl 
Scheme 2.2. Retrosynthetic starting materials of the original dye-linker 14. 
The first stage of the synthesis of dye-linker 14 involved coupling disperse red to 
methyl 4-hydroxyphenyl acetate (Scheme 2.3). The hydroxy group of disperse 
red was converted into a good leaving group by conversion to firstlýits 
tosylate45 16 and secondly, to its mesylate46 17. It was hoped direct 
nucleophilic displacement of either of these groups by the hydroxyphenyl of 
r 
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methyl 4-hydroxyphenyl acetate would form the protected methyl ester 18. 
Unfortunately, the tosylate and mesylate derivatives of disperse red proved to be 
unstable to the anhydrous basic conditions employed to effect nucleophilic 
displacement, and the product was never formed. 
(a) '0ýN""'ýO-ISFAý\ ý/ 
, -N,,.,, OH I 1'00ýN Ar 16 
Ir 
(b) 0 
disperse red 11 -me N "**"O'o - IS, 
'L 17 
Me ýr IC: ý 
18 
(a) Disperse red (I eq), p-toluene sulfonyl chloride (2.2 eq), triethylamine (3 eq), dichloromedme, room 
temperature, 8 hours, 74%. (b) Disperse red (I eq), methane sulphonyl chloride (2.2 eq), triethylamine (3 
eq), dichloromcthane, room tcmpcrature, 6 hours, 80%. (c) 16 or 17 (1 eq), 4-hydroxyphenylacetic acid (I. I 
eq), base (1.2 eq), tetrahydrofiiran, room temperature. 
Scheme 2.3. Nucleophilic displacement of either disperse red tosylate 16 or 
mesylate 17 resulted in a complex mixture of polar compounds, under basic 
conditions. 
Several bases were investigated and these included potassium carbonate, sodium 
hydride, potassium hydridc and tert-butyl lithium. When tert-butyl lithium was 
employed, TLC indicated the disperse red derivatives were quickly converted to 
a complex mixture of polar compounds. The other bases afforded the same 
45 
4-hydroxyphenyl 
acetic acid 
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complex mixture of polar compounds, but took several hours. The 1H nuclear 
magnetic resonance (NMR) of the crude reaction mixture was complicated and 
the presence of product was not indicated. The difficulty of achieving the 
nucleophilic displacement was surprising and could have been accountable to the 
leaving group being beta to the tert-amine in disperse red (Scheme 2.4). Initial 
formation of an aziridonium ring could cause polymerisation of the disperse red 
giving rise to a complicated mixture of polar products. 
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0,00, ý N 
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I_ 
O=s io- NOý ll 0 
Scheme 2.4. Formation of an aziridoniurn ion via P-elimination could have 
given polymerisation. 
Another attempt to form a similar analogue to 18 was undertaken. Methyl 4- 
hydroxyphenyl acetate was converted to 19 upon nucleophilic displacement with 
1,3-dibromopropane in reasonable yield (Scheme 2.5). Displacement of the 
bromide of 19, by disperse red under anhydrous basic conditions, was attempted. 
Although a complex mixture of polar compounds was not observed, regrettably 
after 48 hours no conversion to 20 was observed. 
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(a) Mcthyl 4-hydroxyphenyl acetate (I eq), 1,3-dibromopropane (2 eq), sodium hydride (I eq), 
tctrahydrofuran 12 hours, 42%. (b) Disperse red (I eq), 19 (1.2 cq), base (1.2 eq), tetrahydrofuran, room 
ternpcrature, 12 hours. 
Scheme 2.5. Disperse red was found to be stable to the anhydrous basic 
conditions, however nucleophilic displacement of the bromide did not occur. 
Having found that disperse red did not readily effect nucleophilic displacement 
of the bromide of 19, and its derivatives 16 and 17 were unstable to the 
anhydrous basic conditions, a different approach utilising reductive arnination 
with sodium cyanoborohydride was investigated. Sodium cyanoborohydride is a 
useful reagent for achieving reductive amination47 because it readily reduces 
carbonyl compounds at pH 3-4 whereas it quickly reduces iminium ions at pH 6- 
8 (Scheme 2.6). 
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sodium cyanoborohydride. 
RO'0ý11 --N- 
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However, once the iminium. 
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R, N -, %. R2 
ion has formed, it is readily R"'ýýH 
reduced to the amine. 
Scheme 2.6. Reductive amination via sodium cyanoborohydride 
To effect the coupling of disperse red to methyl 4-aminophenyl acetate via 
reductive amination to give 21, the procedure shown in Scheme 2.7 was 
proposed. However this required the alcohol function of disperse red to be 
oxidised to the aldehyde. 
0 
NH2 
H 
N methyl 4-aminophenyl 0 +ýýNoo"ý 
acetate (a) II Me 
rý y 
Ar + 10. 
Aý4ýtý I 
lo""ýN 10'"Y 
1 
Ar H 
the aldehyde of 
disperse red 
(b) 
t 
H 
Me,,, 
0 21 
Af 
(a) Formation of the iminiurn ion in tevahydrofuran. (b) Reduction by sodium cyanoborohydride. 
Scheme 2.7. Coupling via reductive amination. 
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However, the oxidation of disperse red was problematic and a second derivative, 
23 bearing a propoxy chain, was investigated simultaneouslY (Scheme 2.8). 
"'-"N -,,.., OH 
Ar (a) disperse red 
+ Ar 22 
allyl bromide 
(b) 
Ir 23 
(a) Disperse red (1.0 eq), allyl bromide (1.2 eq), sodium hydride (1.0 eq), cesium carbonate (catalytic), 
tetrahydrofuran, room temperature, 4 hours, 97%. (b) 22 (1.0 4, borane methylsulfide (3.0 eq), toluene, 
room temperature, 3 hours. Methanol (excess), hydrogen peroxide (2.0 cq), sodium hydroxide (2.5 eq), 
room temperature, 2 hours, 40%. 
Scheme 2.8. The primary alcohol function of disperse red was extended through 
a propoxy chain. 
The alcohol function was extended by allylation of disperse red to give 22, 
followed by hydroboration with borane dimethyl sulfide48 and oxidative work 
up with hydrogen peroxide and sodium hydroxide to give 23. Previously it had 
not been possible to displace the bromide of 19 by disperse red and it was also 
difficult to displace the bromide of allyl bromide. Favourable conditions 
involved the use of the dipolar aprotic solvent dimethylfonnamide to encourage 
nucleophilic attack, with sodium hydride as base giving a moderate yield of 67% 
over a period of 18 hours. 
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However, the protocol was later improved by the addition of cesium carbonate, 
giving full conversion within I hour where the yield was improved to 97%. 
Cesium carbonate is known to aid the esterification of protected amino acids by 
alkyl halides in dimethylformamide49 and the di-cesium salts of catechol and 
resorcinol are also reported to be superior to other alkali metal salts in the 
reaction with dibromoethers in dimethylformamide, to give crown ethers. 50 
Disperse red and 23 were subjected to Swern5 1, tetra-n-propylammonium 
perruthenate (TPAP)52,53 and pyridinium dichromate (PDC)54 oxidative 
conditions (Scheme 2.9). Regrettably, no conversion to of either disperse red or 
23 was observed during the Swern oxidation conditions. Crude 1H NMR 
revealed only the presence of starting material. 
TPAP was initially used in catalytic amounts with 4-methylmorpholine N-oxide 
(NMO) which was the standard oxidising agent required to regenerate T? AP 
during its catalytic cycle. In both instances only partial immediate conversion 
was observed giving no further conversion after several hours. TPAP was also 
investigated on a smaller scale to see if a reasonable conversion could be 
achieved using a stoichiometric amount of reagent. Full conversion to a complex 
mixture of polar compounds was observed within I hour. However, TLC (ethyl 
acetate: hexane, 1: 4) did not reveal the presence of the product and the 1H NMR 
of the crude reaction mixture was complicated. 
50 
Results and Discussion 
The PDC oxidative reactions were undertaken using dichloromethane as solvent. 
It is known from the literature precedent54 that PDC converts primary alcohols 
to their corresponding aldehydes in aprotic solvents. However, if further 
oxidation to the carboxylic were desired, then a more-polar solvent such as 
dimethylformamide was advised. Again no conversion for either starting 
material was observed for several hours. However, when the oxidation of 
disperse red was heated to 40*C, full conversion to a new product within 20 
minutes occurred and the solution changed its colour from dark red to light 
orange. Unfortunately the 'H NMR of the crude reaction mixture revealed the 
oxidative conditions had cleaved the ethyl group from the tert-nitrogen of the 
dye. 
-------- 
(a) 
....... No conversion 
"0""' N Swern oxidation 
Ar 
diperse red 13 
(b) 
No conversion under catalytic 
................. 
conditions. Many side 
T? AP oxidation 
products aquired under 
stoichiometric conditions. 
N'00'ý 0 NO"*Ný OH 
22 (c) No conversion at room 
................. temperature. Unwanted 
-0-J, PDC oxidation cleavage occurred at 
40'C. 
(a) Alcoholic substrate (I. Oeq), oxalyl chloride (1.1 eq), dizncthyl sulfoxide(I. 1 eq), triethylaraine(I. 5 eq), 
tetrahydrofuran, -780C to room temperature, 10 hours. (b) Alcoholic substrate (1.0 cq), TPAP, NMO (I. I 
eq), molecular sieves, tetrahydrofuran, room temperature, 10 hours. (c) Alcoholic substrate (1.0 eq), PDC 
(1.1 eq), dichloromediane, room tempcraturc. 
Scheme 2.9. Attempted oxidation of disperse red and 22 via Swern, TPAP and 
PDC oxidation. 
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Disperse red was proving to be difficult to manipulate so a Mitsunobu alkylation 
was considered. The Nfitsunobu reaction55-57 follows an SN2 mechanism and is 
quite often applied in natural product synthesis to convert a chiral secondary 
alcohol into an ester via Mitsunobu esterification, with concomitant inversion of 
configuration at the secondary carbon center. Subsequent hydrolysis of the ester 
yields the original alcohol but as the opposite enantiomer (Scheme 2.10). 
OH 
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Rl'o'ýO 
DEAD, PPh3 0 
)ý 
R hydrolysis OH + 
""R 
0 Rl 
R"OY 
HO 
)ý 
R 
Scheme2.10. Mitsunobuesterification. 
The Mitsunobu alkylation between disperse red and methyl 4-hydroxyphenyl 
acetate, is shown in Scheme 2.11. Initially the formation of the disperse red 
dimer predominated the overall reaction, therefore the reagents order of addition 
was investigated. It was known that it was possible to control the Mitsunobu 
reaction to a greater degree by allowing the phosphoniurn ion to form before the 
final addition of one of the starting materials. In this instance, it was, found that 
if the reaction was performed in toluene at 80*C and disperse red was added last 
after stirring the other reagents at 80"C for 10 minutes, full conversion to the 
product in reasonable yield could be achieved within 30 minutes. 
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(a) Disperse red (1.0 eq), methyl 4-hydroxyphenyl acetate (2.0 eq), diethyl azodicarboxylate (DEAD) (2.0 
eq), triphenylphosphine (PPh3) (2.0 eq), toluene, 800C, 58%. (b) 18 (1.0 eq), lithium hydroxide (2.0 eq), 
water: tcuahydrofuran, 1: 15,45 OC, 30 minutcs, 79%. 
Scheme 2.11. Mitsunobu alkylation between disperse red and methyl 4- 
hydroxyphenyl acetate. 
Once 18 had been formed, the methyl ester was saponified using lithium 
hydroxide in wet tetrahydrofuran58 to give 24 in 79% yield. 
The next stage towards the synthesis of the original dye-linker 14 was formation 
of the benzyl protected linker 27 (Scheme 2.12). Compound 27 was synthesised 
from ethylene glycol by mono-benzylation, allylation and hydroboration with an 
oxidative workup. To avoid double protection, ethylene glycol was used as the 
solvent in large excess with sodium hydroxide as the base. The mono- 
benzylation was afforded by quenching the mono-sodium salt of ethylene glycol 
with benzylbromide at 90*C for 3 hours to give 25 in 61% yield. Allylationof 
the other teffninal alcohol was then performed in tetrahydrofuran with anhydrous 
basic conditions and allyl bromide to give 26 in reasonable yield. The 
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hydroboration was undertaken with borane dimethyl sulfide in toluene, and an 
oxidative work up with hydrogen peroxide in the presence of sodium hydroxide 
gave 27 in 45 % yield. 
OH 0, ^,,., OH HO'^ý I Ilk 
(b) 
I 
(a) 00ý 0"ý 
ethylene 
00 
25 14 26 
glycol 
0 (e) 
4. - 1, 
-, 0 
14 27 
(a) Ethylene glycol (8 eq), sodium hydroxide (I eq), molecular sieves, benzylbromide (I eq), 9011C, 3 hours, 
61%. (b) 25 (1.0 eq), sodium hydride (1.1 eq), allyl bromide (1.2 eq), tetrahydrofuran, room temperature, 4 
hours, 78%. (c) 26 (1.0 eq), borane methyl sulfide (1.0 eq), room temperature 3 hours, methanol, hydrogen 
peroxide (1.2 eq), sodium hydroxide (2.5 eq), room temperature, 2 hours, 45%, 
Scheme 2.12. The synthesis of the mono-benzylated linker 27. 
Coupling the mono-protected linker 27 to the acid derivative 24 of disperse red, 
was performed by forming the acid chloride of 24 via oxalyl chloride59 in 
toluene, and then addition of 27 (Scheme 2.13). 
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(a) 24 (1.0 eq), oxalyl chloride (1.0 eq), &nethylformamidc (catalytic), toluene, room temperature, 4 hours, 
fidl conversiom (b) 27 (1.0 4, triethylamine (2 cq), toluene, room temMatme, 4 hours, 3 1%. 
Scheme 2.13. Formation of 29 via the acid chloride of 24. 
The formation of the acid chloride could be monitored by observing the 
disappearance of 24 which was only sparingly soluble in toluene, and the 
evolution of carbon dioxide. The reaction was also followed by infra red 
spectroscopy; the carbonyl of the acid appeared at 1695 cm" and the carbonyl of 
the acid chloride appeared at 1765 cm". The formation of the acid chloride was 
also catalysed by the addition of dimethy1formamide (3 drops) and took about 2 
hours. Unfortunately the yield of 29 via the acid chloride, was only 31% due to 
the formation of an unknown complex polar mixture. Therefore a second route 
to synthesise 29, utilising the Mitsunobu alkylation, was investigated and a 
higher yield of 58% was achieved in which the dimerisation of disperse red was 
a minor competing reaction. Again the order of reagent addition was important 
and the acid derivative of disperse red 24, had to be added last. The reaction was 
performed at room temperature and full conversion was achieved within I hour. 
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The final stage of the synthesis of the original dye-linker 14, was the removal of, 
the benzyl group (Scheme 2.14). This was performed by catalytic hydrogenation 
in the presence of (5 mol%) palladium on activated carbon. Unfortunately the 
dye-linker exhibited complete colour loss within 2 minutes. This was probably 
due to the reduction of the azo component which we had hoped would have been 
stabilised sufficiently via delocalisation. It might have been possible to apply a 
milder reducing system to effect selective deprotection of the benzyl group in the 
presence of the azo component, such as transfer hydrogenation. However, we 
rationalised that this might not have been a productive strategy and a different 
protecting group was sought. 
Ar 
29 
Ar 
00 
14 
(a) 29 (1.0 cq), palladium on activated carbon (5 mol*/o), methanol, room temperature, complete colour loss 
within 5 minutes. 
Scheme 2.14. Removal of the benzyl protection by hydrogenation gave 
reduction of the azo component of the dye. 
The second protecting group of choice was trialkylsilyl protection. 60 The tert- 
butyldimethylsilyl (TBS) group6l was chosen in preference to triisopropylsilyl 
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(TIPS) and tert-butyldiphenylsilyl (TBDPS) groups because it was more labile to 
deprotection conditions whilst still stable to flash column chromatography. 
Initially the synthesis of the TBS protected linker 33 shown in Scheme 2.15, was 
performed by allylation of ethylene glycol. The glycol was again used as the 
solvent in a large excess to avoid bis-allylation with sodium hydroxide as the 
base. Surprisingly a low yield of 2-allyloxyethanol 30 was obtained and the 
major product was the bis-allyl glycol. This was also observed during the 
synthesis of mono-allyl glycol substrates for vancomycin derivatives. It appears 
the mono-allyl products are more reactive to subsequent allylation than ethylene 
glycol. However, silylation of 2-allYloxyethanol 30 with tert- butyl dimethyl 
silyl chloride gave 31 in a reasonable yield of 80%. 
Me 
Ho, ^, _, 
OH 
(a) (b) 
I 
- HO 
S, 
ethylene Me 
glycol 30 31 
Me 
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Me 
33 
(a) Ethylene glycol (5.0 eq), sodium hydroxide (1.0 eq), molecular sieves, 900C, 3 hours, allyl bromide (1.0 
cq), 900C, 6 hours, 391/9. (b) 30 (1.0 eq), TBSCI (1.5 eq), imidazole (1.5 eq), dichloromethane, room 
temperature, 3 hours, 80%. (c) 31 (1.0 eq), borane dimethyl sulfide (1.0 eq), toluene, OOC, 30 minutes, 
methanol, hydrogen peroxide (2.0 eq), sodium hydroxide (2.5 eq), room tempaature, 8 hours, 41 I/o. 
Scheme 2.15. Synthesis of the tert- butyldimethylsilyl protected linker 33. 
In view of this, mono-silylation62 of ethylene glycol with TBSCI was 
undertaken. A5 fold excess of ethylene glycol in dimethylforinamide was used 
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with imidazole as base, and mono-silylated ethylene glycol 32 was obtained in a 
reasonable yield of 74% (Scheme 2.16). Subsequent allylation of 32 with allyl 
bromide was not undertaken at this stage as a large amount of 2-allyloxyethanol 
30 had already been synthesised. 31 was then subjected to hydroboration with 
borane dimethyl sulfide in toluene followed by an oxidative work up with 
sodium hydroxide to yield the TBS protected linker 33, with a terminal hydroxy 
function. 
Me Me 
, ^,, _, 
OH II 
HO (a) *, I 1ý0, -, ý, 
OH (b) * S, 
ethylene Me Me 
glycol 32 31 
Me 
(c) 
Me 
33 
(a) Ethylene glycol (5.0 eq), TBSCI (1.0 eq), iniidazole (2.0 eq), dimcthylformamide, room temperature, 12 
hours, 741/o. (b) Allylation with allyl bromide under anhydrous basic conditions. (c) Hydroboration with 
borane dimethyl sulfide followed by an oxidative work up with hydrogen peroxide. 
Scheme 2.16. Plausible contingency should silylation be undertaken before 
allylation. 
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The coupling of 33 to 24 via Mitsunobu alkylation was then investigated and 
again it was found it was favourable to add the acid derivative of disperse red 24 
last, although at a different temperature of 50*C (Scheme 2.17). The reaction 
mixture was stiffed at this temperature for 5 hours and then at room temperature 
for two days. This afforded 34 in an excellent yield of 83% on a relatively large 
scale of 6 g. 
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MI et 
34 
(a) 33 (1.0 eq), DEAD (1.0 Clq), PPh3 (1.0 eq), 24 (0.67 cq), tolucne, 50"C 5 hours, room tempcrature 2 
days, 83%. 
Scheme 2.17. Coupling the silyl protected linker 33 to the acid derivative of 
disperse red 24 via Mitsunobu alkylation. 
The final deprotection of 34 was initially performed using TBAF in 
tetrahydrofuran. 61 On a small scale a low yield of 34% was realised however, 
unfortunately on a larger scale the yield was very low, 9%, and a complex 
mixture of polar compounds was formed. This may be due to 34 being unstable 
to the basic conditions of TBAF although it was shown previously that disperse 
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red itself was relatively stable to these conditions. In view of this we decided to 
effect the silyl deprotection with aqueous hydrogen fluoride (HF) in acetonitrile 
at room temperature. 63,64 Complete conversion was observed within 90 
minutes to give the unprotected dye-linker 14 in a reasonable yield of 92% 
(Scheme 2.18). 
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(a) 34 (1.0 eq), TBAF. 3H20 (1.1 eq), tetrahydrofuran, 400C, 2 hours, 34%. (b) 34 (1.0 eq), 40*/o aqueous 
HF (5.0 eq), acetonitrile, room temperature, 90 minutes, 92% 
Scheme 2.18. Silyl deprotection was cleanly afforded with aqueous HE 
2.1.2 Polymer Support 
A variety of polymer supports were commercially available and physical 
properties in which we were interested included, the polymer's ability to swell in 
a range of solvents, the level of loading and resistance to abrasion.. The choice of 
polymer support also depended on one of two general strategies for synthesising 
peptides on polymer support. These were the 9-fluorcnylmethoxycarbonyl 
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(Fmoc) and tert- butoxycarbonyl (Boc) N-a-methods which will be discussed in 
more detail below. The Fmoc strategy was eventually chosen because it was a 
milder and more reliable method. There was also a significantly larger range of 
polymer supports available for the Fmoc method than the Boc strategy. 
Merrifield resin65 was the'original resin developed for solid phase peptide' 
synthesis (SPPS) and consists of polystyrene beads functionalised with 
chloromethyl groups onto which the first amino acid of the peptide is attached 
(Figure 2.1). This resin is used to synthesise peptides via the Boc strategy. 
Three resins that have been developed to increase the level of loading that can be 
achieved on a bead, and increase their swelling abilities to a varietý of solvents 
allowing active sites to be less hindered to reagents, are: Tentagel, Kieselguhr 
and PEGA gel resins. 66-68 
(D-0--o'cl 
Merrified resin. Polystyrene beads 
functionalised with chloromethyl groups 
Figure 2.1. Merrifield resin, 
Tentagel resin67 consists of hydroxyethyl polystyrene beads onto which 
polyethylene glycol (PEG) chains of molecular weight 3000 - 4000 Da, have 
been grafted (Scheme 2.19). Tle long PEG chains give Tentagel the favourable 
physicochemical properties of being able to swell in a wide range of solvents 
from toluene to water, a high loading and improved chemical efficiency. 
Tentagel also has a reasonable resistance to mechanical abrasion. 
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Kieselguhr resins also have excellent swelling capabilities due to their high 
permeability to macromolecules. However Kieselguhr resin suffers attrition in 
stiffed reactions and is more suitable for use in packed beds. 
PEGA resins shown in Scheme 2.19, consist of 2-acrylamidoprop-1-yl-(2- 
aminoprop-1-yl) polyethylene glycol8oo and dimethylacylamide cross linked with 
bis 2-acrylamidoprop-1-yl polyethylene glycol8oo. These supports swell 
extensively in a wide range of solvents and are freely permeable to 
macromolecules up to 35 KDa, making them well suited for the preparation of 
peptide libraries and on-resin enzyme assays. 
In view of this we decided to use the cheaper Tentagel resin as it had the physical 
properties we required and the systems to be investigated were relatively small 
(-1-2kDa). The average loading of a Tentagel resin was 0.15 - 0.30 mmol/g 
and the average bead size 90 AM. 
oO( 
Tentagel 
NH2 
Scheme 2.19. Tentagel and PEGA resin both utilise long ethylene glycol chains. 
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2.1.3 Attaching Disperse Red and Dye-Linker 14 to Tentagel 
After choosing to manually synthesise our sixteen unit peptide, we decided it 
would be prudent to investigate whether it was possible to directly attach 
disperse red or the original dye-linker 14 to the same polymer support. 'If 
difficulties were experienced during simpler coupling to the polymer support, 
undertaking the same coupling technique to attach the dye-linker to the terminal 
end of a large and sterically hindered supported peptide, might also be difficult. 
We also wished to investigate if any physical staining of the resin occurred. The 
synthetic route chosen involved functionalising the free arnino group of Tentagel 
resin with 4-hydroxyphenylacetic acid to give 35 and then coupling disperse red 
and the dye-linker 14 via Mitsunobu alkylation (Scheme 2.20). Tentagel resin 
was readily functionalised with 4-hydroxyphenylacetic acid in 
dimethylformamide and full conversion was observed within I hour at room 
temperature. The coupling agent PyBOP, will be discussed in more detail 
below. The method of analysing the conversion via the Kaiser test, will also be 
discussed below. 
After the Tentagel resin functionality had been changed from a free amino to a 
free hydroxyphenyl group 35, it was found that the best conditions to couple 
both disperse red and the dye-linker 14, were tetrahydrofuran as solvent at room 
temperature in the presence of triethylamine which had been shown by Richter et 
al. 69 to assist Mitsunobu reactions on polymer resins. It was also shown that it 
was important to use a concentrated reaction mixture and to stir the resin 
carefully to avoid the beads from disintegrating. Relying on diffusion only gave 
partial coupling to surfaces of resin readily exposed to the solution. Upon a high 
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level of loading the beads were converted from a pale yellow coloration to an 
extremely dark red, when solvated. in methanol, and jet black when dry. 
To investigate the possibility of physical adsorption, the resin 35 was subjected 
to the same Mitsunobu alkylation reaction conditions except where one of the 
reagents, DEAD, was excluded. The resin did acquire a slight light red 
coloration, however this was easily removed by light washing in methanol to 
give a resin that had a very light pink colour. 
It was also demonstrated that no coupling occurred directly between amino 
functionalised Tentagel resin and the dye-linker under the optimum Mitsunobu 
alkylation conditions. Again a resin with a very light pink coloration was 
obtained. 
OH 
OH 
NH, + 
HO 
(a) 
Ztýkl 
IN 
4-hydroxyphenyl 
35 
Tentagel resin acetic acid Tentagel resin with 
(b) hydroxyphenyl functionality 
4 
0 
Ar 0 
36 
A high level of loading was achieved to give jet black 
beads 
(a) Tentagel (1.0 eq), 4-hydroxyphenylacetic acid (2.5 4, PyBOP (2.5 eq), HOBt (2.5 eq), DIPEA (5.0 eq), 
dimethylfonnamide, room temperature, 2 hours, Kaiser test negative. (b) 35 (1.0 eq), DEAD (2.0 eq), PPh3 
(2.0 eq), 14 (2.5 eq), triethylaminc (5.0 eq), tetrahydrofuran, room temperature, I hour. 
Scheme 2.20. Attaching the original dye-linker 14 to Tentagel. 
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2.1.4 Synthesis of The Sixteen Residue Peptide 
2.1.4.1 The Fmoc Strategy 
The SPPS involved the sequential addition of (x-amino acid and side chain 
protected cc-amino acid residues to an insoluble polymeric support. The two 
general strategies for applying SPPS required the use of the base-labile Fmoc 
group and acid-labile Boc group, for N-cc-protection. The Fmoc group and its 
removal are shown in Scheme 2.2 1. 
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(a) Tentagel (1.0 eq), (x-N-alanine Fmoc (2.5 eq), PyBOP (2.5 eq), HOBt (2.5 eq), DIPEA (5.0 eq), 
dimethylformamide, room temperature, 2 hours, Kaiser test negative. (b) Piperidinc. ditnethylformamide, 
1: 19, room temperature, 20 minutes, Kaiser test positive. 
Scheme 2.2 1. N-cc-Fmoc protection of an alanine, (x-arnino acid and it removal 
by piperidine. 
After removal of the protecting group, the next protected amino acid is added 
using either a coupling reagent or pre-activated protected amino acid derivative. 
The resulting peptide is attached to the resin via a linker, and may be cleaved to 
yield a peptide acid or amide, depending on the linking agent used. Side chain 
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protecting groups are often chosen so as to be cleaved simultaneously with 
detachment of the peptide from the resin. 
Cleavage of the Boc protecting group is achieved by trifluoroacetic acid (TFA) 
and the Fmoc protecting group by piperidine. With regard to the Boc strategy, 
final cleavage of the peptidyl resin and side chain deprotection requires acidic 
conditions, such as IHF or trifluoromethanesulfonic acid (TTMSA). For the 
Fmoc strategy, the final cleavage and deprotection is effected with trifluoroacetic 
acid (TFA). Dichloromethane and dimethylforrnamide are the routine solvents 
used for resin deprotection, coupling and washing. An advantage of the mild 
base process of Fmoc SPPS is repetitive TFA hydrolysis (as used in Boc-group 
deprotection) is avoided. The final cleavage and deprotection in the Boc strategy 
with BF is also potentially dangerous and requires expensive laboratory 
equipment. 
2.1.4.2 Coupling Reagents 
Carbodiimides have been some of the most popular in situ activating agents in 
peptide synthesis and an example is dicyclohexylcarbodiimide (DCC) which was 
first described in the 1950S. 70 DCC is an effective coupling agent and its 
activity can be increased by the addition of N-hydroxybenzotriazole (HOBt). 
However, a major drawback of DCC is that is it generates dicyclohexylurea, 
which is insoluble in DCM and can be a cause of contamination. 
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Several other coupling reagents have been designed, some of which are shown in 
Figure 2.2. The phosphoniurn and uronium. salts are commonly employed due to 
their ease of use and high efficiency of forming activated esters in the presence 
of HOBt7I and a tertiary base such as diisopropylethyl amine (DEPEA). Side 
reactions and epimerisation of chiral centers are also reduced. However, care 
should be taken when using benzotriazole-lyl-oxy-tris-(dimethylamino)- 
phosphoniurn hexafluorophosphate (Bop)72 as a side product is 
hexamethylphosphotriamide (HWA) which is thought to be a carcinogen. 
Benzotriazole-1-yl-oxy-tris-pyrrolidinophosphonium hexafluorophosphate 
(PyBOP)73 can be used in place of BOP without loss of performance. However, 
the uronium, salts 24N-benzotriazole- I -yl)- 1,1,3,3, -tetramethyluronium 
hexafluorophosphate (HBTU)74,75 and 2-(N-benzotriazole- I -yl)- 1,1,3,3, - 
tetramethyluronium. tetrafluoroborate (TBTU) can be troublesome if used in an 
excess to the amino acid, since capping of the amino terminal end can occur 
through guanidine formation. The phosphoniurn coupling reagents, with the 
exception of bromo-tris-pyrrolidino-phosphonium hexafluorophosphate 
(PyBrop)76 in dimethylformamide, do not give rise to such by-products. 
However, PyBroP is particularly useful for the coupling of N-methyl amino 
acids which can be a difficult and slow process. PyBroP allows efficient, fast 
and enantiomerisation free coupling. 
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Figure 2.2. Six common coupling reagents used during SPPS. 
In view that PyBOP was an efficient coupling reagent whereas BOP was a 
possible source of a carcinogen, the uronium. salts could be problematic if used 
in excess and that PyBroP was expensive, PyBOP was the coupling reagent 
chosen to synthesise the sixteen residue peptide. 
2.1.4.3 The Linker and Amino Acid Protection Groups 
As discussed in the previous chapter we wished to use a polymer support of 
which 10% contained an acid labile linker77 before the peptide. This would 
allow 
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10% of the peptide to be cleaved from the support during deprotection of the 
peptide thus giving a means for analysis via mass spectrometry. An extensive 
range of resins based on the acid labile Rink amide linker78 for the production of 
peptide amides by Fmoc synthesis were commercially available. This included 
Tentagel which was supplied with the Rink amide linker attached, but 
unprotected allowing its direct use alongside the normal Tentagel resin. The 
structure of the supported Rink amide linker and its mechanism of cleavage are 
shown in Scheme 2.22. 
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Scheme 2.22. Acid catalysed cleavage of the Rink linker. 
Other supported linkers were available such as Rink acid resin and 2- 
chlorotrity1chloride resin (Figure 2.3). However, these linkers were highly labile 
to acid and designed to be cleaved in conditions mild enough not to affect 
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deprotection of the peptide's arnino acid side chains. This allows a possible 
route for the synthesis of a peptide that is still protected. 
OH 0 
O"me 
Rink acid resin 
2-Chlorotrityl resin 
cl 
Figure 2.3. Two supported linkers that are highly acid labile are Rink acid resin 
and 2-Chlorotrityl resin. 
Choosing the amino acid derivatives with suitable side chain protection for the 
peptide synthesis, can only be done once the Fmoc or Boc strategies have been 
decided. Fortunately there were a wide variety of amino acid derivatives with 
suitable side chain protection commercially available. Some amino acids such as 
alanine whose side chain was simply a methyl group, did not need protection. 
However others, such as histidine, could readily suffer from epimerisation and 
the choice of protecting group was more important. The peptide sequence, HO- 
Lys-Ala-Ala-Ala-Glu-Ser-Lys-Ala-Ala-His-Glu-Leu-Glu-Asp-Pro-Asp-NH-NH2 
that we wished to synthesise, contained five amino acids which needed side 
chain protection. These and the protecting groups for the side chains selected on 
the basis of known stability and deprotection protocol, were: 
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a) tert-Butyl for aspartic acid, glutamic acid and serine. 
b) tert-Butyl carbarnate for lysine. 
c) Trityl for histidine. 
During the removal of a-amino acid side chain protection and cleavage of the 
Rink linker, reactive cationic species are generated which can react with residues 
which contain nucleophilic groups. To prevent this, scavengers are employed to 
react with these ions. A scavenger used in the Fmoc strategy is 
triisopropylsilane (TIS) , which is known to be a hydride source in TFA79 and 
this was used below. 
2.1.4.4 Resin Tests 
A widely used qualitative test for the presence or absence of free amino groups 
during coupling and deprotection, was devised by Kaiser. 80,81 The test 
involves 3 different solutions: ninhydrin dissolved in ethanol, phenol dissolved 
in ethanol and potassium cyanide dissolved in pyridine. The test is simple, quick 
and similar to a normal ninhydrin test where a free amine reacts with the 
ninhydrin upon heating. A blue solution and a resin that is also stained blue, is 
obtained if an amine is present. The phenol is present to help swell the resin and 
the potassium cyanide is present to sensitise the test The procedure involves 
subjecting a few milligrams of the resin in a test tube, to 3 drops of each solution 
and the green suspension is heated for 2-3 minutes at 80*C in a water bath. Any 
colour changes are recorded. An intermediate Kaiser test is indicated by the 
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solution remaining a green colour (no colour change) but the resin is dyed red 
when viewed under a microscope. A negative Kaiser test is indicated when both 
the solution and resin remain the same colour. 
Although the Kaiser test is general, it should be noted that some deprotected 
amino acids do not always show a positive test. Examples of this are serine, 
asparagine, aspartic acid and the secondary amino acid proline. Strongly 
aggregated sequences can also give false negative tests. Therefore, it is 
important to be careful when assessing the extent of deprotection. 
Other resin tests available include 2,4,6-trinitrobenzenesulfonic acid (TNBS) and 
p-chloroanil where p-chloroanil is recommended for proline. The two tests are 
described below-, 
TNBS resin test. A few milligrams of resin are suspended in dimethylformamide 
to which three drops of diisopropylethyl amine (DIPEA): dimethylforinamide, 
1: 9 and three drops of TNBS: dimethylformamide, 1: 99 are added. The 
suspension is left to stand at room temperature for 5 minutes after which the 
resin is washed with dimethylformamide. A positive test (indicating the 
presence of free amino groups) is indicated by the resin being stained red. 
However, if this test is required to prove a coupling stage has gone to completion 
(a negative test is required), it is important not to apply heat as the Fmoc 
protecting group can be cleaved. Subsequently a false positive test will result. 
p-Chloroanil test. A few milligrams of resin are suspended in 
dimethylformamide (0.5 ml) to which three drops of 
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acetaldehyde: dimethylformatnide, 1: 49 and three drops ofp- 
chloroanil: dimethylformamide, 1: 49 are added. The suspension is allowed to 
stand at room temperature for 10 minutes after which time a positive test 
(indicating the presence of free secondary amino groups) is indicated by the resin 
being stained blue. 
2.1.4.5 SPPS Reaction Vessel 
The simple peptide vessel shown in Figure 2.4 was constructed from a sintered 
glass funnel. It has a three way teflon tap at the bottom and a B24 ground glass 
joint at the top which could be connected to a nitrogen bubbler. Agitation of the 
reaction mixture within the peptide vessel was achieved by gently passing 
nitrogen through the sinter via the three way tap. The rate of nitrogen flow was 
observed by use of the nitrogen bubbler. After the reaction had gone to 
completion, the reaction solution could then be removed under reduced pressure 
via the three way tap. Washing the resin with various solvents was undertaken in 
the same manner which meant the resin was continuously contained within the 
peptide vessel. Small samples could be removed from the bulk with a long glass 
pasteur pipette. 
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Figure 2.4. The peptide reaction vessel. The reaction mixture could be 
subjected to a supply of nitrogen or reduced pressure via the three way tap. 
2.1.4.6 Synthesis of a Pentapeptide 
A short supported pentapeptide HO-Ala-Ala-Ala-Ala-Ala-NH2 was initially 
synthesised on Tentagel. in the peptide vessel to gain experience of using the 
reaction vessel and the general procedures needed to synthesise the larger sixteen 
residue peptide. Although the dye-linker had been shown to couple to Tentagel 
functionalised with 4-hydroxyphenylacetic acid via Nfitsunobu alkylation, we 
decided it would also be prudent to show the same could be done with the 
supported pentapeptide. 
The pentapeptide was sequentially synthesised with the Fmoc strategy (Fmoc-L- 
Ala-OH) on Tentagel. (I g) using the coupling regent HBTU and the Kaiser resin 
test (Scheme 2.23). 
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Scheme 2.23. Manual synthesis of a pentapeptide on Tentagel via the Fmoc 
strategy. 
Although each coupling stage took approximately 3 hours, the due to steric 
hindrance the last stage required double coupling. The Fmoc deprotection took 
approximately 20 minutes. After the supported pentapeptide 37 had been 
synthesised and its Fmoc protection removed to give a free terminal amino 
group, the pentapeptide was further functionallsed with 4-hydroxyphenylacetic 
acid in the same manner Tentagel gel itself had been previously to give the 
supported pentapeptide derivative 38. The dye-linker was then successfully 
coupled to this via Mitsunobu alkylation in the same manner previously 
undertaken for the functionalised Tentagel 35 to yield a dark red resin 39 when 
solvated. in methanol, and a jet black resin when dry (Scheme 2.24). 
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(a) 37 (1.0 eq), 4-hydroxyphenylacetic acid (2.5 eq), PyBOP (2.5 eq), HOBt (2.5 eq), DIPEA (5.0 eq), 
dimethylformainide, room temperature, 2 hours, Kaiser test negative. (b) 38 (1.0 eq), DEAD (2.0 eq), PPh3 
(2.0 eq), 14 (2.5 eq), triethylamine (5.0 eq), tetrahydrofuran, room temperature, I hour. 
Scheme 2.24. A high level of dye-linker loading was achieved giving a jet black 
resin. 
The supported pentapeptide derivative 38 was then subjected to the coupling 
conditions vAth the DEAD omitted to reveal the resin was stained a light pink 
colour after light washing with methanol and dimethylformamide. 
2.1.4.7 Synthesis of The Sixteen Residue Peptide 
In view of this we were confident it would be possible to attach the dye-linker 14 
to a derivative of the sixteen residue peptide which had been functionalised with 
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4-hydroxyphenylacetic acid via Mtsunobu alkylation- The sixteen unit peptide 
was synthesised using; 
" The Fmoc strategy. 
" Tentagel Rink resin: standard Tentagel resin, 1: 9 (2 g). 
" Coupling reagent PyBOP. 
" Tert-base DEPEA and additive HOBt. 
" Reaction solvent dimethylformamide. 
" Relevant protected amino acids described above. 
" Resin tests described above. 
It was found that after residue four, the coupling times increased from 3 hours to 
6 hours and after residue eight, from which point, double and triple coupling was 
required to achieve full conversion. This was due to the reactive terminal site of 
the peptide being sterically hindered as the peptide grew. After the last protected 
amino acid had been successfully coupled and its Fmoc protection removed, the 
bulk resin was thoroughly washed, dried under reduced pressure and stored 
under nitrogen to give a pale yellow resin 40 (Scheme 2.25). Note the peptides 
side chain protecting groups still remained. 
A small sample (200 mg) was then subjected to a TIS: TFA, 1: 99 solution. The 
reaction mixture was gently stirred using a magnetic stirrer bar for 2 hours after 
which time the resin supporting the fully deprotected peptide 41 was removed by 
filtration, thoroughly washed with dimethylformamide and methanol and dried 
under reduced pressure to give a pale yellow material. The filtrate was 
concentrated and then thoroughly dried under reduced pressure to give an off 
white powder 42 (5 mg) which was expected to contain the fully deprotected 
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peptide which had been cleaved from the resin upon cleavage of the acid labile 
Rink linker. 42 was analysed by high resolution tandem electrospray mass 
spectrometry at the EPSRC Swansea Mass Spectrometry Service. It was shown 
that the sixteen unit peptide was present and the crude material was free from 
shorter peptides. The terminal carboxylic acid group was also shown to have 
been converted to an amino group. This was expected to occur during cleavage 
of the Rink linker (Scheme 2.22). 
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Scheme 2.25.. Removal of side chain protection and partial cleavage from the 
support. 
2.1.5 Glycol Dye-Linkers 
An important part of the intramolecular synthetic esterase model was to use a 
range of dye-linkers With varying lengths and we envisaged that modifying the 
acid derivative of disperse red 24 with di - hexaethylene glycol units would 
achieve this. A second acid derivative of disperse red 45 was also synthesised 
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and modified with the glycol units (Scheme 2.25). The substrates were 
synthesised whilst acquiring the mass spectrometry analysis of the peptide, since 
this took several weeks to complete. 
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(a) 3-(4-hydroxyphenyl) propionic acid (1.0 cq), sulphuric acid (catalytic), methanol, reflux, 3 hours, 94%. 
(b) 43 (1.0 eq), DEAD (1.0 eq), PPh3 (1.0 eq), disperse red (0.9 eq), toluene, 80*C, 6 hours, 52%. (c) 44 
(1.0 eq), lithium hydroxide (1.5 cq), tetrahydrofuran, room temperature, 12 hours, 400C, 3 hours, 75%. (d) 
24 (1.0 eq), DEAD (1.5 eq), PPh3 (1.5 cq), glycol (1.5 eq), toluene, room temperature, 5 days, 68-81%: 45 
(1.0 eq), DEAD (1.5 eq), PPh3 (1.5 oq), glycol (1.5 eq), dichloromethane. 3 hours, 60-74%. 
Scheme 2.26. Synthesis of the second acid derivative of disperse red and the ten 
glycol dye-linkers. 
The second acid derivative of disperse red was initially synthesised from 3-(4- 
hydroxyphenyl) propionic acid. The carboxylic acid was protected by forming 
the methyl ester 43 by refluxing 3-(4-hydroxyphenyl) propionic acid, in 
methanol in the presence of acid for 3 hours. The methyl ester 43 was then 
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coupled to disperse red via Mitsunobu. alkylation as before, except a longer 
reaction time of 6 hours was required (ca. 30 minutes) to give 44 in a moderate 
yield of 52%. The Mitsunobu alkylation reactions were never optimised. and a 
major competing side product was formation of the corresponding dimer. 
_ 
Subsequent saponification with lithium hydroxide, gave the second acid 
derivative of disperse red 45 in a reasonable yield of 75%. 
Upon accumulating reasonable amounts of both disperse red derivatives 24 and 
45 the glycol units were individually coupled to give ten new dye-linkers, At 
this point we decided to abbreviate the dye-linkers to DLmn shown in Scheme 
2.26 and Table 2.1. 
Glycol unit, m Ester component, n Dye-linker, DLmn Product number 
2 1 DL21 46(81%) 
3 1 DL31 47(71%) 
4 1 DL41 48(73%) 
5 1 DL51 49(78%) 
6 1 DL61 50(68%) 
2 2 DL22 51(74%) 
3 2 DL32 52(69%) 
4 2 DL42 53(70%) 
5 2 DL52 54(66%) 
6 2 DL62 55(60%) 
Table 2.1. Nomenclature of the glycol dye-linkers. 
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Note DL21 - 1341 were synthesised via Mitsunobu alkylation in toluene and the 
reactions took 5 days to achieve full conversion giving yields within the range of 
68-81%. However, DL22 - DL62 were synthesised in dichloromethane and the 
reaction rate was dramatically increased; fidl conversion was achieved within 3 
hours, giving yields within the range of 60-74%. 
2.1.6 Attaching Dye-Linker DL52 to The Sixteen Residue Peptide, 
Having shown the peptide had been successfully synthesised we attempted to 
attach the glycol dye-linkers to the supported peptide (with side chain protecting 
groups) 40 via the methodology developed. The free amino group of the peptide 
was functionalised with 4-hydroxyphenylacetic acid to give 56 (Scheme 2.27). 
The glycol dye-linker used in the initial studies was DL52 as a relatively large 
amount of material was available. 
Upon subjecting 56 to the glycol dye-linker DL52 to the previous Mitsunobu 
conditions, a resin with a high level of loading affordingjet black beads was 
obtained within 10 minutes and the colour remained throughout washes with 
dimethylformamide, methanol, toluene, diethyl ether and ethyl acetate. This was 
very encouraging although it was surprising a high level of loading was achieved 
within 10 minutes for a system so sterically hinderecL Previous coupling with far 
less hindered systems had required a reaction time of approximately 2 hours. 
81 
Results and Discussion 
OH 
protected sixteen-"*L (a) j"O"% --- 
I 
_(protected 
sixteený 
rPe si 
NH, N 
X"'a 
C r( Ij 
res idue peptide j-%, If Lresidue peptide J-11 
+ 
40 56 
OH 
4-hydroxyphenyl 
acetic acid 
only a low level of dye-linker 
DL52, loading was achieved 
DYE-UNKER, DL52 
protected silxteeý ZLII N (]due 
peptiide H res 
C 
57 
(a) Supportod peptide 40 (1.0 eq), 4-hydroxyphenylacetic acid (2.5 eq), PyBOP (2-5 eq), HOBt (2.5 eq), 
DIPEA (5.0 eq), dimethylformamide, room temperature, 2 hours, Kaiser test negative. (b) 56 (1.0 eq), 
DEAD (2.0 eq), PPh3 (2.0 eq), 54 (2.5 eq), triethylamme (5.0 eq), tetrahydrofuran, room temperature, I 
hour. 
Scheme 2.27. Attaching the glycol dye-linkers to the sixteen residue peptide. 
However, when exposed to dichloromethane, it was suddenly discovered the 
colour began to rapidly leach away from the resin. The best solvent system to 
afford the colour loss was TFA: methanol: dichloromethane, 1: 10: 39. This was 
rather disappointing and it appeared that the glycol dye-linker was physically 
(rather than covalently) binding the peptide. It was clearly apparent the resin 
system was poorly solvated by diethyl ether and dichloromethane in which the 
resin colour would change from a deep red to jet black, the resin would appear to 
shrink in size and instead of being capable of moving freely in the solvent, would 
quickly rise to the surface and stick to edges of glassware. The difference 
between the two solvents (diethyl ether and dichloromethane) was that diethyl 
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ether poorly solvated the non-supported disperse red derivatives, whereas 
dichloromethane solvated the derivatives well. Hence it would appear that upon 
the addition of dichloromethane and following shrinking of the resin, that this 
solvent was capable of leaching the physically bound glycol dye-linkers from the 
resin. Diethyl ether, however, did not physically dissolve the glycol dye-linkers 
away from the shrunken resin. The previous systems 36 and 39 were subjected 
to the washes of dichloromethane and the solvent system 
TTA: methanol: dichloromethane, 1: 10: 3 9, but no further colour loss was 
observed. A range of conditions to optimise the chemical coupling of the glycol 
dye linker DL52 54 to the supported derivative of the peptide 56 were 
investigated, the results from which are shown in Table 2.2. 
Solvent Solvent Volume Colour of Resin 
Tetrahydrofuran 1.0 ml Light Red 
Tetrahydrofuran 0.5 ml Bright red 
Dichloromethane 1.0 ml Light Pink 
Dichloromethane 0.5 ml Light Pink 
Toluene 1.0 ml Light Pink 
Toluene 0.5 ml Light Pink 
Ethyl acetate 1.0 ml Light Pink 
Ethyl Acetate 0.5 ml Light Pink 
Table 2.2. Solvents and concentrations investigated in order to increase the level 
of loading. 
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Resin samples on a 10 mg scale were investigated where a large excess of the 
diethyl azodicarboxylate (DEAD), triphenylphosphine (PPh3) and 54 were used 
and it was found the presence of triethylamine was crucial. The hindered base 
DIPEA was also investigated but a light pink resin was obtained in each case. 
Tetrahydrofuran was the solvent in which the highest level of coupling was 
obtained, and it was important to use a minimum of solvent. The best conditions 
yielded a resin that retained a moderate red coloration. 
Although evidence indicated it was possible to chemically bind the glycol dye- 
linker DL52 to the supported peptide derivative, the level of loading was low and 
the coupling was difficult to reproduce. It was envisaged that the required 
coupling, might be afforded by formation of an amide bond between the 
peptide's terminal amino group and the carboxylate of an acid derivative of 
disperse red, by use of the highly efficient phosphonium coupling reagent 
PyBOP. 
Therefore an attempt to couple the acid derivative 24 directly to the supported 
peptide 40 via the coupling reagent PyBOP, was undertaken (Scheme 2.28). 
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Scheme 2.28. Direct coupling of 24 to the supported peptide via PyBOP. 
Again a high level of loading appeared to be attained after 10 minutes and a jet 
black resin was obtained. However upon subjecting the resin to washes with 
various solvents including the solvent system TFA: methanol: dichloromethane, 
1: 10: 39, the resin was found to remain ajet black. The TFA had been included 
in the solvent system to provide a proton source to help disrupt hydrogen 
bonding that may have been causing the dye-linkers to physically bind to the 
peptide. It was felt that this phenomenon would perhaps be even more relevant 
with regard to the acidic derivatives of disperse red. Note the acid derivative 24 
was only sparingly soluble in dichloromethane. It was also important to examine 
how stable the supported peptide-disperse red system was to TFA because this 
was to be used in the final deprotected and partially cleaved peptide. 
Remarkably, upon suspending the jet black resin 58 in TFA, the coloration 
changed to a brilliant bright red, although only slight colour was observed to 
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leach into the TFA (this was attributed to the cleavage of the Rink linker). 
Placing the brilliant bright red beads into dichloromethane changed the 
coloration to a dark red, Whilst methanol gave the original jet black resin. This 
process could be repeated and no finther colour loss was observed but a colour 
change was observed which depended on the solvent used. (Interestingly, during 
the Swern oxidation the solution of disperse red was found to lose a significant 
amount of colour upon cooling from room temperature to -780C). 
Thus it appeared a high level of dye-linker loading onto the supported peptide 
might now be quickly achieved with ease. Other solvents for undertaking the 
coupling were investigated (Table 2.3) and the physical binding of 24 to the 
supported peptide in various solvents were also investigated (Table 2.4). It was 
found that dimethylforinamide was a suitable solvent and this was used for the 
future coupling of all the glycol dye-linkers. It was also found that 24 did 
physically stain the supported peptide in all solvents although this was easily 
removed in each case by washing with the TTA: methanol: dichloromethane, 
1: 10: 39 solvent system. 
This is an important point because during the deprotection of the supported 
peptide dye-linker systems with TFA, if hydrolysis occurred, 24 and 45 would be 
released. If the compounds 24 and 45 physically bound to the peptide 
throughout standard solvent washing, they would be present in future hydrolysis 
studies of the synthetic esterase systems. If they were then released during the 
studies, false results could be obtained. 
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Solvent Used 
In Coupling 
Colour of Resin 
Before Washing 
Colour of Resin 
After Washing* 
Dimethylformamide Jet Black Jet Black 
Tetrahydrofuran Jet Black Dark Red 
Toluene Jet Black Dark Red 
Ethyl Acetate Jet Black Dark Red 
Dichloromethane Jet Black Dark Red 
* Solvents used were methanol, dichloromethane, ethyl acetate and dimethylformamide. 
Table 2.3. Coupling 24 to the supported peptide via PyBOP in various solvents. 
Solvent Used Colour of Resin 
Before Washing 
Colour of Resin 
After Washing* 
Colour of Resin 
After Washing" 
Dimethylformamide Jet Black Light Red Light Pink 
Tetrahydrofuran Jet Black Light Red Light Pink 
Toluene Jet Black Dark Red Light Pink 
Ethyl Acetate Jet Black Dark Red Light Pink 
Dichloromethane Jet Black Light Red Light Pink 
Solvents used were methanol, dichloromethane, ethyl acetate and dimethylformamide. 
** The solvent system used was TFA: methanol: dichloromethane, 1: 10: 39. 
Table 2.4. Observing the physical staining of 24 to the supported peptide in 
various solvents. 
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2.1.7 Modifying The Dye-Linkers 
2.1.7.1 Chlorotrityl Resin Method 
It had been demonstrated that the glycol dye-linkers might be coupled to the 
supported peptide using the coupling reagent PyBOP. However, the glycol dye 
linkers would require their terminal primary hydroxy functionality to be 
modified to a free carboxylate. It had been shown previously that the oxidation 
of disperse red was troublesome and to modify all ten glycol dye-linkers would 
require a great deal of efforL Therefore a method using a commercially available 
polymer support preloaded with a glycine amino acid residue was investigated 
(Scheme 2.29). 
As described above, chlorotrityl resins82,83 are highly acid labile. In this 
instance functionalising the free amino group of the supported glycine residue 
with 4-hydroxyphenylacetic acid to give 59 followed by additional coupling with 
the primary alcohol of disperse red gave a supported species 60. When subjected 
to acidic conditions the chlorotrityl component was expected to cleave, yielding 
the new derivative 61. The methodology would therefore quickly exchange the 
alcoholic function for a carboxy function through a short linker. It was 
envisaged that the system could also be used to create a combinatorial library of 
ester components for each individual glycol dye-linker (Scheme 2.30). 
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(a) Chlorotrityl resin (1.0 eq), 4-hydroxyphenylacetic acid (2.5 eq), PyBOP (2.5 eq), HOBt (2.5 eq), DIPEA 
(5.0 eq), dimethylformamide. room temperature, 2 hours, Kaiser test negative. (b) 59 (1.0 eq), DEAD (2.0 
eq), PPh3 (2.0 eq), disperse red (2.0 eq), triethYlamine (5.0 eq), tetrahydrofuran, room temperature, I hour. 
(c) TFA: methanol: dichloromethanc, 1: 1: 98, room temperature, 5 minutes. 
Scheme 2.29. Modifying the terminal functionality of the glycol dye-linkers via 
a chlorotrityl resin. 
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(a) Supported chlorotntyl dye-link-er syStem (1.0 eq), LDA (1.0 eq), tetrahydrofuran, -78'C. (b) 
Electrophile (1.0 eq), -78'C to room temperature. (c) TFA: methanol: dichloromethanc, 1: 1: 98, room 
temperature. 
Scheme 2.30. The chlorotrityl resin could potentially provide a method to create 
a combinatorial library of glycol dye-linkers. 
The chlorotrityl resin is known to stable to basic conditions. Deprotonation of 
the supported dye-linker with a suitable base such as lithiw-n dilsopropyl amide 
(LDA), splitting the bulk into several batches, quenching of each batch with a 
different electrophile, recombination of the batches and finally, cleavage from 
the resin could potentially yield a large range of glycol dye-linkers. However, 
two immediate problems with this method would be; a) controlling the site of 
deprotonation and b)controlling the mono C-alkylation. 
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Results and Discussion 
During the synthesis of the system shown in Scheme 2.30, it was found that the 
initial coupling of 4-hydroxphenylacetic acid proceeded smoothly to give full 
conversion within 2 hours in the presence of PyBOP. The coupling of disperse 
red was effected by Mitsunobu alkylation in tetrahydrofuran as solvent, to give a 
red black resin within I hour. However, upon cleavage in 
TFA: methanol: dichloromethane, 1: 1: 98 only a small amount of crude material 
was obtained (approximately 7 mg crude material from 200 mg of supported 
substrate). Crude 1H NMR indicated the presence of the product although it was 
not isolated. The low yield was surprisingly as the particular resin used had a 
fairly high level of loading (0.54 mmol/g) and a product yield of approximately 
58 mg was expected if full conversion was seen at each stage of the synthesis for 
200 mg of resin. It was felt the synthesis could be optimised, however, we 
decided to modify each glycol dye-linker manually and readdress the chlorotrityl 
resin method at a later date. 
2.1.7.2 Manual Synthesis 
The individual conversion of each glycol dye-linker was undertaken by using the 
tert-butyl ester of 3-(4-hydroxyphenyl) propionic acid 62 (Scheme 2.3 1) 
followed by deprotection with TFA. The product numbers of each derivative are 
summarised in Table 2.5. 
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(a) Dye-linker (1.0 eq), DEAD (1.5 eq), PPh3 (1.5 eq), 62 (2.0 eq), dichloromethane, room temperature, 
hours. (b) Dichloromedme: TFA, 1: 99, room temperature, 5 minutes. 
Scheme 2.3 1. Manual modification of each glycol dye-linker. 
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Dye-Linker Tert- Butyl Derivative Acid Derivative 
DL21 63(53%) 73(85%) 
DL31 64(55%) 74(87%) 
DL41 65(52%) 75(84%) 
DL51 66(53%) 76(79%) 
DL, 61 67(58%) 77(86%) 
DL22 68(57%) 78(77%) 
DL32 69(38%) 79(81%) 
DL42 70(47%) 80(84%) 
DL52 71(44%) 81(79%) 
DI-62 72(56%) 82(82%) 
Table 2.5. Nomenclature of the modified glycol dye-linkers. 
The tert-butyl ester was synthesised by a procedure reported by Ohta et al. 84 It 
involves forming the corresponding activated imidazole ester of 3-(4- 
hydroxyphenyl) propionic acid via reaction with carbonyl diimidazole in 
dimethy1formamide at 40"C, and subsequent decarboxylation. The intermediate 
activated ester is then treated with 2.5 equivalents of tert-butanol and 2 
equivalents 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) at 65T for 48 hours to 
give the product 62 in 65% yield after isolation. This reaction was sometimes 
difficult to perform and yields would quite often be low for no apparent reason. 
For example, three reactions run in parallel, using the same reagents and in 
which all addition and reaction conditions were exactly the same, gave yields of 
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10%, 19% and 30% (these reactions were conducted at 40"C throughout for 12 
hours using I equivalent of all reagents). 
The coupling of 62 to the glycol dye-linkers 46-55 was undertaken via 
Mitsunobu alkylation using dichloromethane as solvent. The reactions took 5 
hours to afford full conversion with yields between 38-58% (the major side 
products were the corresponding dimers). After isolation, the deprotection of the 
carboxyl group was cleanly achieved by dissolving the dye-linker derivative in a 
minimum of dichloromethane and adding the solution, to TFA containing I% 
TIS. Full conversion could be observed by TLC (ethyl acetate: hexane, 4: 1) 
within 5 minutes. 
2.1.8 Attaching The Modified Dye-Linkers 73-82 to The Supported Peptide 40 
Attaching the modified dye-linkers 73-82 was accomplished using the same 
method described above for attaching 24 to the supported peptide (Scheme 2.28). 
The solvent of choice was dimethylfonnamide and the coupling reagent of 
choice was PyBOP (Scheme 2.32). It was found all the dye-linkers could be 
attached with a high level of loading within 3 hours and after washing with 
various organic solvents, ajet black resin was obtained to give the supported 
protected peptidyl systems 83-92 (Table 2.6). 
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(a) Supported peptide 40 (1.0 eq), dye-linker (2.5 eq), PyBOP (2.5 eq), HOBt (2.5 eq), DIPEA (5.0 eq), 
dimethylformamide, room temperature, 2 hours. 
Scheme 2.32. Each glycol dye-linker 73-82 was directly coupled to the 
supported peptide via PyBOP. Peptidyl deprotection afforded 93-102. 
Dye-Linker Protected Peptide 
On Support 
Deprotected Peptide 
On Support 
DL21 83 93 
DL31 84 94 
DL41 85 95 
DL51 86 96 
DL61 87 97 
DL22 88 98 
DL32 89 99 
DL42 90 100 
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DL52 91 101 
D42 92 102 
Table 2.6. Nomenclature of the peptide glycol dye-linker systems. 
Side chain deprotection and partial cleavage of the supported peptide-dye-linker 
derivatives 83-92 was achieved by use of a TIS: TFA, 1: 99 solution. 
Approximately 20 mg of 83-92 resin was individually subjected to 3 ml of 
TIS: TFA solution. Some colour was seen to leach from the resin during the 
deprotection and partial cleavage, causing the TIS: TFA to become a red colour. 
However, within the resin that was recovered, the majority of beads still had a 
high level of dye-linker loading and were ajet black colour. Some beads within 
the bead mixture had lost a significant amount of colour and become a light red. 
The beads that lost a significant amount of coloration were presumed to be the 
resin that had contained the Rink linker. 
The red solution of TIS: TFA was concentrated and dried under reduced pressure 
to give in each case a red residue. All ten residues were analysed by low 
resolution mass spectrometry at the EPSRC Mass Spectrometry Service Swansea 
to confirm that each of the ten glycol dye-linker-peptide systems had been 
successfully synthesised and cleaved from the support. Picture 2. La shows the 
Tentagel. resin prior to any loading and Picture 2. Lb shows the resin of 101. The 
pictures were obtained by examining the resin under a microscope, to which a 
Cannon camera had been attached. The resin used had a high level of glycol 
dye-linker loading and normally appearedjet black. However, when examined 
under the microscope, a strong light source was used to illuminate the resin from 
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below. This had an effect which seemed to illuminate the individual beads from 
inside their structures and gave them a bright red appearance. 
Picture 2.1. (a) Left: unfunctionalised Tentagel. (b) Right: Supported peptide 
dye-linker system 101. 
2.1.9 Analysis of The Ten Glycol Dye-Linker Peptide Systems 
The methodology used to synthesise the intramolecular synthetic esterase 
systems had been accomplished and ten supported peptidyl systems with 
different linker lengths had been synthesised. A qualitative study was 
undertaken to investigate the degree of hydrolysis of these systems, in different 
solvents and pH values. The analysis involved swelling 50 small resin samples 
(0.5 mg) in small vials, in a buffer solution of pH 6 (0.5 in]), 50 resin samples in 
a buffer solution of pH 7 (0.5 ml) and 50 resin samples in a buffer solution of pH 
8 (0.5 ml), at room temperature overnight. Within each batch of 50 resin 
samples, the 10 individual glycol dye-linker peptidic systems were represented 5 
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times. After being allowed to swell, the resin samples were then diluted with 
one of five organic co-solvents (I ml); acetonitrile, tetrahydrofuran, dioxane, 
ethyl acetate and dimethylforinamide. It was found that no hydrolysis was 
observed during the overnight swelling and, in a separate analysis, it was found 
that very little hydrolysis was observed when the supported glycol dye-linker 
peptidic systems were subjected to just the five organic solvents above. 
However, upon the addition of the organic co-solvents to the swollen resin 
samples, it was generally found there was no hydrolysis but under certain 
conditions there was significant hydrolysis. The samples were not stirred or 
shaken but allowed to mix via difrusion. The results are summarised in Table 
2.7. 
pH 6 
MeCN TBF Dioxane MeOH EtOAc DMF 
DL21 x x x x x x 
DL31 x x x x x x 
DLU x x x x x x 
DL51 x x x x x x 
DL61 x x x x x x 
DL22 x s x s x x 
DL32 x x x x x x 
DL42 s s x 1( x 1( 
DL52 1( x x x x x 
DL62 x x x x x x 
pH 7 
MeCN THF Dioxane MeOH EtOAc DNM 
DL21 x x x x x x 
DL31 x x x x x x 
DL41 x x x x x x 
DL51 x x x x x x 
DL61 x x x x x x 
DL22 x s s x x x 
DL32 x x x x x x 
DL42 s s s x x 
DL52 x 1( s s x x 
DL62 x x x x x x 
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pH 8 
MeCN THF Dioxane MeOH EtOAc DMF 
DL21 x x x x x x 
DL31 x x x x x x 
DL41 x x x x x x 
DL51 x x x x x x 
DL61 x x x x x 
DL22 x x x x x x 
DL32 x x x x x x 
DL42 1/ 1( s x x x 
DL52 V Q/ I 
x s X. I/ 
x xI x x x x 
The most hydrolysis 
S Slight hydrolysis 
"I Reasonable hydrolysis 
x Very slight or no hydrolysis 
Table 2.7. Qualitative study to determine which conditions afforded the best 
intramolecular hydrolysis. 
It was found that the peptidyl glycol dye-linker systems DL42 and DL52 gave the 
most hydrolysis whereas the systems DL21 to DL61 gave no or very slight 
hydrolysis. The system DL42 when subjected to the organic co-solvent, dioxane 
at pH 7, was found to give the most hydrolysis. The second and third most active 
systems were DL52 in tetrahydrofuran at pH 8 and acetonitrile at pH 6 
respectively although the difference between the three was very slight. The 
analysis of hydrolysis was undertaken by visually comparing the intensity of the 
solutions red colour and an accurate qualitative analysis was not conducted. It is 
also important to note that none of the systems gave total hydrolysis in which 
colourless resin would have been obtained. The amount of colour loss was 
purely comparative and a significant level of loading remained throughout, 
leaving resin a dark red colour. The solution of the systems which had yielded 
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the most colour loss were examined by TIC (ethyl acetate: hexane, 4: 1) and the 
only compounds present, were the corresponding hydrolysis products, 24 and 45 
disperse red derivatives. It waý noticed that most of the hydrolysis occurred 
within the first two hours and very slight increases were observed over a further 
3 days. 
2.1.10 Intermolecular Investigation 
Although complete hydrolysis to colourless beads had not been achieved, it was 
encouraging that some systems were more active than others. This indicated the 
length of dye-linker and the ester being cleaved by intramolecular hydrolysis, 
was important. A further qualitative examination undertaken involved the 
intermolecular hydrolysis of the p-nitrophenyl ester 103 by the supported 
deprotected peptide 41 (Scheme 2.33). 
0 ---a (a) 
OH 
N02 
phenylacetic acid 
4-nitrophenyl ester 103 
phenylacetic 
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HO 1*: zk 
wecý NCý 
4-nitrophenol 
Scheme 2.33. Hydrolysis of the ester gave phenyl acetic acid and 4-nitrophenol. 
Both products are UV active and can be detected by TLC. 
The two organic solvents, acetonitrile and dioxane, had been shown in the 
previous studies to be suitable co-solvents to effect intramolecular hydrolysis. 
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These were used in the intermolecular analysis. Small resin samples of the 
supported pepticle (0.5 mg, - 3.0 x 10-3 mmol) were again swollen overnight in 
buffer solutions (I ml) of pH 6,7 and 8. After swelling, 103 (0.5 mg, 1.9 mmol) 
dissolved in the appropriate solvent (0.5 ml) was added. Identical blank 
experiments were also run in parallel, where the presence of the peptide had been 
omitted. The hydrolysis of thep-nitrophenyl ester was followed by observing 
the formation ofp-nitrophenol by TLC (ethyl acetate: hexane, 2: 3) and the results 
are summarised in Table 2.8. 
pH 6 
No Peptide Present Peptide Present 
Dioxane s s 
Acetonitrile x 
pH 7 
No Peptide Present Peptide Present 
Dioxane 
Acetonitrile 
pH 8 
No Peptide Present Peptide Present 
Dioxane s s 
Acetonitrile s s 
1( Complete hydrolysis 
S Slight or incomplete hydrolysis 
x no hydrolysis 
Table 2.8. Intermolecular hydrolysis of 103 in the presence of the supported 
peptide. 
It was found that for each condition except one, that if hydrolysis was observed 
in the presence of the peptide, the same level of hydrolysis was observed without 
the peptides presence. The exception was when the hydrolysis was undertaken at 
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pH 6 using acetonitrile as co-solvent. No hydrolysis was observed without the 
peptide present, however complete hydrolysis was observed when the peptide 
was present. Regrettably the rate of hydrolysis in each case was slow and the 
experiments were observed over a ten day period. 
Having established one particular set of conditions under which hydrolysis of 
103 was only observed in the presence of the peptide, the experiment was 
repeated using a larger ratio of supported peptide (10 mg, - 60 x 10-3) . It was 
found on closer examination that very slight hydrolysis of the p-nitrophenyl ester 
occurred within the first 24 hours. The intensity ratio of the UV spots on TLC 
corresponding to 103 and to p-nitrophenol, as approximately 20: 1 respectively. 
Over a further 4 days the ratio increased to approximately 1: 1 and a strong 
conversion had been observed by day 6 giving a ratio of 1: 4. The rate of 
hydrolysis of the remainingp-nitrophenyl ester then appeared to slow down 
again and a further 4 days were required to give complete conversion. A blank 
experiment (omitting the peptide) was again run in parallel and the presence of 
p-nitrophenol was not observed. 
This was interesting as it appeared that the peptide required a period of time to 
become activated upon which the rate of hydrolysis increased until 
approximately 80% of the substrate had been converted to its hydrolysis 
products. The rate then appeared to slow down again during the final hydrolysis 
of remaining substrate. Complete hydrolysis had again taken 10 days clearly 
indicating that if the peptide was catalysing the hydrolysis, it was not very 
efficient. - 
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One explanation for the apparent increase and decrease of the peptide's activity 
could be that initially the peptide required 24 hours to form an active secondary 
structure after which it assisted the hydrolysis of 103. Subsequently a relative 
increase in activity was observed where the peptide was attacking 103 in a 
nucleophilic manner releasing the p-nitrophenol. However, the peptide then 
suffers product inhibition, possibly due to its active site being acylated by the 
phenylacetic acid in a stable manner and subsequent hydrolysis of the remaining 
substrate relied upon the rate at which the peptide could be regenerated. Note, at 
no time was the presence of phenylacetic acid observed during the hydrolysis 
although an unidentified baseline product did accompany cases of successful 
hydrolysis. 
If the peptide was indeed successfully aiding the hydrolysis of 103 via a single 
active component, it could possibly have been operating in a catalytic sense 
because an excess of substrate was being processed. Further work is however, 
necessary to prove the peptide retained its original composition and additional 
investigations would certainly be necessary to prove whether an increase of 
reaction rate was being observed. The active components of the peptide's 
structure would also need to elucidated. It is known the imidazole group of 
histidine is capable of catalysing the hydrolysis of similar esters. 85,86 The 
hydrolysis we observed may have been due to the histidine residue within the 
peptide. The reduced rate of hydrolysis could then, for example, be rationalised 
to the binding of the hydrolysis products to the peptide and causing steric 
hindrance to the imidazole group of the histidine. 
However, our concern during this study had been to demonstrate that the 
supported peptide was capable of inducing hydrolysis of an ester in order to 
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support the previous intramolecular studies. It was rationalised that further 
detailed studies of intermolecular hydrolysis should be undertaken, possibly with 
a far more active peptide sequence, if one should be realised. 
2.1.11 Synthesis of a Chiral Ester Peptidic System 
Having found that the optimal glycol dye-linker length to be DL52 and 
favourable hydrolysis conditions to effect its intramolecular hydrolysis, we 
envisaged it would be prudent to investigate if it was possible to observe if 
enantloselective control was being expressed during the hydrolysis. This was 
undertaken by synthesising another supported peptidic DL52 system where a 
chiral center was incorporated alpha to the carbonyl on the ester being 
hydrolysed (Figure 2.5). A racemic center was created and it was envisaged that 
any enantioselective control during the hydrolysis would be evaluated via chiral 
HPLC analysis. 
0 
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Figure 2.5. Supported peptidic DL52 system involving a chiral ester. 
The synthesis of the racemic chiral glycol dye-linker 111 was initially 
undertaken by protecting the hydroxyphenyl group of 62 with tert-butyl 
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dimethylsilyl chloride in a reasonable yield of 79% (Scheme 2.34). Formation of 
the enolate of 104 via deprotonation alpha to the carbonyl with lithium 
diisopropyl amide at -78"C, followed by quenching at -78*C with a ten fold 
excess of methyl iodide in the presence of a ten fold excess of 
hexamethylphosphotriamide (HWA) afforded 105 in a 60% yield. The HNVA 
was required to reduce unwanted side products arriving from polyalkylation of 
the enolate intermediate, and di-carbon and oxygen alkylation during the methyl 
iodide quenching. 87 The silyl protecting group of 105 was then removed with 
tetrabutylammonium fluoride in tetrahydrofuran. The deprotection was very 
quick and full conversion was observed within 3 minutes to give 106 with a yield 
of 82%. 
00 
I "ý 
(a) 0)ý me (b) +e I-+II 62 1! 0 OH 104 AO O. OSI 
Mm 
'a 
00 
0 Nk me 0 Nk 
12.: % (: ). 
Ai 
106 
OH 
105 
(a) 62 (1.0 eq), TBSCI (I. I eq), triethylamine (1.5 eq), dimethylaminopyridine (DMAP) (catalytic), 
dichloromethane, room temperature, 8 hours, 79%. (b) 104 (1.0 eq), LDA (I. I eq), HMPA (10 eq), methyl 
iodide (10 eq), tctrahydrofunm, -78*C, 6 hours, room temperature, 12 hours, 60%. (c) 105 (1.0 eq), TBAF 
(1.0 eq), tctrahydrofuran, room temperature, 20 minutes, 82%. 
Scheme 2.34. Introducing a racernic chiral center a- to the carbonyl of 62. 
The coupling of 106 to disperse red was successfully achieved via Mitsunobu 
alkylation using dichloromethane as solvent (Scheme 2.35). Full conversion was 
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observed within 3 hours to 107 with a yield of 33%. It was found the major side 
product was the dimer of disperse red. Removal of tert- butyl protection to 
afford 108 was successfidly undertaken with a reasonable yield of 81% by 
dissolving the substrate in a minimum of dichloromethane and direct delivery to 
a solution of TIS: TFA, 1: 49. It was found if a higher concentration of TIS was 
present or too much dichloromethane was used to dissolve the substrate, efficient 
deprotection was difficult to achieve. 
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(a) 106 (1.0 eq), DEAD (1.0 eq), PPh3 (1.0 eq), disperse rod (1.0 eq), dichloromedme, room temperature, 3 
hours, 33%. (b) TIS: TFA, 1: 49, dichloromethane, room temperature. 10 minutes, 8 1%. (c) 108 (1.0 eq), 
DEAD (I. I eq), PPh3 (1-1 cq), pentaglycol (1.3 eq), dichloromethane, room temperature, 4 hours, 56%. 
Scheme 2.35. Synthesis of the racemic dye-linker. 
The coupling of 62 to 109 was also afforded via Mitsunobu alkylation with a 
moderate yield of 59% using dichloromethane as the solvent and the final 
deprotection was again achieved by dissolving the substrate in a minimum of 
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dichloromethane followed by addition to a solution of TIS: TFA, 1: 49. The 
removal of the tert-butyl group gave 111 in a 79% yield (Scheme 2.36). 
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(a) 63 (I. Oeq), DEAD (1.1 C'q), PPh3 (1-1 eq), 110(l. Oeq), dichloromcthane, rc)om temperature, 2 hours, 
59%. (b) TIS: TFA, 1: 49, dichloromethane, room temperature, 10 minutes, 79*/*. 
Scheme 2.36. Deprotection of the final racemic glycol dye-linker. 
Having synthesised the chiral glycol dye-linker 111, it was coupled to the 
supported side chain protected peptide 40 (10 mg, ) using the coupling reagent 
PyBOP in the same manner as above. The solvent of choice was 
dimethy1formamide and an excellent level of loading was achieved after gentle 
stirring at room temperature for 2 hours to give a jet black resin 112. Sidechain 
protection was afforded by gently stirring 112 (9 mg) at room temperature for I 
hour in a solution of TIS: TFA, 1: 49. After subjecting the resin to washes with 
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various solvents including the solvent system TFA: methanol: dichloromethane, 
1: 10: 39, the resin was found to retain a high level of loading, giving the 
supported deprotected peptidic system 113 as ajet black resin (Scheme 2.37). 
sixteen resi NH2 
peptide 
----------- 
(EHý) 
Supported peptide with 
side chain protection 40 
0 
110ýt"'ýý 
+0 
0--ýO--40 Ar 
4 
(a) 
------------ (EEý) - 112 
(b) 
cv=f! ý= 
113 
(a) Supported pepticle (1.0 eq), dye-linker (2.5 eq), PyBOP (2.5 eq), HOBt (2.5 eq), DIPEA (5.0 eq), 
dimethylformamide, room temperature, 2 hours. (b) TIS: TFA, 1: 49, room temperature, I hour, 
Scheme 2.37. Deprotection of the supported peptidyl racemic glycol dye-linker. 
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2.1.12 Synthesis of a Blank Dye-Linker DL52 System 
We were concerned during the of the hydrolysis studies that false results might 
have been observed if the esters in the peptidyl dye-linker systems were being 
cleaved when the peptide was being subjected to TFA and the hydrolysis 
products were subsequently physically binding to the peptide. It had been shown 
this was unlikely because the supported peptide had been shown to bind 24 
poorly in acidified organic solvent. Therefore, a blank system where the glycol 
dye-linker 54 was coupled directly to 35 was synthesised (Scheme 2.38). 
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H 
0 
Ar 
0"-" 114 
(a) Functionalised Tentagcl 35 (1.0 eq), DEAD (2.0 eq), Pftýj (2.0 eq), 54 (2.5 eq), triethylamine (5.0 eq), 
tetrahydrofttran, room temperature, 2 hours. 
Scheme 2.38. Blank Tentagel dye-linker DL52 system- 
A similar system 36 had already been synthesised with the dye-linker 14 and this 
could have been used in the investigations. However, it was envisaged that it 
would be prudent to use the same dye-linker currently under investigation. The 
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blank Tentagel dye-linker DL52, system 114 was synthesised by standard 
Mitsunobu alkylation conditions above. After 2 hours ajet black resin was 
acquired which retained its loading upon several washes with various organic 
solvents and the solvent system TTA: methanol: dichloromethane, 1: 10: 39.114 
was then subjected to the TIS: TFA solution used to deprotect the peptidyl 
systems and it was found that no colour loss was observed over a period of 4 
hours which was four times longer than the peptidyl deprotection stage. A very 
slight light pink solution was acquired after 24 hours in solution. 
In view of this and that the hydrolysis product 24 did not bind the peptidyl 
system in acidified organic solvent, it was concluded contamination by the 
hydrolysis product was unlikely. 
2.1.13 Comparison of The Hydrolysis Efficiencies of 114,101 and 113 in The 
Presence of Various Additives 
Intramolecular hydrolysis of the peptidyl glycol dye-linker system DL52 101 and 
intermolecular hydrolysis of phenylacetic acid 4-nitrophenyl ester 103 had both 
occurred with relatively high levels at pH 6 when acetonitrile was used as a co- 
solvent. These conditions were again used for the following qualitative analysis. 
Small resin samples (0.5 mg) of the supported glycol dye-linker 114, peptidyl 
glycol dye-linker 101 and the peptidyl glycol racemic dye-linker 113 were 
individually swollen in a buffer solution (0.5 ml) of pH 6 overnight. Various 
additives were then introduced (- 2 pmol) followed by acetonitrile (0.5 ml). The 
results of the subsequent hydrolysis are surnmarised in table 2.9. 
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Acetonitrile at pH 6 
Additive Support-DL52 
114 
Support-peptide-DL52 
101 
Support-peptide-chiral 
DL52 113 
1 Ce2(CO3)3 x 4/ x 
2 CS2CO3 x I/ s 
3 CuCN x V*l x 
4 Pb(N03)2 x x x 
5 NaF x V x 
6 AIC13 x x x 
7 Lil x x 
8 ZnC12 x x 
9 CuBr2 x x 
10 NaOAc x x 
II AuC13 x x x 
12 CeC13 x x x 
13 FeC13 x x x 
14 Cul x x x 
15 CaC12 x s x 
16 KCI x x 
17 Vancomyciq x x 
18 ScTf3 I x x 
pH 6 
Additive None CS2CO3 Lil 
Dioxane x 1( x 
Acetonitrile x s x 
pH 7 
Additive None CS2CO3 Lil 
Dioxane x 1( x 
Acetonitrile x S x 
pH 8 
Additive None CS2CO3 Lil 
Dioxane x x 
Acetonitrile x x 
The most hydrolysis Reasonable hydrolysis 
S Slight hydrolysis x Very slight or no hydrolysis 
* strongest yet. The others were comparable to the previous systems. 
Tables 2.9 and 2.10. Qualitative Study to Determine if simple additives could 
enhance hydrolysis. 
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Several points of interest were evident: 
No hydrolysis occurred in any of the conditions for the supported glycol dye- 
linker system 114. This was encouraging because it confirmed the presence 
of the peptide was important. 
For the majority of the conditions investigated, the same level of hydrolysis 
that had been experienced in the'previous; intramolecular studies, was also 
observed. However, for one example (additive lithium iodide) the highest 
level of hydrolysis given by any system, was observed. Several additives 
prevented any hydrolysis from occurring. 
Unfortunately hydrolysis of the peptidyl glycol racemic dye-linker 113 was 
only observed for one particular condition (additive cesium carbonate) and 
the level of hydrolysis was not very high. 
Thus the two additives that had shown significant positive effects towards the 
hydrolysis of the peptidic systems were lithium iodide and cesium carbonate. 
Therefore in an attempt the level of hydrolysis, the peptidic glycol chiral dye- 
linker system 113 was then subjected to the two additives at different pH levels 
and also in dioxane as co-solvent. The results are summarised in Table 2.10 
above. 
It was found that when no additive or the additive lithium iodide which had 
caused the most hydrolysis to occur for the peptidyl glycol dye-linker system 
101, were applied to the chiral system 113 under the various new conditions, no 
hydrolysis was observed. However, when the additive cesium carbonate was 
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employed, hydrolysis was observed to occur for all cases. The conditions which 
gave the most hydrolysis were at pH 8 using acetonitrile as a co-solvent 
Regrettably there was not enough of the peptidyl glycol chiral dye-linker system 
113 available to acquire enough of the hydrolysis product 108 to allow analysis 
via chiral IHPLC. It was possible to conform by TLC (ethyl acetate: hexane) that 
the hydrolysis product was indeed 108. 
2.1.14 Conclusion and Future Recommendations 
The synthesis of the model system allowing the investigation of intramolecular 
hydrolysis involving an ester tethered to a sixteen residue peptide through 
various lengthed glycol linkers was achieved. It was possible to show that the 
peptide appeared to be responsible for the intramolecular and intermolecular 
hydrolysis observed, and that the ester under investigation and the length of 
glycol linker employed, were important. 
It was disappointing that the hydrolysis of the racernic peptidic glycol dye-linker 
system 113 could only be achieved under one set of conditions and this could 
have been due to the chiral center creating too much steric hindrance within the 
ester group for nucleophilic attack to occur. The glycol linker length employed 
for this system may not have been ideal. However, it was encouraging to 
observe that the hydrolysis seen in this example, was not observed within the 
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supported glycol dye-linker system 114 where no peptide was present, indicating 
the peptide was responsible for the hydrolysis. 
It was observed during the hydrolysis experiments that the polymer support did 
not appear to swell noticeably once the glycol dye-linkers had been attached. 
Even with the most successful examples, significant levels of dye remained 
loaded on the support leaving a dark red resin. It is envisaged that utilising the 
PEGA gel resin, which is known to have a superior swelling capability to 
Tentagel described above, could give an improvement to the model system. 
A further concern with the model system we have developed is that product 
inhibition may be occurring. Intramolecular cleavage of the ester within the 
glycol dye-linker component to forrn a new intermediate ester on the peptide 
may occur, however the new intermediate might be too stable to allow 
subsequent regeneration of the peptide via hydrolysis (Scheme 2.39). 
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within the glycol dye-linker would give a 
peptidyl intermediate. 
Subsequent hydrolysis of the intermediate 
releases the dye and regenerates the peptidyl 
system. 
Scheme 2.39. Product inhibition. 
A possible modification to the peptidyl system could be the incorporation of a 
metallo center adjacent to the peptides active center. The function of the metallo 
center would be to bind a molecule of water in close proximity to assist the 
hydrolysis (Scheme 2.40). 
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Scheme 2.40. Incorporation of a metallo center in close proximity to the active 
center of the peptide may assist the hydrolysis and regeneration of the active 
peptide. 
It is envisaged that although the synthetic esterase would operate through a 
metallic center, an active peptidyl sequence might still afford enantioselective 
control by providing a chiral environment around the active center. 
A group to bind the metal ion could be introduced via unnatural bipyridyl amino 
acid residues88 or residues designed by Barbara Imperiali el a/. 89-91 who is 
interested in the development of fluorescent chemosensors. The incorporation of 
the unnatural amino acids (S)-2-amino-N-9-fluorenylmethoxycarbonyl-3-(oxine- 
2-yl) propionic acid 115 and (, 'ý)-2-amino-N-9-fluorenylmethoxycarbonyl-3- 
(oxine-5-yi) proplonic acid 116 into short 7 residue peptides has shown that 
different metal ions can be selectively bound (Scheme 2.4 1). The selectivity is 
dependant on the amino acids incorporated in the seven residue peptide and is 
elucidated by observing the systems' fluorescence. 
116 
Results and Discussion 
HO fl N 
N 
OH 
Fmoc-N 
ý 
OH 
Fmoc-N 
OH 
H0H0 
115 116 
Scheme 2.41. Two unnatural amino acids incorporated in chemosensor systems. 
We envisage using the above strategy it would be possible to modify our model 
peptide to bind divalent zinc in close proximity to the potential active center. 
Tight binding of divalent zinc to our modified peptide could be investigated by 
fluorescent studies prior to attaching the glycol dye-linker component and 
undertaking the hydrolysis studies. 
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2.2 Vancomycin 
2.2.1 Initial Formation of The Vancomycin Monomers 
It was known that the activity of vancomycin can be increased by forming its 
dimer through a covalent linkage. We proposed it would be possible to modify 
vancomycin at the carboxy group of amino acid 7 with glycol linkers of varying 
lengths attached through an amide bond, bearing a terminal double bond to 
create a range of vancomycin monomers (Figure 1.14). It was envisaged that 
subjecting the vancomycin monomers to cross coupling metathesis (CCM) with 
Grubb's catalyst would yield a range of vancomycin dimers covalently tethered 
through different lengthed glycol linkers. A vancomycin dimer tethered through 
a glycol linker of an optimum length might show favourable activity against 
target bacteria which would be screened for via the ESI-MS technique developed 
by Professor Albert Heck described above. 
The methodology for the synthesis of the vancomycin monomers was initially 
investigated by attempting to form an ester bond between vancomycin and 2- 
allyloxyethanol 30 via the coupling reagent PyBOP (Scheme 2.42). It was found 
upon analysis of the crude reaction mixture by reverse phase HPLC that a new 
species did form after 4 days although full conversion was not observed. The 
coupling was also attempted via Mitsunobu alkylation, however, the reverse 
phase HPLC analysis revealed the presence of several new products. 
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117 
(a) Vancomycin hydrochloride (1.0 eq), 30 (5.0 eq), PyBOP, (2.5 eq), HOBt (2.5 eq), DIPEA (5.0 eq), room 
temperature, 5 days. 
Scheme 2.42. Formation of vancomycin monomer 117 through an ester bond. 
A difficulty encountered when handling vancomycin was that it was only 
sparingly soluble in most organic solvents including dimethylformamide. 
Solvents in which vancomycin did dissolve in well included; dimethyl sulfoxide, 
methanol and water. Therefore dimethyl sulfoxide was used as the reaction 
solvent when synthesising the vancomycin monomers. However, a drawback of 
dimethyl sulfoxide is that it has a high boiling point (I 89'C) and it was found 
that when attempting to remove the dimethyl sulfoxide under reduced pressure at 
the elevated temperature of 351C, 117 decomposed. It was possible to remove 
dimethyl sulfoxide by freeze drying however due to the instability of 117 to 
moderately elevated temperatures, the synthesis of the vancomycin monomers 
through an amide, than an ester, bond was investigated (Scheme 2.43). The 
coupling of allylamine to vancomycin was undertaken via the coupling reagent 
PyBOP with dimethyl sulfoxide as solvent. It was found that a new product 118 
was formed and the rate of reaction appeared by reverse phase 14PLC analysis, to 
be greater than for the ester formation. The product was not isolated, however it 
was found to be stable at the elevated temperature of 50"C. Indeed, it was 
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decided that a more productive course of action would be to move on to the 
direct synthesis of vancomycin derivatives bearing longer side chains. 
00 
Vancomycin: 
YýOH + H2N (a) 
III 
r& 
Vancomyci: n-J, 
U"N 
allylamine 
118 
(a) Vancomycin hydrochloride (1.0 eq), allylarnine (5.0 eq), PyBOP, (2.5 eq), HOBt (2.5 eq), DIPEA (5.0 
eq), room temperature, 3 days. 
Scheme 2.43. Formation of vancomycin monomer 118 through an amide bond. 
2.2.2 Synthesis of The Glycol Linkers 
The linkers used to modify vancomycin were synthesised from di, tri and 
tetraethylene glycol (Scheme 2.44). Modification of the ethylene glycol starting 
materials was initially attempted by forming the mono-allyl derivatives under 
anhydrous basic conditions in tetrahydrofuran using allyl bromide. A five fold 
excess of the ethylene glycol was used in each case to reduce the formation of 
the unwanted bis-allyl product. However, it was observed by TLC (ethyl 
acetate: hexane, 3: 2) that in each case the bis-allyl product predominated. It 
appeared that the mono-allyl products were more reactive during the allylation 
conditions than their corresponding ethylene glycol starting materials. 
Therefore, due to the difficulty of forming the mono-allyl products, the mono- 
tosyl derivatives 119-121 were synthesised. An excess of the ethylene glycol 
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starting materials was used and the mono-tosylate derivatives were obtained in 
moderate yields of 39-43%. 
(a) 0n=1; 119, (43%) 
HO-týoýýOH n=2; 120, (3 9%) nn 0n=3; 121, (40%) 
n=1; diethylene glycol 
n=2; triethylene glycol 
n=3; tetraethylene glycol 
(b) 
HO'f'ýý 
0 
1; 122, (80%) 
2; 123, (76%) 
3; 124 --- 
1; 125, (61%) 
2; 126, (5 8%) 
3; 127, (42%) 
1; 128, (72%) 
2; 129, (75%) 
3; 130, (68%) 
(a) Di-Tetra-ethylene glycol (5.0 eq), tosyl chloride (1.0 eq), triethylamine (3.0 eq), DMAP (catalytic), 
dichloromethane, room temperature, 8 hours, 39-43%. (b) 119-121 (1.0 eq), potassium phthalimide (I. I 
eq), dimethytformamide, 60'C, 12 hours, 76-80%. (c) 122-124 (1.0 eq), allyl bromide (1.5 eq), sodium 
hydride (I. I eq), cesium carbonate (catalytic), room temperature, 4 hours 58-61%. (d) 125-127 (1.0 eq), 
hydrazine monohydrate (excess), HCI (1.0 eq), ethanol, room temperature, 2 hours, 68-75%. 
Scheme 2.44. Synthesis of the glycol linkers. 
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The displacement of the tosylate groups by potassium phthalimide could be 
achieved in reasonable yields (76-80%) in dimethylformamide at 60'C for 12 
hours. However, the tetraethylene derivative 124 was found to be too polar to 
allow its efficient isolation from dimethylformamide during the work up stage. 
Therefore, 124 was allylated with allyl bromide under anhydrous basic 
conditions without prior isolation to give 127 in 42% overall yield. 122 and 123 
were allylated with allyl bromide under anhydrous basic conditions in 
dimethy1formamide to give 125 and 126 in 61 and 58 % yields respectively. 
Removal of the phthalimide groups with hydrazine monohydrate in ethanol gave 
the final glycol linkers 128-130 in reasonable yield. 
2.2.3 Coupling The Glycol Linkers 128-130 to Vancomycin 
Coupling the glycol linkers 128-130 to vancomycin was undertaken using 
PyBOP as the coupling reagent in dimethyl sulfoxide (Scheme 2.45). The 
reactions were followed by analytical reverse phase HPLC and it was found the 
starting materials vancomycin, PyBOP and HOBt co-ran to give a broad peak 
with a retention time of 2.09 minutes which slowly sharpened over a period of 
five days. After two days a second peak with a retention time of 3.29 minutes 
began to show and this became more predominant over a further three days. The 
original mobile phase (MP) used during the reverse phase HPLC analysis was 
acetonitrile: water, 1: 4; however a higher resolution was achieved when a small 
amount of TFA (0.5%) was included in the mobile phase. After the reaction had 
been stirred at room temperature for 5 days the dimethyl sulfoxide was removed 
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by freeze drying and the vancomycin monomers were isolated by preparative 
reverse phase HPLC to give 131-133 in 29-34% yield. 
0 
n=1; 128 
Vancomycin OH 
Oj-"ý' 
NH, n=2; 129 
Lnomyci yl- 
nn=3; 130 
(a) 
n=1; 131, (33%) 
Vancomycin N 0)"-o-,, 
ý n=2; 132, (29%) 
nn=3; 133, (34%) 
(a) Vancomycin (1.0 eq), glycol linker (excess), PyBOP (1.2 eq), HOBt (1.2 eq), DIPEA (1.2 eq), dimethyl 
sulfoxide, room temperature, 4 days. 
Scheme 2.45. Synthesis of the vancomycin monomers, 
2.2.4 Dimerisation of 131-133 via CCM with Grubb's Catalyst 
Samples (I mg) of the vancomycin monomers where subjected to CCM via 
Grubb's catalyst92,93 in dichloromethane (Scheme 2.46). The dichloromethane 
was previously degassed under reduced pressure and both Grubb's catalyst and 
the vancomycin monomers were dissolved in dichloromethane by ultra 
sonification over a period of ten minutes. The vancomycin monomers were only 
sparingly soluble in the dichloromethane and the reaction mixtures were stiffed 
at room temperature for 2 days after which time the dichloromethane was 
removed under reduced pressure. 
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(a) Vancomycin monomer (I eq), Grubb's catalyst (25 mol%), dichloromethane, 
room temperature, 2 days. 
Scheme 2.46. Dimerisation via CCM %Nq*th Grubb's catalyst. 
Samples of the vancomycin monomers 131-133 and their corresponding 
potential dimers 134-136 were sent to Professor Albert Heck in Utrecht for ESI- 
NIS analysis and the vancomycin derivatives have been demonstrated to bind N- 
acetyl-L-LyS-D-Ala-D-Ser (Picture 2.2). The model peptide N-acetyl-L-LYS-D- 
Ala-D-Ser was chosen for the initial binding studies as this represents a strain of 
bacteria whose pentapeptide has shown resistance to vancomycin, as described 
above. 
124 
Results and Discussion 
ý 1=2DAIMI* 12 LAA K#Aw W ý. acsftb pH .5 
214107 1 C. (I 2t) 
132. Doubl N, 
135 reaction 
charged ion. 
nuxture + 
addition of 
peptide model 
132. Doubly 
charged ion. 
135 reaction 
nuxture only 
toF me Fs. 
132 + tx)und peptide. 
EOubly charged ion. 
A 
S 
- an Io 
Top specftum 
Bottom spectnun 
112 
M DAWK - 12 ýM KASw 1. ý 846tob PH -4 
dn2jI (10711 Sm(9G b200t Cmj 1 211 TOF WS 
low 
wýV#_135. Triply 
135 reaction M3 charged 
ion. 
mixture + 
135 + peptide bound. Top spectrum 
addition of 
Triply charged ion. continued 
peptide model 
UU, 1131=7132 self 
I ZZ34 S. (SG. W OM. 'C. '(l 264 ... 
A Wit 
135. Tnplý 
135 reaction 
charged ion. 
rmxture only 
Bottom spectrum 
continued 
IUM. 
12,61.7s 
14D 1500 14i "M IM I= Ino 1100 IM 
.4 
i IM 1100 1190 IXO 120 13M Ino We 
Picture 2.2. The ESI-MS for 135 is shown in the bottom spectrum. The ESI-MS 
for 135 and binding with the N-acetyl-L-LyS-D-Ala-D-Ser model peptide Is 
shown in the top spectrum. 
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The ESI-MS spectrum above is the analysis of the crude potential triglycol 
vancomycin dimer. It can be seen that both the vancomycin monomer starting 
material 132 and its corresponding dimer 135 are present where the monomer is 
the major mass ion indicating the dimerisation has not gone to completion. 
Upon addition of the peptide model, binding to the vancomycin monomer and 
dimer can be clearly observed. Although the presence of the covalent 
vancomycin dimers has been confirmed by ESI-MS loss of the CCM by-product, 
ethylene, has not been observed. This is unusual although ring closing 
metathesis has been observed to occur without loss of ethylene, by Furstner et 
al. 94 (Scheme 2.47). 
Ts Ts 
II 
Ts (a) N 
+ NQA 
67% 20% 
0 (a) [(p-cumene)RuC1212 (2.5 MOI /0), PCY3 (5.5 mol%), toluene, 80'C, 30 hours. 
Scheme 2.47. Ring closing metathesis without loss of ethylene. 
2.2.5 Conclusion and Future Recommendations 
A range of vancomycin monomers have been successfully synthesised and 
shown to bind N-acetyl-L-LyS-D-Ala-D-Ser. The dimerisation of the vancomycin 
monomers via CCM has been attempted with Grubb's catalyst and the presence 
and the ability of vancomycin dimers to bind N-acetyl-L-LyS-D-Ala-D-Ser has 
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been shown. However, further work is required to indicate that the vancomycin 
monomers have indeed fortned covalently linked dimers, or if the dimers are 
spontaneously forming in solution. Other catalysts to afford the CCM of the 
vancomycin monomers shall also be investigated to encourage a higher 
conversion than previously observed. 
The vancomycin dimers; are to be isolated by preparative reverse phase HPLC 
and in vivo studies are to be undertaken for both the potential vancomycin dimers 
and their corresponding monomers, to establish if enhanced activity can be 
observed. Studies are also ongoing to elucidate the binding efficiencies of the 
vancomycin monomers and dimers to N-acetyl-L-LyS-D-Ala-D-Ser and other 
peptide model systems. 
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3. Experimental 
All air and moisture sensitive reactions were performed under an atmosphere of 
dry nitrogen in flame dried glassware. All anhydrous solvents were used as 
supplied by Romil in HyDry Tm bottles except dimethyl sulfoxide and 
dimethylfortnamide which were supplied by Aldrich in Sure Seal bottles. 
Commercially available starting materials were used without further purification 
unless otherwise stated. Petroleum ether refers to that fraction which boils in the 
range 40-60 *C and MgS04 was used as the drying agent for solutions. 
The reactions were monitored by TLC using aluminium backed silica gel (F254) 
plates, pre-coated with a layer of silica (MERCK), visualised by UV254. and 
then 2,4-dinitrophenolhydrazine, phosphomolybdic acid, potassium 
permanganate or ninhydnin solution. All organic layers were removed by rotary 
evaporation on a BUchi rotary evaporator, the final traces of solvents being 
rcmoved on a static oil pump (0.2 mbar). Column chromatography was carried 
out on silica gel 60 (40-63 gm). 
Melting points were measured on a Stuart Scientific SMP I instrument and are 
uncorrected. Infrared spectra (ER) were recorded on a Perkin Elmer 13 10 FTIR 
spectrometer between sodium chloride plates. Nuclear magnetic resonance 
spectra (NMR) were recorded on either a Brucker AC 250 MHz or 300 MHz 
spectrometer. The chemical shift values were quoted in values of ppm and these 
were relative to the standard tetramethyl si lane (TMS) for 1H NMR and to the 
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centre line of the chloroform triplet, 8 77.0, for 13C NMR. The peak 
multiplicities were specified as singlet (s), doublet (d), doublet-doublet (dd), 
triplet (t), quartet (q) or quintet (quint) and coupling constants ('I) quoted in Hz. 
For all AA'BB' aromatic systems, the multiplicity is quoted as d with the 
coupling constant quoted as JAB. Mass Spectra (MS) were obtained from the 
EPSRC Mass Spectrometry Service Centre, Swansea, as were high resolution 
determinations unless indicated, then Mass Spectra were obtained with a Kratos 
analytical MS80 RFAO spectrometer. Elemental analyses were performed with 
a Carlo Erba 1106 elemental analyser. Reverse phase HPLC was performed with 
a C18 Anachem ODS2 analytical column or a C18 technology ODS semi- 
preparative column using a Krontron HPLC pump 422 and 332 UV detector. 
The absorbance was measure at 254 nm. 
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Toluene-4-suýfonic acid 2- ([4-(2-chloro-4-nitrophenylazo) -phenyl]-ethylamino) - 
45 
ethyl ester, 16 . 
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To a solution of disperse red (3 g, 8.6 mmol) in dichloromethane (40 ml) was 
added triethylamine (3.6 ml, 25.8 mmol, 3 eq) and p-toluene sulfonyl chloride 
(3.6 g, 18.9 mmol, 2.2 eq) at OC. The reaction mixture was then stirred at room 
temperature for 12 hours after which time TLC (ethyl acetate: hexane, 4: 1) 
indicated that the starting material had been consumed. The organic solution was 
then washed with water (3 x 30 mi), the organic extract dried (MgS04) and 
concentrated in vacuo. The product was eluted by flash column chromatography 
(ethyl acetate: hexane, 2: 3) to give a reddish brown powder. The product was 
further purified by recrystallisation using ethyl acetate/hexane to give 16 as dark 
metallic green elongated needles, (3.2 g, 6.4 mmol, 74%). mp 127-1291C (ethyl 
acetate/hexane); (Found: C, 54.78; H, 4.60; N, 11.05. C23H23CIN405S requires C, 
54.92; H, 4.6 1; N, 11.14%); v,,., (Nujol)/cm-1 1598,1463,1338; 8IK300 N4Hz; 
CDC13) 8.3 5 (1 H, d, J 2.4, ArCH), 8.12 (1 H, dd, J 8.9,2.4, ArC. H), 7,85 (2 H, 
d, JAB 9.2, ArCH), 7.75 (1 H, d, J 8.9, ArCH), 7.73 (2 H, d, JAB 8.2, ArCH), 7.27 
(12 H, d, JAB 8.2, ArCH), 6.61 (2 H, d, JAB 9.2, ArCH), 4.22 (2 H, t, 15.9, 
TsOCH2CH2), 3.71 (2 H, t, J 5.9, TsOCH2CH2), 3.44 (2 H, q, J 7.1, CH2Me), 
2.39 (3 H, s, ArMe), 1.19 (3 H, t, J 7.1, CH2Me); 8c(75 MHz; CDC13) 152.7 (C), 
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150.8 (C), 147.0 (C), 145.0 (C), 144.3 (C), 133.9 (C), 132.2 (C), 129.7 (2CH), 
127.6 (2CH), 126.6 (CH), 125.8 (CH), 122.4 (2CH), 117.8 (CH), 111.2 (2CH), 
66.2 (CH2), 48.8 (CH2), 45.9 (CH2), 21.4 (CH3), 12.0 (CHA m1z (El) 502 (M), 
504 (M++2); (Cl) 503 (ME + ), 505 (MH++2); COSY and FfMQC spectra both 
exhibited a good correlation with the proposed structure. 
Methanesulfonic acid 2-([4-(2-chloro-4-nitrophenylazo)-phenyl]-ethylamino)- 
eth I ester, 17.46 y 
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N ýs Me '01 
N4,:. 
N 
cl 
N02 
To a solution of disperse red (3 g, 8.6 mmol) in dichloromethane (40 ml) was 
added triethylamine (3.6 ml, 25.8 mmol, 3 eq) and methane sulphonyl chloride 
(1.48 ml, 18.9 mmol, 2.2 eq) at OIC. The reaction mixture was then stiffed at 
room temperature for 2 hours after which time TLC (ethyl acetate: hexane, 4: 1) 
indicated that the starting material had been consumed. The organic solution was 
then washed with water (3 x 30 ml), the organic extract dried (MgS04) and 
concentrated in vacuo. The product was eluted by flash column chromatography 
(ethyl acetate: hexane, 2: 3) to give a dark red powder. The product was further 
punfied by recrystallisation using ethyl acetate/hexane to give 17 as dark 
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metallic green elongated needles, (2.94 g, 6.89 mmol, 80%). mp 138-139'C 
(ethyl acetate/hexane); (Found: C, 47.83; H, 4.47; N, 13.15. C17HigCIN405S 
requires C, 47.83; H, 4.49; N, 13.12%); v,.,, (Nujol)/cm-1 1600,1516,1332; 
8H(300 MHz; CDC13) 8.32 (1 H, d, J 2.5, ArCH), 8.09 (1 H, dd, J 9.0,2.5, 
ArCH), 7.90 (2 H, d, JAB 9.2, ArCH), 7.72 (1 H, d, J 9.0, ArCH), 6.77 (2 H, d, 
JAB 9.2, ArCH), 4.42 (2 H, t, J 6.0, MSOCH2CH2), 3.81 (2 H, t, J 6.0, 
MSOCH2CH2), 3.56 (2 H, q, J 7.1, CH2Me), 3.02 (3 H, s, MsMe), 1.27 (3 H, t, J 
7.1, CH2Me); 8c(75 MHz; CDC13) 153.2 (C), 151.6 (C), 147.6 (C), 145.0 (C), 
134.5 (C), 127.3 (CH), 126.4 (CH), 123.0 (CH), 118.4 (2CH), 112.0 (2CH), 66.4 
(CH2), 49.8 (CH2), 46.5 (CH2), 3 8.0 (CH3), 12.7 (CHA nil. (El) 426 (M), 42 8 
(M+-f 2); (C) 427 (MI-1), 429 (Nfll++2); COSY and HMQC spectra both 
exhibited a good correlation vvith the proposed structure. 
(2-Allyloxyethyl)-[4-(2-chloro-4-nitrophenylazo)-phenyll-ethylamine, 22. 
N 
ci 
N02 
To a solution of disperse red (1.0 g, 2.87 mmol) dissolved in dimethylformamide 
(10 ml) was carefully added cesium carbonate (100 mg, catalytic), sodium 
hydride [50% w/w dispersion in mineral oil], (276 mg, 5.75 mmol, 2.0 eq) and 
allyl bromide (0.37 ml, 4.31 mmol, 1.5 eq) at O*C. The reaction mixture was 
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stirred at room temperature for 4 hours after which time TLC (ethyl 
acetate: hexane, 4: 1) indicated that the starting material had been consumed. The 
solution was quenched with water, diluted with diethyl ether (40 ml), washed 
with water (3 x 30 ml), dried (MgS04), and concentrated in vacuo. The product 
was eluted by flash column chromatography (ethyl acetate: hexane, 1: 4) to give 
22 as a dark metallic green oil, (1.08 g, 2.78 mmol, 97%). mp 51-52'C (ethyl 
acetate/hexane); (Found: C, 58.55; H, 5.38; N, 14.47. C19H21CIN403 requires C, 
58.69; H, 5.44; N, 14.41%); vn., ý(Nujol)/cm-1 1602,1511,1337; 8H(300 Nfflz; 
CDC13) 8.32 (1 H, d, J 2.5, ArCH), 8.08 (1 H, dd, J 9.1,2.5, ArCH), 7.88 (2 H, 
d, JAB 9.2, ArCH), 7.73 (1 H, d, J 9.1, ArCH), 6.74 (2 H, d, JAB 9.2, ArCH), 5.90 
(I H, ddt, J 17.1,10.4,5.5, CH2CHCH20), 5.27 (1 H, ddt, J 17.1,1.5,1.5, trans- 
CH, CHCH, O), 5.19 (1 H, ddt, J 10.4,1.3,1.3, CiS-CH2CHCH20), 4.01 (2 H, dt, 
J 5.5,1.3, CH2CHCH20), 3.64 (4 H, br t, OCH2CH2N), 3.54 (2 H, q, J 7.1, 
CH2Me), 1.24 (3 H, t, J 7.1, CH2Me); 6c(75 MHz; CDC]-I) 153.5 (C), 152.3 (C), 
147.3 (C), 144.6 (C), 134.8 (CH), 134.2 (C), 127.4 (CH), 126.3 (CH), 123.0 
(2CH), 118.3 (CH), 117.6 (CH2), 111.8 (2CH), 72.7 (CH2), 68.0 (CH2), 50.8 
(CH2), 46.5 (CHA 12.6 (CF13); mýz (EI) 388 (M), 390 (M++2); (CI) 389 (mH+), 
391 (MH++2); COSY and HMQC spectra both exhibited a good correlation with 
the proposed structure. 
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3- (2- ([4- (2-Chloro-4-nitrophenylazo) -phenyll-ethylamino) -ethoxy) -propan- I -ol, 
23.48 
cl 
N02 
To a solution of the allyl derivative of disperse red 22 (200 mg, 0.57 mmol) in 
toluene (I ml) was added borane methyl sulfide (2 M in toluene, 0.29 ml, 0.57 
mmol) at O'C. The reaction mixture was stiffed at room temperature for 3 hours 
after which time TLC (ethyl acetate: hexane, 2: 3) indicated that the starting 
material had been consumed. This was then quenched carefully at O'C with 
methanol (2 ml), then hydrogen peroxide (30% aq. 0.13 ml, 1.15 mmol, 2 eq) and 
sodium hydroxide (2 M, 0.72 ml, 1.43 mmol, 2.5 eq) were carefully added. The 
reaction mixture was stirred at room temperature for 2 hours, washed with water 
(3 x 40 ml), dried (MgS04) and concentrated in vacuo. The product was clutcd 
by flash column chromatography (ethyl acetate: hexane, 1: 4) to give 23 as a dark 
metallic green oil, (93 mg, 0.23 mmol, 40%). v,,.,, (Nujol)/cm-1 3384,1600, 
1517,1336; 8H(300 MHz; CDC13) 8.39 (1 H, d, J 2.4, ArCH), 8.16 (1 H, dd, J 
9.0,2.4, ArCH), 7.94 (2 H, d, JAB 9.2, ArCH), 7.78 (1 H, d, J 9.0, ArCH), 6.78 
(2 H, d,. JAB 9.2, ArCH), 3.77 (2 H, dt, J 5.6, HOCH2CH2CH2), 3.69-3.62 (6 H, 
m, CH2), 3.56 (2 H, q,. l 7.2, CH2Me), 1.99 (1 H, t,. l 5.6, HOCH2CH-, CH2), 1.85 
(2 H, quint,. l 5.6, HOCH2CH2CH-, ), 1.25 (3 H, t,. l 7.2, CH-, )Me); 8c(75 MHz; 
CDC13) 153.5 (C), 152.3 (C), 147.4 (C), 144.6 (C), 134.3 (C), 127.4 (CH), 126.4 
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(CH), 123.0 (2CH), 118.4 (CH), 111.8 (2CH), 70.7 (CHA 69.0 (CHA 61.9 
(CH2), 50.7 (CHA 46.5 (CHA 32.5 (CH2), 12.6 (CH3); m1z (CI) 407 (MH+), 409 
(MH++2); (Found: MFl+, 407.1490. C19H23 35CIN404 requires MH+, 407.1486). 
COSY spectra exhibited a good correlation with the proposed structure. 
[4-(3-Bromo-propoxy)-phenyl]-acetic acid methyl ester, 19. 
Me" .I Nzý 
Br 
To a solution of methyl 4-hydroxyphenyl acetate (5.0 g, 30 mmol), in 
tetrahydrofuran (20 ml) was added 1,3-dibromopropane (6.1 ml, 60 mmol, 2 eq) 
and sodium hydride (50% w/w dispersion in mineral oil], (1.4 g, 30 mmol). The 
reaction mixture was stirred at room temperature for 12 hours after which time 
TLC (ethyl acetate: hexane, 1: 4) indicated that the starting material had been 
consumed. This was then diluted with diethyl ether (30 ml), washed with water 
(3 x 30 ml), dried (MgS04) and concentrated in vacuo. The product was 
isolated by flash column chromatography (ethyl acetate: hexane, 1: 4) to give 19 
as a clear colourless oil, (3.6 g, 12.5 mmol, 42%). (Found: C, 50.27; H, 5.26. 
C12HI5BrO3 requires C, 50.19; H, 5.27%); vj,,,, (Nujol)/cm-1 1736,1611; 8H(300 
MHz; CDC13) 7.19 (2 H, d, JAB 8.7, ArCH), 6.86 (2 H, d, JAB 8.7, ArCH), 4.07 
(2 H, t, J 6.5, CH2CH2CH2Br), 3.67 (2 H, s, ArCH2) 3.59 (2 H, t, J 6.5, 
CH2CH2CH2Br), 3.56 (3 H, S, C02Me), 2.29 (2 H. quint, J 6.5, CH2CH2CH2Br); 
8c(75 Nfflz; CDC13) 172.7 (C), 15 8.2 (C), 130.7 (2CH), 126.7 (C), 115.2 (2CH), 
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65.7 (CH2), 52.4 (CH3» 40.7 (CH2)2 32.7 (CH2), 30.5 (CH2); mlz (EI) 286 (M), 
288 (M++2); (CI) 181 (ME), 198 (MNH4+). 
[4- (2- ([4- (2-Chloro-4-nitrophenyla,: o) -phenyl]-ethylam ino) -ethoxy) -phenylj- 
acetic acid methyl ester, 18.55-57 
00 
Me, 
0 
N 
I cl 
N02 
To a solution of methyl 4-hydroxyphenyl acetate (4-8 g, 29 mmol), 
triphenylphosphine (7.6 g, 29 mmol) and diethyl azodicarboxylate (4.6 ml, 29 
mmol) in toluene (350 ml) at 80'C was added disperse red (5 g, 14.3 mmol, 0.5 
eq). The reaction mixture was stirred at 80*C for 30 minutes and then cooled to 
room temperature. This was then concentrated at 50*C under reduced pressure, 
then firstly crystallised and secondly recrystallised from ethyl acetate/hexane to 
give 18 as dark purple fine needles, (4.18 g, 8.41 mmol, 58%). mp 109-1 IOIC 
(ethyl acetate/hexane); (Found: C, 60.50; H, 5.09; N, 11.28. C25H25CIN405 
requires C, 60.42; H, 5.07; N, 11.27%); v,,., (Nujol)/cm-1 1737,1602,1512, 
1339; 811(300 MHz; CDC13) 8.33 (1 H, d, J 2.5, ArCH), 8.09 (1 H, dd, J 9.0,2.5, 
ArCH), 7.91 (2 H, d, JAB 9.2, ArCH), 7.74 (1 H, d,. f 9.0, ArCH), 7.19 (2 H, d, 
JAB 8.8, ArCH), 6.84 (2 H, d, JAB 8.8, ArCH), 6.78 (2 H, d, JAB 9.2, ArCH), 4.16 
136 
Experimental 
(2 H, t, J 5.8, ArOCH2CH2), 3.83 (2 H, t, J 5.8, ArOCH2CH2), 3.67 (3 H, 
C02Me), 3.60 (2 H, q, J 7.1, CH2Me), 3.56 (2 H, s, ArCH2), 1.28 (3 H, t, J 7.15 
CH2Me); 8c(75 MEz; CDC13) 172.7 (C), 158.0 (C), 153.4 (C), 152.1 (C), 147.5 
(C), 144.7 (C), 134.3 (C), 130.8 (2 CH), 127.4 (CH), 127.1 (C), 126.4 (CH), 
123.0 (CH), 118.4 (2 CH), 115.0 (2 CH), 111.9 (2 CH), 65.7 (CH2), 52.4 (CH3)5 
50.3 (CH2), 46.7 (CH2), 40.6 (CH2), 12.7 (CHA m1z (EI) 496 (M), 498 (M++2); 
(CI) 497 (MH+), 499 (MH++2); COSY and HMQC spectra both exhibited a good 
correlation vvith the proposed structure. 
[4-(2- (14- (2-Chloro-4-n itrophenylazo) -phenyll-ethylamino) -ethoxy) -phenyl]- 
acetic aci , 4.58 
01 al-zý 
0 N"""' N 
N 
N 
cl 
N02 
To a solution of the protected disperse red derivative 18 (1.08 g, 2.17 mmol) in 
tetrahydrofuran (150 ml) and water (10 ml) was added lithium hydroxide 
monohydrate (182 mg, 4.34 mmol 2.0 eq). The reaction mixture was stiffed at 
451C for 30 minutes after which time TLC (ethyl acetate: hexane, 4: 1) indicated 
that the starting material had been consumed. This was then cooled to room 
temperature, concentrated at 30'C under reduced pressure, diluted with 
dichloromethane (40 ml), washed with HCI (2 M, 3x 30 ml), water (3 x 30 ml), 
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dried(MgSO4) and concentrated in vacuo to give 24 as a red powder, (828 mg, 
1.71 mmol, 79%). mp 192-193'C (ethyl acetate/hexane); (Found: C, 59.43; H, 
4.82; N, 11.65. C24H23CIN405 requires C, 59.69; H, 4.80; N, 11.60%); 
Vmax(Nujol)/cm-1 1695,1601,1511,1337; 81ý300 MHz; CDC13) 12.26 (1 H, br s, 
C02H), 8.37 (1 H, d, J 2.5, ArCH), 8.20 (1 H, dd, J 9.0,2.5, ArCH), 7.84 (2 H, 
d, JAB9.3, ArCH), 7.74 (1 H, d, J 9.0, ArCH), 7.17 (2 H, d, JAB8.7, ArCH), 6.94 
(2 H, d, JAB9.3, ArCH), 6.88 (2 H, d, JAB8.7, ArCH), 4.17 (2 H, t, J 5.4, 
ArOCH2CH2), 3.86 (2 H, t, J5.4, ArOCH2CH2), 3.62 (2 H, q, J7.0, CH2Me), 
3.48 (2 H, s, ArCH2), 1.19 (3 H, t, J 7.0, CH2N[e); 5c(75 MHz; CDC13) 173.3 
(C), 157.4 (C), 152.6 (C), 152.5 (C), 147.0 (C), 143.7 (C), 132.7 (C), 130.8 (2 
CH), 127.7 (C), 127.1 (CH), 126.0 (CH), 123.6 (CH), 118.3 (2 CH), 114.5 (2 
CH), 112.2 (2 CH), 65.7 (CH2), 49.6 (CH2), 45.8 (CH2), 40.1 (CH2), 12.4 (CH3); 
m1z (EI) 482 (M), 484 (M++2); (CI) 483 (MH+), 485 (MH++2); COSY and 
HMQC spectra both exhibited a good correlation with the proposed structure. 
2-Benzyloxyethanol, 25.95 
0, -N,,, 
OH 
Ethylene glycol (80 ml, 1.44 mol, 8 eq) was heated to 90'C and sodium 
hydroxide (7.2 g, 180 mmol, I eq) and 3A molecular sieves (60 g) were added. 
The reaction mixture was stiffed at 90'C until the sodium hydroxide dissolved 
(ca. 3 hours), after which time benzylbromide (21.8 ml, 180 mmol, I eq) was 
carefully added and the reaction mixture was stirred for a further 3 hours at 900C. 
138 
Experimental 
The reaction mixture was then cooled to room temperature, diluted with acetone 
and the molecular sieves removed by filtration. The filtrate was concentrated 
under reduced pressure, diluted with ethyl acetate (60 ml) and washed with water 
(3 x 40 ml). The organic extract was dried (MgS04) and concentrated at 40'C 
under reduced pressure and the product eluted by flash column chromatography 
(ethyl acetate. - hexane, 1: 4) to give 25 as a clear colourless oil, (16.6 g, 109 mmol, 
61%). v,,,,,, (Nujol)/cm-1 3403; 8H(300 MHz; CDC13) 7.34-7.22 (5 H, m, ArCH) 
4.50 (2 H, s, ArCH2), 3.68 (2 H, t, 14.7, CH2CH20H), 3.51 (2 H, t, J 4.7, 
CH2CH20H), 3.08 (1 H, s, OH); 5c(75 MHz; CDC13) 138.4 (C), 129.4 (CH), 
12 8.9 (CH), 12 8.3 (CH), 12 8.2 (CH), 12 7.8 (CH), 73.6 (CHA 71.7 (CH2), 62.1 
(CH2); m: (EI) 152 (M); (CI) 153 (MH+), 170 (MNH4+) (Found: MN114+, 
170.1181. CgH1202 requires MNH4+, 170.1179). 
(2-Allyloxyethoxymethyl) -benzene, 26.96 
Nk 
To a solution of mono protected ethylene glycol 25 (10.0 g, 65.8 mmol) 
dissolved in tetrahydrofuran (50 ml) was carefully added sodium hydride [50% 
w/w dispersion in mineral oil], (3.47 g, 72 mmol, 1.1 eq) and allyl bromide (6.7 
ml, 79 mmol, 1.2 eq) at OOC. The reaction mixture was stirred at room 
temperature for 4 hours after which time TLC (ethyl acetate: hexane, 1: 4) 
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indicated that the starting material had been consumed. This was carefully 
quenched with water at O*C, diluted with diethyl ether (40 ml), washed with 
water (3 x 30 ml), dried (MgS04), and concentrated in vacuo. The product was 
eluted by flash column chromatography (ethyl acetate: hexane, 1: 49) to give 26 as 
a clear colourless oil, (9.79 g, 5 1.0 mmol, 78%). (Found: C, 74.80; H, 8.37. 
C12HI602 requires C, 74.97; H, 8.39%); vna,, ý11jol)/cm-1 1645; 6000 MHz; 
CDC13) 7.3 8-7.22 (5 H, in, ArCH), 5.93 (1 H, ddt, J 17.3,10.4,5.7, 
CH2CHCH20), 5.2 8 (1 H, ddt, J 17.3,1.93 1.3, trans-CH2CHCH20), 5.18 (1 H, 
ddt, J 10.4,1.9,1.3, CiS-CH2CHCH20), 4.56 (2 H, s, ArCE[2), 4.02 (2 H, dt, J 
5.7,1.3, CH2CHCH2O), 3.62 (4 H, br s, OCH2CH2); 8c(75 MHz; CDC] 3) 13 8.7 
(C), 13 5.2 (CH), 12 8.8 (2 CH), 12 8.2 (2 CH), 12 8.0 (CH), 117.5 (CHA 73.7 
(CHA 72.7 (CHA 69.9 (CH2), 69.8 (CHA ml-'- (El) 192 (M); (CI) 2 10 
(N4NH4+). COSY spectra exhibited a good correlation with the proposed 
structure. 
3-(2-Bený-yloxyethoxy)-propan-l-ol, 27.97 
I Nzý 
To a solution of the allyl substrate 26 (4 g, 20.8 mmol) in toluene (30 ml) was 
added borane methyl sulfide (2 M in toluene, 10.4 ml, 20.8 mmol) at O'C. The 
reaction mixture was stiffed at room temperature for 3 hours after which time 
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TLC (ethyl acetate: hexane, 1: 4) indicated that the starting material had been 
consumed. This was then quenched carefully at O'C with methanol (37 ml), then 
hydrogen peroxide (30% aq. 2.8 ml, 25 mmol, 1.2 eq) and sodium hydroxide (2 
M, 26 ml, 52 mmol, 2.5 eq) were carefully added. The reaction mixture was 
stirred at room temperature for 2 hours. This was then washed with water (3 x 
40 ml), dried (MgS04) and concentrated in vacuo. The product was eluted by 
flash column chromatography (ethyl acetate: hexane, 1: 9) to give 27 as a clear 
very pale yellow oil, (1.97 g, 9.38 mmol, 45%). v,,.,, (Nujol)/cm-1 3417; 8,1(300 
MHz; CDC13) 7.39-7.23 (5 H, in, ArCH), 4.53(2 H, s, ArCHA 3.69 (2 H, t, J 
6.0, CH2CH2CH20H), 3.60 (2 H, t, J 6.0, CH2CH2CH20H), 3.59 (4 H, br s, 
OCH2CH2), 3.31 (1 H, s, OH), 1.80 (2 H, quint, J 6.0, CH2CHCH20); 6c(75 
MHz; CDC13) 138.5 (C), 130.4 (2 CH), 129.3 (2 CH), 128.0 (CH), 73.6 (CH2), 
70.6 (Cff2), 70.0 (CH2), 69.7 (CH2), 61.2 (CH2), 32.8 (C142); m1z (El) 2 10 (M); 
(CI) 211 (MH); m,. - (Found: MNH4+, 228.1599. C12HI803 requires MN144+, 
228.1600). COSY spectra exhibited a good correlation with the proposed 
structure. 
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[4-(2-t[4-(2-Chloro-4-nitrophenylazo) -phenyl]-ethylamino)-ethoxy) -phenyl]- 
acetic acid 3-(2-ben-, yloxyethoxy)-propyl ester, 29. '9,9" 
00 
.- 
X ýi leý 
N*ý 
N 
, ci 
NO2 
To a suspension of 24 (500 mg, 1.04 mmol) in toluene (60 ml) oxalyl chloride 
(0.10 ml, 1.14 mmol, 1.1 eq) and one drop of dimethylformamide were added 
and the reaction mixture was stirred at 40*C for I hour. This was then 
concentrated at 50*C under reduced pressure, dissolved in dichloromethane (30 
ml) and quenched with triethylamine (10 ml). The alcohol 27 (326 mg, 1.55 
mmol, 1.5 eq) was then added and the reaction mixture stiffed at room 
temperature for 2 hours after which time TLC (ethyl acetate: hexane, 2: 3) 
indicated that the starting material 24 had been consumed. The reaction mixture 
was washed with HCI (2 M, 3x 30 ml), water (3 x 30 ml), dried (MgSO4), and 
concentrated in vacuo. The product was eluted by flash column chromatography 
(ethyl acetate: hexane, 1: 4) to give 29 as a dark metallic green oil, (216 mg, 0.32 
mmol, 3 1%). v.,, (Nujol)/cm-1 1736,1598,1518,1337; 6IK300 MHz; CDC13) 
8.3 5 (1 H, d, J 2.4, ArCH), 8.12 (1 H, dd, J 8.9,2.4, ArCH), 7.93 (2 H, d, JAB 
9.2, ArCH), 7.76 (1 H, d, J 8.9, ArCH), 7.35-7.23 (5 H, m, ArCH), 7.18 (2 H, d, 
JAB 8.8, ArCH), 6.83 (. 2 H, d, JAB 8.8, ArCH), 6.80 (2 H, d, JAB 9.2, ArCH), 4.55 
(2 H, s, ArCHA 4.18 (2 H, t, J 6.4, CH2CH2CH202C), 4.16 (2 H, t, J 5.5, 
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BnOCH2CH2), 3.84 (2 H, t, J5.5, BnOCH2CH2), 3.64-3.48 (10 H, m, CHAI-90 
(2 H, quint, J 6.4, CH2CH2CH202C), 1.28 (3 H, t, J 7.1, CH2Me); 8c(75 MHz; 
CDC13) 172.2 (C), 157.9 (C), 153.5 (C), 152.1 (C), 147.5 (C), 144.8 (C), 138.6 
(C), 134.3 (C), 130.8 (2 CH), 128.8 (2 CH), 128.1 (2 CH), 128.0 (2 CH), 127.4 
(CH), 127.2 (C), 126.4 (CH), 123.0 (CH), 118.4 (CH), 114.9 (2 CH), 111.9 (2 
CH), 73.6 (CHA 70.7 (CHA 69.8 (CHA 68.1 (CHA 65.7 (CH2), 62.5 (CHA 
50.4 (CH2), 46.7 (CH2), 40.9 (CH2), 29.3 (CH2). 12.7 (CH3); m1z (EI) 674 (M), 
676 (M++2); (CI) 575 (MH+), 577 (MH++2); (Found: Nffiý, 675.2585. 
C3617139 35CIN407 requires M14+, 675.2585). COSY and HMQC spectra both 
exhibited a good correlation with the proposed structure. 
2-Allyloxyethanol, 30 
Ethylene glycol (150 ml, 2.7 mol, 5 eq) was heated to 90'C and sodium 
hydroxide (21.6 g, 540 mmol, I eq) and 3A molecular sieves (100 g) were added 
at 60*C. The reaction mixture was stiffed at 90*C until the sodium hydroxide 
dissolved (ca. 3 hours), after which time allyl bromide (45.7 ml, 540 mmol, I eq) 
was carefully added. The reaction mixture was stiffed at 60*C for 6 hours. The 
reaction mixture was then cooled to room temperature, diluted with acetone and 
the molecular sieves removed by filtration. The filtrate was concentrated at 400C 
under reduced pressure, diluted with ethyl acetate (50 mi) and washed with water 
(3 x 40 ml). The organic extract was dried (MgS04) and concentrated in vacuo. 
The product was eluted by flash column chromatography (ethyl acetate: hexane, 
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1: 9) to give 30 as a clear colourless oil, (21.5 g, 211 mmol, 39%). 
vmx(Nujol)/cm- 1 3406 (OH); 8H(300 MHz; CDC13) 5.93 (1 H, ddt, J 17.3,10.4, 
5.7, CH2CHCH2O) 5.29 (1 H, ddd, J 17.3,3.0,1.5, trans-CH2CHCH20), 5.21 (1 
H, ddd, J 10.4,3.0,1.5, cis-CH2CHCH20), 4.04 (2 H, dt, J 5.7,1.5, 
CH2CHCH2O), 3.75 (2 H, t, J 4.6, HOCH2CH2) 3.56 (2 H, t, J 4.6, HOCH2CH2), 
2.41 (1 H, s, OH); 8c(75 Nfflz; CDC13) 134.2 (CH), 117.0 (CH2), 71.8 (CH2), 
71.2 (CH2), 61.3 (CH2); nL11Z (CI) 120 (NWH4+) (Found: MNH4+, 120.1026. 
C51-11002 requires MNH4+, 120.1025). COSY and HMQC spectra both exhibited 
a good correlation with the proposed structure. 
61,62 (2-Allyloxyethoxy)-tert-butyldimethylsilane, 31 
. 
Me 
Meý, I 
, 0ý0N, -'o-S 
5< 
To a solution of the ally] substrate 30 (3 g, 29 mmol) and imidazole (3 g, 44 
mmol, 1.5 eq) in dichloromethane (20 ml), t-butyldirnethyl silane (3 g, 44 mmol, 
1.5 eq) were added at O`C. The reaction mixture was stirred at room temperature 
for 3 hours after which time TLC (ethyl acetate: hexane, 1: 4) indicated that the 
starting material had been consumed. This was then washed with water (3 x 30 
ml), dried (MgS04) and concentrated in vacuo. The product was eluted by flash 
column chromatography (ethyl acetate: hexane, 1: 99) to give 31 as a clear 
colourless oil, (5.0 g, 23 mmol, 80%). (Found: C, 61.2 8; H, 11.15. CII H2402Si 
requires C, 61.05; H, 11.18%); v,,.,, (Nujol)/cm-1 3374; 6H(300 MHz; CDC13) 5-90 
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(I H, ddt, J 17.3,10.6,5.6, CH2CHCH20) 5.27 (1 H, ddt, J 17.3,1.7,1.7, trans- 
CH2CHCH20), 5.16 (1 H, ddt, J 10.6,1.5,1.3, cis-CH2CHCH20), 4.02 (2 H, dt, 
J 5.6,1.4, CH2CHCH20), 3.77 (2 H, t, J 5.4, OCH2CH2) 3.51 (2 H, t, J 5.4, 
OCH2CH2). 0-90 (9 H, s, SjCMe3). 0-09 (6 H, s, SiMe2); 5c(75 MHz; CDC13) 
13 5.9 (CH), 117.7 (CH2), 73.2 (CH2), 72.6 (CH2), 63.8 (CHA 26.9 (CHA 19.4 
(C), 4.3 (CH3); m//ý- (CI) 217 (NM+); COSY and FIMQC spectra both exhibited a 
good correlation vvith the proposed structure. 
3-[2-(Iert-But 48 yldimethylsilanyloxy)-ethoxyl-propan-l-ol, 33. 
Me 
Me 
To a solution of the allyl substrate 31 (2.5 g, 11.6 mmol) in toluene (10 ml) was 
added borane dimethyl. sulfide (I. I ml, 11.6 mmol) at O*C. The reaction mixture 
was stirred at room temperature for 30 minutes after which time TLC (ethyl 
acetate: hexane, 1: 4) indicated that the starting material had been consumed. This 
was then quenched carefully at OI'C with methanol (4 mi), then hydrogen 
peroxide (30% aq. 2.6 ml, 23 mmol, 2 eq) and sodium hydroxide (920 mg, 23 
mmol, 2 eq) was carefully added. The reaction mixture was stirred at room 
temperature for 8 hours. This was then washed with water (3 x 30 ml), dried 
(MgS04) and concentrated in vacuo. The product was eluted by flash column 
chromatography (ethyl acetate: hexane, 1: 49) to give 33 as a clear colourless oil, 
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(I. I g, 4.7 mmol, 41 %). v ýNujol)/cm-l 3414; 8H(300 MHz; CDC13) 3.75 (2 H, 
t, J 5.6, CH2CH2CH20H), 3.74 (2 H, t, J 5.5, TBSOCH2CH2). 3.66 (2 H, t, J 5.5, 
TB SOCH2CH2), 3.51 (2 H, t, J 5.6, CH2CH2CH20H), 2.68 (1 H, s, OH), 1.81 (2 
H, quint, J 5.6, CH2CH2CH20H), 0.88 (9 H, s, SiCMeA 0.05 (6 H, s, SiMeA 
6C(75 MHz; CDC13) 72.8 (CHA 7 1.0 (CHA 63.0 (CHA 62.1 (CHA 32.3 (CHA 
26.1 (CHA18.7 (C), -5.0 (CHA m/ý- (CI) 235 (ME), 252 (Wm4) (Found: 
MNH4+, 252.1998. CIIH2603Si requires MNIIý+, 252.1995). 
2-(tert-Butyldimethylsilanyloxy)-ethanol, 32.61,62 
Me Me 
Si 
0 >< 
To a solution of ethylene glycol (7.38 ml, 132 mmol, 5 eq) and imidazole (3.6 g, 
5.3 mmol, 2 eq) in dimethylformamide (100 ml), lert-butyldimethylsilyl chloride 
(4 g, 26.5 mmoI) was carefully added at OIC. The reaction mixture was stirred 
for 12 hours at room temperature after which TLC (ethyl acetate: hexane, 1: 4, and 
PMA dip to visualise) indicated that the tert-butyldimethylsilyl chloride had been 
entirely consumed. The reaction mixture was diluted with water (70 ml) and the 
product extracted with diethyl ether (5 x 30 ml). The diethyl ether fractions were 
combined and washed with water (2 x 20 ml), dried (MgSO4) and concentrated in 
vacuo to give a pale yellow oil. The product was eluted by flash column 
chromatography (ethyl acetate: hexane, 1: 49) to give 32 as a clear colourless oil, 
(3.45 g, 19.6 mmol, 74%). (Found: C, 54.31; H, 11.34. C81-12002Si requires C, 
146 
Experimental 
54.49; H, 11.43%); v.,, (Nujol)/cm-' 3374; M300 MHz; CDC13) 3.69 (2 H, t, J 
4.9, CH2CH2OH), 3.61 (2 H, t, J 4.9, CH2CH20H), 2.42 (1 H, s, CH2CH20H), 
0.87 (9 H, s. SiCMeA 0.06 (6 H, s, SiMeA 8c(75 MHz; CDC13) 64.5 (CH2), 
64.1 (CH2), 26.3 (CHA18.7 (C), -5.0 (CH3); MIZ (Cl) 177 (MH+); COSY and 
HMQC spectra both exhibited a good correlation with the proposed structure. 
[4- (2- [[4- (2-Chloro-4-n itrophenylazo) -phenyl]-ethylamino) -ethoxy) -phenyl]- 
acelic acid 3-[2-(tert-butyldimethylsilanyloxy)-ethoxy]-propyI ester, 34.55-57 
Me 
'%Sl-o,, ýO, -ý 0ý 
Me 
N 
cl 
N02 
To a solution of the alcohol 33 (2.57 g, 11.0 mmol), triphenylphosphine (2.90 g, 
11.0 mmol) and diethyl azodicarboxylate (1.71 ml, 11.0 mmol) in toluene (300 
ml) was added the acid 24 (3.55 g, 7.37 mmol, 0.67 eq). This was stiffed at 501V 
for 5 hours and then room temperature for 2 days after which time TLC (ethyl 
acetate: hexane, 2: 3) indicated that the acid had been consumed. The solution 
was then concentrated at 50'C under reduced pressure, diluted with 
dichloromethane, washed with water (3 x 30 ml), dried (MgS04) and 
concentrated in vacuo. The product was eluted by flash column chromatography 
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(ethyl acetate: hexane, 1: 4) to give 34 as a dark metallic green oil, (6.0 g, 8.60 
mmol, 83%). mp 38-39'C (diethyl ether/cyclohexane); (Found: C, 60.07; H, 
6.71; N, 7.99. C351-147CIN407Si requires C, 60.11; H, 6.77; N, 8.01%); 
v. x(Nujol)/cm-1 1741,1604,1514,1376; 6H(300 MHz; CDC13) 8.39 (1 H, d, J 
2.5, ArCH), 8.16 (1 H, dd, J 9.0,2.5, ArCH), 7.96 (2 H, d, JAB 8.9, ArCH), 7.79 
(I H, d, J 9.0, ArCH), 7.19 (2 H, d, JAB 8.9, ArCH), 6.84 (4 H, d, JAB 8.9, 
ArCH), 4.18 (2 H, t, J 5.8, ArOCH2CH2), 4.17 (2 H, t, J 6.1, CH2CH2CH202C), 
3.86 (2 H, t, J 5.8, ArOCH2CH2), 3.73 (2 H, t, J 5.3, SiOCH2CH2), 3.63 (2 H, q, 
J 7.1 CH2Me) 3.55 (2 H, s, ArCH2) 3.49 (2 H, t, J 6.1, CH2CH2CH202C) 3.46 (2 
H, t, J5.3, SIOCH2CH2), 1.88(2 H, quint, J6.1, CH2CH2CH202C), 1.30(2 H, t, 
J 7.1, CH2Me), 0.89 (9 H, s, SiCMe3), 0.06 (6 H, s, SlMe2); 8c(75 MHz; CDC13) 
171.6 (C), 157.3 (C), 152.8 (C), 151.5 (C), 146.8 (C), 144.1 (C), 133.7 (C), 130.2 
(2 CH), 126.8 (CH), 126.6 (C), 125.7 (CH), 122.4 (CH), 117.7 (2 CH), 114.2 (2 
CH), I 11.3 (2 CH), 72.2 (CH2), 67.4 (CH2), 65.1 (CH2), 62.5 (C142), 61.9 (CHA 
49.7 (CH2), 46.1 (CHA 40.2 (CH2), 28.8 (CH2), 25.7 (CHA 18.2 (C), 12.1 
(CHA-5.0 (CH3); m1z (EI) 698 (M+), 670 (M'-+2); (Cl) 699 (MH+), 701 
(MH++2), COSY and HMQC spectra both exhibited a good correlation with the 
proposed structure. 
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[4-(2- ([4-(2-Chloro-4-nitrophenylazo) -phenyl]-ethylamino) -ethoxy) -phenyl]- 
61 
acetic acid 3-(2-hydroxyethoxy)-propyl ester, 14 . 
0 "ýt 
OýýNýý 
N,, 
N 
cl 
N02 
To a solution of 34 (70 mg, 0.10 mmol) in tetrahydrofuran (5 ml) was added 
tetrabutylammoniurn fluoride trihydrate (35 mg, 0.11 mmol, 1.1 eq). The 
reaction mixture was stirred at 40"C for 2 hours after which time TLC 
(tnethylamine: ethyl acetate: hexane, 1: 20: 30) indicated that the starting material 
had been consumed. This was then diluted with diethyl ether (30 mi), washed 
with IM HCI (3 x 30 ml), water (3 x 30 ml), dried (MgSO4), and concentrated in 
vacuo. The product was eluted by flash column chromatography (ethyl 
acetate: hexane, 1: 4) to give 14 as a dark metallic green oil, (20 mg, 34 PLmol, 
34%). mp 92-93'C (ethyl acetate/hexane); v.,, ýqjol)/cm-' 1714,1603,1509, 
1462,1377; 8H(300 MHz; CDC13) 8.38 (1 H, d, J 2.4, ArCH), 8.14 (1 H, dd, J 
9.0,2.4, ArCH), 7.95 (2 H, d, JAB 8.9, ArCH), 7.78 (1 H, d, J 9.0, ArCH), 7.19 
(2 H, d, JAB 8.7, ArCH), 6.85 (2 H, d, JAB 8.7, ArCH), 6.82 (2 H, d, JAB 8.9, 
ArCH), 4.20 (2 H, t, J 6.3, CH2CH2CH202C), 4.18 (2 H, t, J 5.8, ArOCH2CH2), 
3.86 (2 B, t, J 5.8, A-TOCH2CH2), 3.69 (2 H, t, J 4.5, HOCII12CH2), 3.62 (2 H, q, 
J 7.1, CH2Me) 3.51 (2 H, s, ArCR2) 3.49 (2 H, t, J 4.5, HOCH2CH2) 3.48 (2 H, 
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J 6.3, CH2CH2CH202C), 2.07 (1 H, s, HOCH2CH2), 1.89 (2 H, quint, J 6.3, 
CH2CH2CH2O2C), 1.29 (3 H, t, J 7.1, CH2Me); 8c(75 MHz; CDC13) 171.6 (C), 
157.3 (C), 152.8 (C), 151.5 (C), 146.8 (C), 144.1 (C), 133.7 (C), 130.8 (2 CH), 
127.4 (CH), 127.2 (C), 126.4 (CH), 123.0 (CH), 118.4 (2 CH), 114.9 (2 CH), 
112.0 (2 CH), 72.3 (CHA 67.8 (CHA 65.7 (CHA 62.2 (2 CHA 50.4 (CHA 
46.7 (CHA 40.9 (CHA 29.3 (CHA 12.7 (CHA m1z (EI) 5 84 (M), 5 86 (M++2); 
(CI) 585 (MH+), 587 (MH++2) (Found: M+, 584.2044. C291-133 35CIN407 requires 
M+, 584.2038). COSY and FIMQC spectra both exhibited a good correlation 
with the proposed structure. 
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The 16 residue peptide was sequentially synthesised via a conventional manual 
solid phase Fmoc/TFA strategy on Tentagel polymer support. The peptide's 
sequence was HO-Lys-Ala-Ala-Ala-Glu-Ser-Lys-Ala-Ala-His-Glu-Leu-Glu- 
Asp-Pro-Asp-NH2, where L-lysine was the first amino acid attached, and L- 
aspartic acid was the last. The peptide was prepared on a mixture of 90% 
Tentagel and 10% acid labile Rink linker. 
The amino acids were all Fmoc protected at the amino terminal, leaving the acid 
terminal unprotected. Additional protecting groups were used for the side chains 
if necessary. These were; 
a) t-Butyl for aspartic acid, glutamic acid and serine. 
b) I-Butyl carbamate for lysine. 
c) Trityl for histidine. 
The coupling reagent of choice was PyBOP, utilised with DIPEA and HOBt in 
dimethylformamide. 2g of Tentagel With a loading of 0.60 mmolg-1 and 200 mg 
of Tentagel rink linker with a loading of 0.40 mmolg-' was used, giving a 
mixture with a loading of 0.58 mmolg- . 
The general amino acid coupling and Fmoc deprotection procedures were; 
a) The Tentagel resin (1.0 eq) was swollen for 30 minutes in 
dimethylformamide (15 ml) in a peptide flask designed for nitrogen bubbling 
and suction. Gentle mixing was afforded by bubbling nitrogen through the 
suspension. The protected amino acid, (2.5 eq), PyBOP (2.5 eq), HOBt (2.5 
eq) and DIPEA (5 eq) were then added and the mixing continued by bubbling 
nitrogen through the solution for 3 hours. The solvent was then removed via 
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filtration and the support washed with dimethylfonnamide (2 x 20 ml), 
dichloromethane (2 x 20 ml), methanol (2 x 20 ml) and dimethylformamide 
(I x 20 ml). The conversion was verified by a negative Kaiser and TNBS 
test. A double coupling was undertaken if necessary. 
b) The resin functionallsed with an Fmoc protected amino acid was gently 
mixed in a solution of pipendine: dimethylformamide, 1: 4, by bubbling 
nitrogen through for 20 minutes. The solution was then removed by filtration 
and the resin washed with dimethylforinamide (2 x 20 ml). The Kaiser and 
TNBS tests indicated the successful deprotectiOn by yielding a positive 
result. 
Upon coupling the last amino acid residue and removal of its Fmoc protection, 
the bulk resin was washed with dimethylformamide (2 x 20 ml), dichloromethane 
(2 x 20 ml) and methanol (2 x 20 ml) and dried under reduced pressure to give 40 
as a pale yellow resin (3.8 g, 71 %). The yield was based on the expected 
increase of the resin's weight. 
Removal of the peptide's side chain protecting groups and partial cleavage of the 
peptide was performed on a small sample of 40 (200 mg) by gently bubbling 
nitrogen through a suspension of the resin in a solution of 
triisopropylamine: TFA, 1: 49 (2 ml) for I hour. The solution was removed by 
filtration and the filtrate was collected and dried under reduced pressure to give 
an off white powder 42 (6 mg) ); m1z (FAB) 1681 (M) (Found (ES) 561.2787 
(MH3 3+)ý 841.4056 (NlH22+), C7oHj 14N21027 requires (ES) 561.2809 (MH3 3+ 
841.4175 (MH22+)). 
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The supported deprotected peptide was washed with dimethylformamide, 
dichloromethane and methanol, and dried under reduced pressure to give a pale 
yellow resin 41 (160 mg). 
[4-(2- f [4-(2-Chloro-4-nitrophenylazo)-phenyl]-ethylamino) -ethoxy)-phenylj- 
55-57 
acetic acid-2-(2-hydroxyethoxy)-ethyl ester, 46 . 
01 "zk 
0'*ý 
N'-"' 
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N, x 
N 
ci 
N02 
To a solution of 24 (200 mg, 0.41 mmol), triphenylphosphine (162 mg, 0.62 
mmol, 1.5 eq) and diethyl azodicarboxylate (108 mg, 0.62 mmol, 1.5 eq) in 
toluene (20 ml) diethylene glycol (66 mg, 0.62 mmol, 1.5 eq) was added. The 
reaction mixture was stirred for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 501C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 46 as a dark red oil, (190 mg, 0.33 mmol, 
81 %). vm (Nujol)/cm-1 3451,1731,1599,1514,1335; 6IK300 MHz; CDC13) 
8.3 8 (1 H, d, J 2.4, ArCH), 8.14 (1 H, dd, J 9.0,2.4, ArCH), 7.95 (2 H, d, JAB 
9.0, ArCH), 7.78 (1 H, d, J 9.0, ArCH), 7.21 (2 H, d, JAB 9.3, ArCH), 6.85 (2 H, 
d, JAB 9.0, ArCH), 6.82 (2 H, d, JAB 9.3, ArCH), 4.26 (2 H, t, J 4.7, CH2), 4.18 
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(2 H, t, J 5.7, ArOCH2CH2), 3.86 (2 H, t, J 5.6, ArOCH2CH2), 3.72-3.67 (4 H, 
CH2), 3.64-3.54 (6 H, m, CH2), 1.95 (1 H, S, OH), 1.29 (3 H, t, J 7.0, 
CH2Me); 8c(75 MRz; CDC13) 172.2 (C), 158.0 (C), 153.5 (C), 152.0 (C), 147.5 
(C), 144.8 (C), 134.3 (C), 130.8 (2 CH), 127.4 (CH), 127.0 (C), 126.4 (CH), 
123.0 (CH), 118.4 (2 CH), 114.9 (2 CH), 112.0 (2 CH), 72.7 (CH2), 69.4 (CHA 
65.7 (CH2), 64.2 (CHA 62.1 (CHA 50.4 (CH2), 46.8 (CHA 40.7 (CHA 12.7 
(CHA m1z (CI) 571 (NIH), 573 (MH++2) (Found: MH+, 571.1947. 
C2817131 35 CIN407 requires ME+, 571.1960); HMQC spectra exhibited a good 
correlation vAth the proposed structure. 
[4- (2- t[4- (2- Chloro-4-n itrophenylazo) -phenyl]-ethylam ino) -ethoxy) -phenyl]- 
55-57 
acetic acid 2-[2-(2-hydroxyethoxy)-ethoxy]-ethyl ester, 47 . 
HOýý 
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z 
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To a solution of 24 (200 mg, 0.41 mmol), triphenylphosphine (162 mg, 0.62 
mmol, 1.5 eq) and diethyl azodicarboxylate (108 mg, 0.62 mmol, 1.5 eq) in 
toluene (20 ml) was added triethylene glycol (93 mg, 0.62 mmol, 1.5 eq). The 
reaction mixture was stiffed for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
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The toluene was removed at 50"C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 47 as a dark red oil, (180 mg, 0.29 mmol, 
71 %). v .. a,, (Nujol)/cm-1 3439,1736,1599,1513,1336; 8H(300 MHz; CDCII) 
8.3 7 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.0,2.5, ArCH), 7.93 (2 H, d, JAB 
9.2, ArCH), 7.76 (1 H, d, J 9.0, ArCH), 7.20 (2 H, d, JAB 8.7, ArCH), 6.84 (2 H, 
d, JAB 8.7, ArCH), 6.81 (2 H, d, JAB 9.2, ArCH), 4.25 (2 H, t, J 4.7, CHA 4.17 
(2 H, t, J 5.7, ArOCH2CH2), 3.85 (2 H, t, J 5.7, ArOCH2CH2), 3.74-3.68 (4 H, 
m, CHA 3.66-3.58 (10 H, m, CHA 2.41 (1 H, s, OH), 1.29 (3 H, t, J 7.0, 
CH2Me); 8c(75 MHz; CDC13) 172.3 (C), 158.0 (C), 153.5 (C), 152.1 (C), 147.5 
(C), 144.7 (C), 134.3 (C), 130.9 (2 CH), 127.4 (CH), 127.0 (C), 126.4 (CH), 
123.0 (CH), 118.4 (2 CH), 114.9 (2 CH), 111.9 (2 CH), 72.9 (CHA 70.9 (CHA 
70.7 (CHA 69.5 (CHA 65.7 (CHA 64.2 (CHA 62.1 (CHA 50.4 (CHA 46.7 
(CH2), 40.6 (CH2), 12.7 (CHA nz/ý- (CI) 615 (MH), 617 (MH++2) (Found: M+, 
614.2140. C3oH35 35CIN40s requires M+, 614.2143); HMQC spectra exhibited a 
good correlation Nkrith the proposed structure. 
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[4-(2- [[4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylam ino) -ethoxy) -phenylj- 
acetic acid 2-[2-[2-(2-hydroxyethoxy) -ethwyl-ethoxy) -ethyl ester, 48.55-57 
01 14; ze 
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To a solution of 24 (200 mg, 0.41 mmol), triphenylphosphine (162 mg, 0.62 
mmol, 1.5 eq) and diethyl azodicarboxylate (108 mg, 0.62 mmol, 1.5 eq) in 
toluene (20 ml) was added tetraethylene glycol (120 mg, 0.62 mmol, 1.5 eq). 
The reaction mixture was stirred for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 5011C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 48 as a dark red oil, (198 mg, 0.30 mmol, 
73%). v,,., (Nujol)/cm-1 3441,1737,1600,1514,1337; 6H(300 MHz; CDC13) 
8.37 (1 H, d, J 2.5, ArCH), 8.14 (1 H, dd, J 9.0,2.5, ArCH), 7.94 (2 H, d, JAB 
9.1, ArCH), 7.77 (111, d, 3 9.0, ArCH), 7.20 (2 H, d, JAB 8.6, ArCH), 6.84 (2 H, 
d, JAB 8.6, ArCH), 6.81 (2 H, d, JýB 9.1, ArCH), 4.25 (2 H, t, J 4.8, CH2), 4.18 
(2 H, t, J 5.7, ArOCH2CH2), 3.86 (2 H, t, J 5.7, ArOCH2CH2), 3.73-3.59 (18 H, 
m, CHA 2.46 (1 H, s, OH), 1.29 (3 H, t, J 7.1, CH2Me); 8c(75 MHz; CDC13) 
172.2 (C), 157.9 (C), 153.5 (C), 152.1 (C), 147.5 (C), 144.8 (C), 134.3 (C), 130.9 
(2 CH), 127.4 (CH), 127.1 (C), 126.4 (CH), 123.0 (CH), 118.4 (2 CH), 114.9 (2 
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CH), 112.0 (2 CH), 72.9 (CH2), 7 1.0 (CHA 70.9 (2 CHA 70.7 (CH2), 69.5 
(CH2), 65.7 (CHA 64.3 (CHA 62.1 (CHA 50.4 (CH2), 46.7 (CH2), 40.6 (CI-12)ý 
12.7 (CH3); m/z (El) 658 (M+), 660 (M++2); (CI) 659 (MH+), 661 (MH++2) 
(Found: M+, 658.2413. C32H39 35CIN409 requires M+, 658.2406); HMQC spectra 
exhibited a good correlation vvith the proposed structure. 
[4-(2-1[4-(2-Chloro-4-nitrophenyla.: o)-phenyl]-ethylamino)-ethoxy)-phenyl]- 
acetic acid 2- (2- (2-[2- (2-hydroxyethoxy) -ethoxy]-ethoxy) -ethoxy) -ethyl ester, 49. 
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To a solution of 24 (200 mg, 0.41 mmol), triphenylphosphine (162 mg, 0.62 
mmol, 1.5 eq) and diethyl azodicarboxylate (108 mg, 0.62 mmol, 1.5 eq) in 
toluene (20 ml) was added pentaethylene glycol (148 mg, 0.62 mmol, 1.5 eq). 
The reaction mixture was stirred for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 50*C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 49 as a dark red oil, (225 mg, 0.32 mmol, 
78%). (Found: C, 57.89; H, 6.17; N, 7.91. C34H43CIN401o requires C, 58,07; H, 
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6.16; N, 7.97%); v,,.,, (Nuj'ol)/cm-1 3466,1731,1599,1518,1336; 8H(300 MHz; 
CDC13) 8.3 7 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.0,2.5, ArCH), 7.94 (2 H, 
d, JAB 9.3, ArCH), 7.77 (1 H, d, J 9.0, ArCH), 7.21 (2 H, d, JAB 8.8, ArCH), 6.84 
(2 H, d, JAB 8.8, ArCH), 6.81 (2 H, d, JAj3 9.3, ArCH), 4.24 (2 H, t, J 4.8, CHA 
4.17 (2 H, t, J 5.8, JA-rOCEl2CH2), 3.85 (2 H, t, J 5.8, ArOCH2CH2), 3.73-3.58 
(22 H, in, CHA 2.66 (1 H, s, OH), 1.29 (3 H, t, J 7.1, CH2N[e); 5c(75 MHz; 
CDC13) 172.2 (C), 157.9 (C), 153.5 (C), 152.1 (C), 147.5 (C), 144.8 (C), 134.3 
(C), 130.9 (2 CH), 127.4 (CH), 127.1 (C), 126.4 (CH), 123.0 (CH), 118.4 (2 
CH), 114.9 (2 CH), 112.0 (2 CH), 72.9 (CH2), 70.9 (5CH2), 70.7 (CH2), 69.4 
(CH2), 65.7 (CH2), 64.3 (CH2), 62.1 (CH2), 5 0.4 (CH2), 46.7 (CH2), 40.6 (CH2), 
12.7 (CHO; m/,: (El) 702 (M), 704 (M + +2); (CI) 703 (ME), 705 (MH + +2); 
HMQC spectra exhibited a good correlation vAth the proposed structure. 
[4-(2- {[4-(2-Chloro-4-nitrophenylazo)-phenyl]-ethylaminoI -ethoxy)-phenyl]- 
acetic acid 2-[2-(2-(2-[2-(2-hydroxyethoxy)-ethoxyl-ethoxy)-ethoxy)-ethoxy]- 
ethyl ester, 50.55-57 
N 
, ci 
N02 
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To a solution of 24 (200 mg, 0.41 mmol), triphenylphosphine (162 mg, 0.62 
mmol, 1.5 eq) and diethyl azodIcarboxylate (108 mg, 0.62 mmol, 1.5 eq) in 
toluene (20 ml) was added hexaethylene glycol (175 mg, 0.62 mmol, 1.5 eq). 
The reaction mixture was stirred for 5 days at room temperature after which TLC 
(methanol. ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 50*C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 50 as a dark red oil, (209 mg, 0.28 mmol, 
68%). v ýujol)/cm-' 3463,1731,1598,1513,1337; 8H(300 MHz; CDC13) 
8.36 (1 H, d, J 2.5, ArCH), 8.12 (1 H, dd, J 9.0,2.5, ArCH), 7.93 (2 H, d, JAB 
9.2, ArCH), 7.76 (1 H, d, J 9.0, ArCH), 7.20 (2 H, d, JAB 8.7, ArCH), 6.84 (2 H, 
d, JAB 8.7, ArCH), 6.81 (2 K d, JAB 9.2, ArCH), 4.24 (2 H, t, J 4.8, CHA 4.17 
(2 H, t, J 5.8, ArOCH2CH2), 3.85 (2H, t, J 5.8, ArOCH2CH2), 3.73-3.58 (26 H, 
M, CHA 2.76 (1 H, s, OH), 1.29 (3 H, t, J 7.1, CH2Me); 8c(75 MHz; CDC13) 
172.2 (C), 157.9 (C), 153.5 (C), 152.1 (C), 147.5 (C), 144.7 (C), 134.3 (C), 130.9 
(2 CH), 127.4 (CH), 127.0 (C), 126.4 (CH), 123.0 (CH), 118.4 (2 CH), 114.9 (2 
CH), I 11.9 (2 CH), 72.9 (CHA 7 1.0 (CH2), 70.9 (6CH2), 70.7 (CHA 69.4 
(CHA 65.7 (CHA 64.4 (CHA 62.1 (CHA 50.3 (CHA 46.7 (CHA 40.6 (CHA 
12.7 (CHA m1z (EI) 746 (M+), 748 (M++2); (CI) 747 (N414), 749 (MH++2) 
(Found: M+, 746.2914. C361147 35 CIN4011 requires M+, 746.2930); I-IMQC spectra 
exhibited a good correlation with the proposed structure. 
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3- (4-Hydroxyphenyl) -propion ic acid methyl ester, 43. 
Me,,, 
0 
To a solution of 3-(4-hydroxyphenyl)-proplonic acid (1.0 g, 6.0 mmol) dissolved 
in methanol (100 ml), 4 drops of concentrated sulphuric acid were carefully 
added. The reaction mixture was refluxed for 3 hours after which TLC (ethyl 
acetate: hexane, 2: 3) indicated complete conversion of the starting material. The 
reaction mixture was allowed to cool to room temperature and the methanol 
removed under reduced pressure. The product was firstly precipitated from 
diethyl ether and hexane at -781C and then further purified by careful 
recrystallisation at -200C from diethyl ether, cyclohexane and hexane to give 43 
as white needles, (594 mg, 3.3 mmol, 55%). Alternatively the product could be 
isolated via reduced pressure distillation on a larger scale at 148'C (0.2 bar) to 
give a comparative yield, (66%). Isolation of the product via flash column 
chromatography (ethyl acetate: hexane, 1: 4) gave an improved yield of 94%. mp 
36-37'C (diethyl ether/cyclohexane); (Found: C, 67.00; H, 6.77. C1OH1203 
requires C, 66.65; H, 6.7 1 %); v,.,, (Nujol)/cm- 1 3398,1715,1614; 84300 MHz; 
CDC13) 7.03 (2 H, d, JAB 8.6, ArCH), 6.75 (2 H, d, JAB 8.6, ArCH), 6.14 (1 H, s, 
ArOU), 3.67 (3 H, S, C02Me) 2.87 (2 H, t, J 7.8, ArCH2CH2), 2.60 (2 H, t, J 7.8, 
ArCH2CH2); 6c(75 MHz; CDC13) 174.7 (C), 154.7 (C), 132.6 (C), 129.8 (2 CH), 
115.8 (2 CH), 52.3 (CHA36.5 (CH2), 30.5 (CH2); nzlýz (El) 180 (M); (CI) 181 
(MH+), 198 (MN144+); COSY spectra exhibited a good correlation vvith the 
proposed structure. 
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3-[4-(2- f [4-(2-Chloro-4-nitrophenylazo)-phenyl]-ethylamino) -ethoxy)-phenyl]- 
propionic acid methyl ester, 44.55-57 
1 ":: e 
Oý'ý 
N'-"' 
0 Me-' ýr 
0 
N, % N 
ci 
NO2 
To a solution of 43 (3 g, 16.7 mmol), triphenylphosphine (4.37 g, 16.7 mmol) 
and diethyl azodicarboxylate (2.59 ml, 16.7 mmol) In toluene (250 ml) at 80*C 
was added disperse red (5.2 g, 15.0 mmol, 0.9 eq). The reaction mixture was 
stiffed at 801C for 6 hours after which time TLC (ethyl acetate: hexane, 4: 1) 
indicated that the disperse red had been entirely consumed. The toluene was then 
removed at 50"C under reduced pressure and the product isolated by flash 
column chromatography (ethyl acetate: hexane, 2: 3) to give 44 as a purple 
powder, (4.43 g, 8.67 mmol, 52%). mp II 6-118'C (ethyl acetate/hexane); 
(Found: C, 61.09; H, 5.32; N, 10.92. C26H27CIN405 requires C, 61.11; H, 5.33; 
N, 10.96%); v,,.,, (Nujol)/cm-1 1734,1599,1512,1336; 434300 MHz; CDC13) 
8.37 (1 H, d, J 2.4, ArCH), 8.13 (1 H, dd, J 8.9,2.4, ArCH), 7.94 (2 H, d, JAB 
8.9, ArCH), 7.77 (1 H, d, J 8.9, ArCH), 7.11 (2 H, d, JAB 8.9, ArCH), 6.81 (4 H, 
d, JAB 8.9, ArCH), 4.17 (2 H, t, J 5.7, ArOCH2CH2), 3.85 (2 H, t, J 5.7, 
ArOCH2CH2), 3.72-3.59 (5 H, M, C02Me, CH2Me), 2.89 (2 H, t, J 7.6, 
CH2CH2CO2), 2.59 (2 H, t, 17.6, CH2CH2CO2), 1.29 (3 H, t, J 7.1, CH2Me); 
8c(75 MHz; CDC13) 173.3 (C), 156.8 (C), 153.0 (C), 151.6 (C), 147.0 (C), 144.3 
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(C), 133.9 (C), 133.2 (C), 129.3 (CH), 126.9 (CH), 126.0 (CH), 122.6 (CH), 
118.0 (CH), 114.4 (CH), 111.5 (CH), 65.2 (CH201.6 (CH. 3), 50.0 (CH2), 46.3 
(CH2), 35.9 (CH2), 30.0 (CHA 12.3 (CH3); m/ý: (El) 5 10 (M+), 512 (M + +2); (CI) 
511 (MH+), 513 (MH++2); COSY and HMQC spectra both exhibited a good 
correlation with the proposed structure. 
3 -[4- (2- ([4- (2-Chloro-4-n itrophenylazo) -phenyl]-ethylam ino) -elhoxy) -phenyl]- 
propionic acid, 45.58 
0*'ýN""" 
HO, 
ýýý 
0 
N,, 
N 
cl 
N02 
To a solution of 44 (2 g, 3.92 mmol) in tetrahydrofuran (150 ml) and water (5 
ml) was added lithium hydroxide monohydrate (247 mg, 5.88 mmol, 1.5 eq). 
The reaction mixture was stirred at room temperature for 12 hours and then 40*C 
for 3 hours after which TLC (ethyl acetate: hexane, 4: 1) indicated that the starting 
material had been consumed. This was then allowed to cool to room 
temperature, concentrated at 30"C under reduced pressure, diluted with 
dichloromethane (40 ml), washed with HCI (2 M, 3x 30 ml) and water (3 x 30 
ml), dried (MgSO4) and concentrated in vacuo. The product was eluted by flash 
column chromatography (ethyl acetate: hexane, 3: 2) to give 45 as a dark red oil, 
(1.46 g, 2.94 mmol, 75%). mp 177-179'C (ethyl acetate/hexane); (Found: C, 
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60.33; H, 5.08; N, 11.13. C25H25CIN405 requires C, 60.42; H, 5.07; N, 11.27%); 
vrmx(Nujol)/cm-1 1698,1603,1511,1341; 8,1(300 N*lz; CDC13) 8.37 (1 H, d, J 
2.5, ArCH), 8.18 (1 H, dd, J 9.0,2.5, ArCH), 7.80 (2 H, d, JAB 9.2, ArCH), 7.73 
(I H, d, J 9.0, ArCH), 7.06 (2 H, d, JAB 8.6, ArCH), 6.91 (2 H, d, JAB 9.2, 
ArCH), 6.78 (2 H, d, JAB 8.6, ArCH), 4.10 (2 H, t, J 5.4, ArOCH2CH2), 3.81 (2 
H, t, J 5.4,. 4-rOCH2CH2), 3.56 (2 H, q, J 7.0, CH2Me), 2.68 (2 H, t, J 7.5, 
CH2CH2CO2), 2.41 (2 H, t, J 7.5, CH2CH2CO2). 1.14 (3 H, t, J 7.0, CH2Me); 
8c(75 NlHz; CDC13) 174.3 (C), 156.8 (C), 152.7 (C), 152.5 (C), 147.1 (C), 143.7 
(C), 133.9 (C), 132.7 (C), 129.6 (2 CH), 127.1 (CH), 126.1 (CH), 123.7 (CH), 
118.4 (2 CH), 114.5 (2 CH), 112.3 (2 CH), 65.7 (CH2), 49.6 (CHA 45.8 (CHA 
36.6 (CHA 30.2 (CHA 12.4 (CHA m1z (CI) 497 (ME), 499 (ME++2); COSY 
spectra exhibited a good correlation with the proposed structure. 
3 -[4- (2- [[4- (2-Chloro-4-n itrophenylazo) -phenyl]-ethylam ino) -ethoxy) -phenylj- 
propionic acid 2-(2-hydroxyethoxy)-etliyl ester, 51.55-57 
1 II: k 
0, 
---, N--*-, 
V2 
0 
N, 
N 
ci 
NO2 
To a solution of 45 (200 mg, 0.40 mmol), triphenylphosphine (158 mg, 0.60 
mmol, 1.5 eq) and diethyl azodicarboxylate (105 mg, 0.60 mmol, 1.5 eq) in 
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dichloromethane (20 ml) diethylene glycol (64 mg, 0.60 mmol, 1.5 eq) was 
added. The reaction mixture was stirred for 3 hours at room temperature after 
which TLC (methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely 
consumed. The toluene was removed at 50'C under reduced pressure and the 
product eluted by gradient flash column chromatography (ethyl acetate: hexane, 
4: 1; methanol: ethyl acetate, 1.9) to give 51 as a dark red oil, (174 mg, 0.30 
mmol, 74%). v .... . (Nujol)/cm-1 3443,1731,1599,1513,1336; 84300 MHz; 
CDC] 3) 8.36 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.0,2.5, ArCH), 7.93 (2 H, 
d, JAB 9.1, ArCH), 7.76 (1 H, d, J 9.0, ArCH), 7.11 (2 H, d, JAB 8.5, ArCH), 6.81 
(2 H, d, JAB 8.5, ArCH), 6.80 (2 H, d, JAB 9.1, ArCH), 4.23 (2 H, t, J 4.6, CH2), 
4.16 (2 H, t, J 5.6, ArOCH2CH2), 3.84 (2 H, t, J 5.6, ArOCH2CH2), 3.73-3.55 (8 
H, m, CHA 2.89 (2 IL t, J 7.6, CH2CH2CO2), 2.63 (2 K t, J 7.6, CH2CH2CO2), 
2.12 (1 H, s, OH), 1,29 (3 H, t, J 7.0, CH2Me); 5c(75 MHz; CDC13) 173.3 (C), 
157.3 (C), 153.5 (C), 152.1 (C), 147.5 (C), 144.7 (C), 134.3 (C), 133.5 (C), 129.8 
(2 CH), 127.4 (CH), 126.4 (CH), 123.0 (CH), 118.4 (2 CH), 114.8 (2 CH), 111.9 
(2 CH), 72.7 (CH2), 69.5 (CHA 65.7 (CH2), 63.9 (CHA 62.1 (CHA 50.4 (CH2), 
46.7 (CH2)5 36.4 (CH2), 30.4 (CH2), 12.7 (CI-13); m1z (CI) 585 (MH), 587 
(N*f*+2) (Found: MH+, 585.2113. C29H33 35CIN407 requires MH+, 585.2116); 
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3-[4- (2- ([4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylamino) -ethoxy) -phenyl]- 
55-57 
propionic acid 2-[2-(2-hydroxyethoxy) -ethoxyl-ethyl ester, 52 . 
HOýýoý31, ýz 
0 
N, ý N 
), " cl 
NO2 
To a solution of 45 (200 mg, 0.40 mmol), triphenylphosphine (158 mg, 0.60 
mmol, 1.5 eq) and diethyl azodicarboxylate (104 mg, 0.60 mmol, 1.5 eq) in 
toluene (20 ml) triethylene glycol (91 mg, 0.60 mmol, 1.5 eq) was added. The 
reaction mixture was stirred for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 50'C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 52 as a dark red oil, (175 mg, 0.28 mmol, 
69%). vmýý, (Nujol)/cm-' 3456,1736,1599,1514,1337; 8f, (300 MHz; CDC13) 
8.36 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.0,2.5, ArCH), 7.93 (2 H, d, JAB 
8.9, ArCH), 7.76 (1 H, d, J 9.0, ArCH), 7.12 (2 H, d, JAB 8.9, ArCH), 6.81 (4 H, 
d, JýB 8.9, ArCH), 4.23 (2 H, t, J 4.7, CH2), 4,16 (2 H, t, J 5.7, ArOCH2CH2), 
3.85 (2 H, t, J 5.7, ArOCH2CH2), 3.73-3.5 8 (12 H, M, CHA 2.89 (2 H, t, J 7.6, 
CH2CH2CO2), 2.63 (2 H, t, J 7.6, CH2CH2CO2), 2.41 (I H, s, OH), 1.29 (3 H, t, 
J 7.0, CH2N[e); 8c(75 MHz; CDC13) 173.3 (C), 157.3 (C), 153.5 (C), 152.1 (C), 
147.5 (C), 144.7 (C), 134.3 (C), 133.6 (C), 129.8 (2 CH), 127.4 (CH), 126.4 
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(CH), 123.0 (CH), 118.4 (2 CH), 114.8 (2 CH), 112.0 (2 CH), 72.9 (CHA 70.9 
(CH2), 70.7 (CHA 69.5 (CHA 65.7 (CH2), 63.8 (CHA 62.1 (CH2)5 50.4 (CHA 
46.7 (CH2), 36.4 (CH2), 30.4 (CH2), 12.7 (CHA nzlz (EI) 628 (M), 630 (M++2); 
(CI) 629 (NM), 631 (MW+2) (Found: M+, 628.2296. C31H37 35CIN408 requires 
M+, 628.2300); 
3-[4- (2- ([4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylamino) -ethoxy) -phenyl]- 
propionic acid 2-[2-[2-(2-hydroxyethoxy)-ethoxy]-ethoxy)-ethyI ester, 53.55-57 
I '; k 
Oýý 
N'-ý" 
eo HO 't 
0 
Nze 
N 
cl 
N02 
To a solution of 45 (200 mg, 0.40 mmol), triphenylphosphine (158 mg, 0.60 
mmol, 1.5 eq) and diethyl azodicarboxylate, (104 mg, 0.60 mmol, 1.5 eq) in 
toluene (20 ml) tetraethylene glycol (117 mg, 0.60 mmol, 1.5 eq) was added. 
The reaction mixture was stiffed for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 50*C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 53 as a dark red oil, (190 mg, 0.28 mmol, 
70%). v.,, (Nujol)/cm-1 3457,1731,1599,1519,1337; 8H(300 MHz; CDC13) 
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8.3 5 (1 H, d, J 2.5, ArCH), 8.11 (1 H, dd, J 9.0,2.5, ArCH), 7.92 (2 H, d, JAB 
9.2, ArCH), 7.76 (1 H, d, J 9.0, ArCH), 7.12 (2 H, d, JAB 8.5, ArCH), 6.81 (2 H, 
d, JAB 8.5, ArCH), 6.80 (2 H, d, JAB 9.2, ArCH), 4.23 (2 H, t, J 4.7, CHA 4.16 
(2 H, t, J 5.7, ArOCH2CH2), 3.84 (2 H, t, J 5.7, ArOCH2CH2), 3.73-3.58 (16 H, 
m, CH2), 2.89 (2 H, t, J 7.7, CH2CH2CO2), 2.62 (2 H, t, J 7.7, CH2CH2CO2), 
2.61 (1 H, s, OH), 1.29 (3 H, t, J 7.0, CH2Me); 8c(75 MHz; CDC13) 173.3 (C), 
157.3 (C), 153.4 (C), 152.1 (C), 147.4 (C), 144.7 (C), 134.3 (C), 133.6 (C), 129.8 
(2 CH), 127.4 (CH), 126.4 (CH), 123.0 (CH), 118.4 (2 CH), 114.8 (2 CH), H 1.9 
(2 CH), 72.9 (cH2), 7 1.0 (CH2), 70.9 (2CH2), 70.7 (CH2), 69.5 (CH2), 65.7 
(CH2), 63,9 (CH2), 62.1 (CH2), 50.4 (CH2), 46.7 (CH2), 36.4 (CH2), 30.4 (CH2), 
12.7 (CH3), m1z (EI) 672 (M+), 674 (M++2); (CI) 673 (Mll+), 675 (MH++2) 
(Found: M+, 672.2553. C33H4 135CIN409 requires M+, 672.2562); 
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3-[4- (2- t[4-(2-Chloro-4-n itrophenylazo) -phenyl]-ethyl-am ino) -ethoxy) -phenyl]- 
propionic acid 2-(2- (2-[2-(2-hydroxyethoxy) -ethoxy]-ethoxy)-ethoxy) -ethyl ester, 
54.55-57 
1 
0--, 
N-"ý" 
HO4-ýý 
045--ýZ 
0 
N, ý N 
, ci 
N02 
To a solution of 45 (200 mg, 0.40 mmol), triphenylphosphine (158 mg, 0.60 
mmol, 1.5 eq) and diethyl azodIcarboxylate (104 mg, 0.60 mmol, 1.5 eq) in 
toluene (20 ml) pentaethylene glycol (144 mg, 0.60 mmol, 1.5 eq) was added. 
The reaction mixture was stiffed for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 501C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate 1: 9) to give 54 as a dark red oil, (190 mg, 0.26 mmol, 
66%). v., (Nujol)/cm-1 3477,1731,1599,1519,1337; 6H(300 MHz; CDC13) 
8.37 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.1,2.5, ArCH), 7.93 (2 H, d, JAB 
8.8, ArCH), 7.77 (1 H, d, J 9.1, ArCH), 7.12 (2 H, d, JAB 8.8, ArCH), 6.81 (4 H, 
d, JAB 8.8, ArCH), 4.22 (2 H, t, 14.8, CR2), 4.16 (2 11, t, J 5.8, ArOCH2CH2), 
3.85 (2 H, t, J 5.8, ArOCH2CH2). 3.73-3.58 (20 H, m, CHA 2.89 (2 H, t, J 7.7, 
CH2CH2CO2), 2.68 (1 H, s, OH), 2.62 (2 H, t, J 7.7, CH2CH2CO2), 1.29 (3 H, t, 
J 7.1, CH2N[e); 8c(75 MHz; CDC13) 173.3 (C), 157.3 (C), 153.5 (C), 152.1 (C), 
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147.5 (C), 144.7 (C), 134.3 (C), 133.6 (C), 129.8 (2 CH), 127.4 (CH), 126.4 
(CH), 123.0 (CH), 118.4 (2 CH), 114.8 (2 CH), 111.9 (2 CH), 72.9 (CH2), 70.9 
(5CH2), 70.7 (CHA 69.5 (CHA 65.7 (CHA 64.0 (CHA 62.1 (CHA 50.4 (CHA 
46.7 (CHA 36.4 (CHA 30.4 (CHA 12.7 (CHA m1z (CI) 717 (MH+), 719 
(MH++2) (Found: MH+, 717.2897. C35H43 35CIN401o requires MH+, 717.2902); 
3-[4-(2- [[4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylam ino) -ethoxy) -phenyl]- 
propi . oni .c acid 2-[2-(2-[2-[2-(2-hydroxyethoxy)-ethoxy]-ethoxyl-ethoxy)- 
elhoayl-ethyl ester, 55.55-57 
1 li: ze 
o'-, '-, N 
HO'k""ý 
46ff "ý 
N 
cl 
NO2 
To a solution of 45 (200 mg, 0.40 mmol), triphenylphosphine (158 mg, 0.60 
mmol, 1.5 eq) and diethyl azodicarboxylate (104 mg, 0.60 mmol, 1.5 eq) in 
toluene (20 ml) hexaethylene glycol (170 mg, 0.60 mmol, 1.5 eq) was added. 
The reaction mixture was stirred for 5 days at room temperature after which TLC 
(methanol: ethyl acetate, 1: 9) indicated that the acid had been entirely consumed. 
The toluene was removed at 50'C under reduced pressure and the product eluted 
by gradient flash column chromatography (ethyl acetate: hexane, 4: 1; 
methanol: ethyl acetate, 1: 9) to give 55 as a dark red oil, (184 mg, 0.24 mmol, 
60%). v .... . (Nujol)/cm-1 3455,1732,1600,1519,1337; SH(300 Nfflz; CDC13) 
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8.37 (1 H, d, J 2.3, ArCH), 8.13 (1 H, dd, J 9.0,2.3, ArCH), 7.94 (2 H, d, JAB 
8.9, ArCH), 7.77 (1 H, d, J 9.0, ArCH), 7.12 (2 H, d, JAB 8.9, ArCH), 6.81 (4 H, 
d, JAB 8.9, ArCH), 4.22 (2 H, t, J 4.7, CHA 4.17 (2 H, t, J 5.7, ArOCH2CH2), 
3.85 (2 H, t, J 5.7, ArOCH2CH2), 3.73-3.58 (24 H, M, CH2Me), 2.89 (2 H, t, J 
7.7, CH2CH2CO2), 2.79 (1 H, s, OH), 2.62 (2 H, t, J 7.7, CH2CH2CO2), 1.29 (3 
H, t, J 7.1, CH2Me); 8c(75 MHz; CDC13) 173.3 (C), 157.3 (C), 153.5 (C), 152.1 
(C), 147.5 (C), 144.7 (C), 134.3 (C), 133.6 (C), 129.8 (2 CH), 127.4 (CH), 126.4 
(CH), 123.0 (CH), 118.4 (2 CH), 114.8 (2 CH), 111.9 (2 CH), 73.0 (cH2), 71.0 
(CHA 70.9 (6CH2), 70.7 (CHA 69.5 (CHA 65.7 (CHA 64.0 (CHA 62.1 (CHA 
50.4 (CH2), 46.7 (CH2), 36.4 (CHA 30.4 (CHA 12.7 (CHA nzlý- (CI) 761 
(NM+), 763 (MR++2) (Found: MH+, 761.3165. C37H49 35CIN4011 requires MH+, 
761.3165); 
3-(4-Hydroxyphenyl)-propionic acid tert-butyl ester, 62.84 
OH 
+0 
Y---Z 
0 
To a solution of 3-(4-hydroxyphenyl) propionic acid (3.32 g, 20 mmol) in 
dimethylformamide (20 ml) was carefully added carbonyl d1jimidazole (3.24 g, 
20 mmol). The reaction mixture was stirred at 40*C for 2 hours. DBU (6.08 ml, 
40 mmol, 2 eq) and tert-butanol (3.70 ml, 50 mmol, 2.5 eq) were then added and 
the reaction mixture stirred at 65"C for 2 days after which time TLC (ethyl 
acetate: hexane, 1: 4) indicated that the starting material had been consumed. The 
reaction mixture was cooled to room temperature, water (40 ml) added and the 
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product extracted with diethyl ether (3 x 20 ml). The organic fraction was dried 
(MgS04), concentrated under reduced pressure and the product isolated by flash 
column chromatography (ethyl acetate: hexane, 1: 4) to give 62 as a clear 
colourless oil (2.89 g, 13 mmol, 65%). v,,,,,,, (Nujol)/cm-1 3400,1700,1601,1516; 
8H(300 Nfflz; CDC13) 7.05 (1 H, s, ArOH), 7.01 (2 H, d, JAB 8.5, ArCH), 6.74 (2 
H, d, JAB 8.5, ArCH), 2.82 (2 H, t, J 7.6, ArCH2CH2), 2.51 (2 H, t, J 7.6, 
ArCH2CH2), 1.41 (9 H, s, CMeA 8c(75 MHz; CDC13) 174.0 (C), 154.9 (C), 
132.4 (C), 129.8 (2 CH), 115.8 (2 CH), 81.5 (C), 38.0 (CH2), 30.7 (CH2), 15.5 
(CHA mIz (Cl) 240 (MNH4+) (Found: MNH4+, 240.1597. C13HI803 requires 
MNH4+, 240.1600); COSY spectra exhibited a good correlation with the 
proposed structure. 
3- [4-[2- (2- f2-[4-(2- [[4- (2-Chloro-4-n itrophenylazo) -phenyl]-ethylam ino) - 
ethoxy)-phenyl]-acetoxy)-ethoxy)-ethoxy]-phenyl)-propionic acid tert-butyl 
ester, 63.55-57 
lIZ* 0--111lý N lý 
ci 
NO2 
To a solution of 46 (144 mg, 0.25 mmol), triphenylphosphine (98 mg, 0.38 
mmol, 1.5 eq) and diethyl azodicarboxylate (66 mg, 0.38 mmol, 1.5 eq) in 
dichloromethane (5 ml) was added tert-butyl ester 62 (111 mg, 0.50 mmol, 2.0 
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eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethYl acetate, 1: 9) to give 63 as a dark red oil, (102 
mg, 0.13 mmol, 53%). v..,, (Nujol)/cm-1 1729,1600,1513,1340; 8H(300 MHz; 
CDC13) 8.39 (1 H, d, J 2.5, ArCH), 8.15 (1 H, dd, J 9.0,2.5, ArCH), 7.95 (2 H, 
d, JAB 9.2, ArCH), 7.78 (1 H, d, J 9.0, ArCH), 7.19 (2 H, d, JAB 8.7, ArCH), 7.10 
(2 H, d, JAB 8.7, ArCH), 6.84-6.79 (6 H, in, ArCH), 4.27 (2 H, t, J 4.8, 
ArOCH2CH2), 4.16 (2 H, t, J 5.8, ArOCH2CH2), 4.07 (2 H, t, J 4.8, 
OCH2CH202C), 3.87-3.74 (6 H, in, CHA 3.62 (2 H, q, J 7.2, CH2Me), 3.5 8 (2 
H, s, ArCHA 2.84 (2 H, t, J 7.6, CH2CH2CO2), 2.50 (2 H, t, J 7.6, 
CH2CH2CO2), 1.41 (9 H, s, CMe3), 1.29 (3 H, t, J 7.2, CH2Me); m/-'- (FAB) 774 
(MH+), 797 (MNa+) (Found: NM+, 775.3120. C411-147 35CIN409 requires MH+, 
775.3110); COSY spectra exhibited a good correlation with the proposed 
structure. 
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eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 63 as a dark red oil, (102 
mg, 0.13 mmol, 53%). v., (Nujol)/cm-1 1729,1600,1513,1340; 6H(300 MHz; 
CDC13) 8.39 (1 H, d, J 2.5, ArCH), 8.15 (1 H, dd, J 9.0,2.5, ArCH), 7.95 (2 H, 
d, JAB 9.2, ArCH), 7.78 (1 H, d, J 9.0, ArCH), 7.19 (2 H, d, JAB 8.7, ArC H), 7.10 
(2 H, d, JAB 8.7, ArCH), 6.84-6.79 (6 H, m, ArCH), 4.27 (2 H, t, J 4.8, 
ArOCH2CH2), 4.16 (2 H, t, J 5.8, ArOCH2CH2), 4.07 (2 H, t, J 4ý 8, 
OCH2CH202Q, 3.87-3.74 (6 H, m, CHA 3.62 (2 H, q, J 7.2, CH2Me), 3.5 8 (2 
H, s, ArCHA 2.84 (2 H, t, J 7.6, CH2CH2CO2), 2.50 (2 H, t, J 7.6, 
CH2CH2CO2), 1.41 (9 H, s, CMeAl. 29 (3 H, t, J 7.2, CH2Me); m1z (FAB) 774 
(NM+), 797 (MNa+) (Fourid: MH+, 775.3120. C41H47 35CIN409 requires MH+, 
775.3110); COSY spectra exhibited a good correlation with the proposed 
structure. 
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3-(4- [2-[2-(2- (2-[4- (2- ([4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylam ino) - 
ethoxy)-phenyl]-acetoxy)-ethoxy)-ethoxy]-ethoxy)-phenyl)-propionic acid tert- 
butyl ester, 64.55-57 
0 
Nk 
3 
0N cl 
N02 
To a solution of 47 (168 mg, 0.27 mmol), triphenylphosphine (108 mg, 0.41 
mmol, 1.5 eq) and diethyl azodicarboxylate (71 mg, 0.41 mmol, 1.5 eq) in 
dichloromethane (5 ml) was added tert-butyl ester 62 (121 mg, 0.55 rnmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 64 as a dark red oil, (123 
mg, 0.15 mmol, 55%). v.,, (Nqjol)/cm-1 1735,1601,1514,1340; 8000 NMz; 
CDC13) 8.39 (1 H, d, J 2.5, ArCH), 8.15 (1 H, dd, J 9.0,2.5, ArCH), 7.95 (2 H, 
d, JAB 9.2, ArCH), 7.78 (1 H, d, J 9.0, ArCH), 7.19 (2 H, d, JAB 8.7, ArCH), 7.09 
(2 H, d, JAB 8.7, ArCH), 6.85-6.79 (6 H, m, ArCH), 4.24 (2 H, t, J 5.3, 
ArOCH2CH2), 4.17 (2 H, t, J 5.7, ArOCH2CH2), 4.09 (2 H, t, J 5.1, 
OCH2CH202C), 3.87-3.81 (4 H, m, CHA 3.71-3.61 (8 H, m, CHA 3.5 8 (2 H, s, 
ArCH2), 2.83 (2 H, t, J 7.7, CH2CI12CO2), 2.49 (2 H, t, J 7.7, CH2CH2CO2), 1.41 
(9 H, s, CMeAI. 30 (3 H, t, J 7.1, CH2Me); m1z (FAB) 819 (MH+), 841 (MNa+) 
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(Found: MNa+, 841.3181. C43H51 35CIN4010 requires MNa+, 841.3191); COSY 
spectra exhibited a good correlation with the proposed structure. 
3-[4- (2- [2-[2- (2- (2-[4- (2- t[4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylam ino) - 
ethoxy) -phenyl]-acetoxy] -ethoxy) -etho)tyl-elhoxy) -elhoxy) -phenyll-propionic 
acid tert-butyl ester, 65.55-57 
IN, N 
N 
N 
cl 
C, 
N02 
To a solution of 48 (300 mg, 0.46 mmol), triphenylphosphine (179 mg, 0.68 
mmol, 1.5 eq) and diethyl azodicarboxylate (120 mg, 0.68 mmol, 1.5 eq) in 
dichloromethane (5 ml) was added tert-butyl ester 62 (202 mg, 0.91 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 65 as a dark red oil, (204 
mg, 0.24 mmol, 52%). v,,. x(Nujol)/cm-1 1733,1601,1513,1266; 84300 MHz; 
CDC13) 8.3 8 (1 H, d, J 2.4, ArCH), 8.14 (1 H, dd, J 8.9,2.4, ArCH), 7.94 (2 H, 
d, JAB 9.0, ArCH), 7.78 (1 H, d, J 8.9, ArCH), 7.19 (2 H, d, JAB 8.7, ArCH), 7.09 
(2 H, d, JAB 8.7, ArCH), 6.86-6.79 (6 H, in, ArCH), 4.24 (2 H, t, J 5.3, 
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ArOCH2CH2), 4.17 (2 H, t, J 5.7, ArOCH2CH2), 4.09 (2 H, t, J 4.9, 
OCH2CH202Q, 3.87-3.56 (16 H, m, CH2), 2.83 (2 H, t, J 7.7, CH2CH2CO2). 
2.49 (2 H, t, 17.7, CH2CH2CO2). 1.41 (9 H, s, CMeA 1.30 (3 H, t, J 7.1, 
CH2Me); nuz (FAB) 863 (MH+), 885 (MNa+) (Found: MH+, 863.3619. 
C45H55 35 CIN4011 requires MH+, 863.3634); COSY spectra exhibited a good 
correlation vvith the proposed structure. 
3- f4-[2- (2- (2-[2- (2- [2-[4- (2- [[4- (2-Chloro-4-nitrophenylazo) -phenyl]- 
ethylam ino) -ethoxy) -phenyt]-acetoxy) -ethoxy) -elhoxy]-ethoxy) -eihoxy) -ethoxyj- 
55-57 
phenyl)-propionic acid tert-butyl ester, 66. 
0 
0 
0N N cl 
N02 
To a solution of 49 (280 mg, 0.40 mmol), triphenylphosphine (108 mg, 0.60 
mmol, 1.5 eq) and diethyl azodicarboxylate (104 mg, 0.60 mmol, 1.5 eq) in 
dichloromethane (5 ml) was added tert-butyl ester 62 (177 mg, 0.80 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
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acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 66 as a dark red oil, (187 
mg, 0.21 mmol, 53%). vna,, ýUjol)/cm-' 1730,1601,1513,1340; 8H(300 MHz; 
CDC13) 8.37 (1 H, d, J 2.4, ArCH), 8.13 (1 H, dd, J 9.0,2.4, ArCH), 7.94 (2 H, 
d, JAB 9.2, ArCH), 7.77 (1 H, d, J 9.0, ArCH), 7.20 (2 H, d, JAB 8.9, ArCH), 7.09 
(2 H, d, JAB 8.7, ArCH), 6.86-6.79 (6 H, in, ArCH), 4.23 (2 H, t, J 4.8, 
ArOCH2CH2), 4.17 (2 H, t, J 5.7, ArOCH2CH2), 4.09 (2 H, t, J 5.0, 
OCH2CH202C), 3.87-3.81 (4 H, in, CHA3.73-3.58 (18 H, m, CHA2.83 (2 H, t, 
J 7.8, CH2CH2CO2), 2.49 (2 H, t, J 7.8, CH2CH2CO2). 1.41 (9 H, s, CMe3), 1.29 
(3 H, t, J 7.1, CH2N[e); m1z (FAB) 907 (MW), 929 (MNa+) (Found: N4H+, 
907.3904. C47H59 35CIN4012 requires MH+, 907.3896); COSY spectra exhibited a 
good correlation vvith the proposed structure. 
3- (4- (2-[2- (2- [2-[2-(2- (2-[4- (2- ([4- (2-Chloro-4-nitrophenylazo) -phenyl]- 
ethylamino) -ethoxy) -phenyl]-acetoxy) -elhoxy) -ethoxy]-ethoxy)-ethoxy) -ethwyl- 
ethoxy] -phenyl) -propion ic acid tert-b utyl ester, 67.55-57 
0 
6 
N 
cl 
N02 
To a solution of 50 (245 mg, 0.33 mmol), triphenylphosphine (129 mg, 0.49 
mmol, 1.5 eq) and diethyl azodicarboxylate (86 mg, 0.49 mmol, 1.5 eq) in 
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dichloromethane (5 ml) was added tert-butyl ester 62 (146 mg, 0.66 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 67 as a dark red oil, (184 
mg, 0.19 mmol, 58%). Vmax(Nujol)/cm-1 1731,1601,1514,1340; 8H(300 MHz; 
CD'Cl3) 8.37 (1 H, d, J 2.4, ArCH), 8.13 (1 H, dd, J 9.1,2.4, ArCH), 7.94 (2 H, 
d, JýB 9.2, ArCH), 7.77 (1 H, d, J 9.1, ArCH), 7.19 (2 H, d, JAB 8.7, ArCH), 7.09 
(2 H, d, JAB 8.7, ArCH), 6.86-6.79 (6 H, m, ArCH), 4.23 (2 H, t, J 4.8, 
ArOCH2CH2), 4.17 (2 H, t, J 5.7, ArOCH2CH2), 4.09 (2 H, t, J 4.9, 
OCH2CH202C), 3.87-3.81 (4 H, m, CHA 3.73 -3.5 5 (22 H, m, CH2), 2.83 (2 H, t, 
J 7.8, CH2CH2CO2), 2.49 (2 H, t, J 7.8, CH2CH2CO2). 1.41 (9 H, s, CMe3), 1.29 
(3 H, t, J 7.1, CH2Me); m1z (FAB) 951 (ME), 973 (MNa+) (Found: MH-, -, 
951.4167. C491463 35CIN4013 requires MH+, 951.4158); COSY spectra exhibited a 
good correlation with the proposed structure. 
178 
Experimental 
3 -[4-(2- [[4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylam ino) -ethoxy) -phenylj- 
propionic acid 2-[2-[4-(2-tert-butoxycarbonylethyl)-phenoxy]-ethoxy)-ethyI 
ester, 6.55-57 
-+O--ýýý 
0-ýý 
02y----ý 
o'-, '-, N""'*' 
NI, 
N 
ci 
02 
To a solution of 51 (178 mg, 0.30 mmol), triphenylphosphine (120 mg, 0.46 
mmol, 1.5 eq) and diethyl azodicarboxylate (78 mg, 0.45 MMOI, 1.5 eq) in 
dichloromethane (5 in]) was added tert-butyl ester 62 (135 mg, 0.61 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 68 as a dark red oil, (138 
mg, 0.18 mmol, 57%). v.., (Nujol)/cm-1 1735,1600,1513,1339,814(300 MHz; 
CDC13) 8.37 (1 H, d, J 2.4, ArCH), 8.13 (1 H, dd, 19.0,2.4, ArCH), 7.94 (2 H, 
d, JAB 9.4, ArCH), 7.77 (1 H, d, J 9.0, ArCH), 7.11 (2 H, d, JAB 8.7, ArC H), 7.09 
(2 H, d, JAB 8.9, ArCH), 6.83 -6.78 (6 H, m, ArCH), 4.24 (2 H, t, J 4.7, 
ArOCH2CH2), 4.16 (2 H, t, J 5.7, ArOCH2CH2), 4.08 (2 H, t, J 4.8, 
OCH2CH202C), 3.83 (2 H, t, J 5.7, ArOCH2CH2), 3.81 (2 H, t, J 4.7, 
ArOCH2CH2), 3.74 (2 H, t, J 4.8, OCH2CH202C), 3.61 (2 H, q, J 7.1, CH2Me), 
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2.88 (2 H, t, J 7.8, CH2CH2CO2), 2.84 (2 H, t, J 7.8, CH2CH2CO2), 2.61 (2 H, t, 
J 7.8, CH2CH2CO2), 2.49 (2 H, t, J 7.8, CH2CH2CO2), 1.41 (9 H, s, CMeA 1.2 8 
(3 H, t, J 7.1, CH2Me); mZ (FAB) 789 (NM+), 811 (MNa+) (Found: MH+, 
789.3252. C42H49 35CIN409 requires MH+, 789.3266); COSY spectra exhibited a 
good correlation with the proposed structure. 
3-[4- (2- [[4- (2-Chloro-4-n itrophenylazo) -phenyl]-ethylamino) -elhoxy) -phenylj- 
propi . om .c acid 2-(2-(2-[4-(2-tert-butoxycarbonylethyl)-phenoxy]-ethoxyj- 
ethoxy)-ethyl ester, 69.55-57 
0 
-+O-M-ýa 
0 
4"ýo 
3y----ý 
0, 
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To a solution of 52 (767 mg, 1.22 mmol), triphenylphosphine (480 mg, 1.83 
mmol, 1.5 eq) and diethyl azodicarboxylate (318 mg, 1.83 mmol, 1.5 eq) in 
dichloromethane (5 ml) was added tert-butyl ester 62 (542 mg, 2.44 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was under reduced pressure and the 
product isolated by gradient flash column chromatography (ethyl acetate: hexane, 
4: 1; methanol: ethYl acetate, 1: 9) to give 69 as a dark red oil, (386 mg, 0.46 
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mmol, 38%). v,,., (Nujol)/cm-1 1736,1600,1512,1339; 8H(300 MHz; CDC13) 
8.37 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.0,2.5, ArCH), 7.93 (2 H, d, JAB 
9.4, ArCH), 7.77 (1 H, d, J 9.0, ArCH), 7.11 (2 H, d, JAB 8.9, ArCH), 7.09 (2 H, 
d, JAB 8.9, ArCH), 6.83-6.79 (6 H, m, ArCH), 4.24 (2 H, t, J 4.7, ArOCH2CH2), 
4.16 (2 H, t, J 5.7, ArOCH2CH2), 4.09 (2 H, t, J 4.9, OCH2CH2O2Q, 3.86-3.81 
(4 H, m, CHA 3.75-3.58 (8 H, m, CHA 2.88 (2 H, t, J 7.8, CH2CH2CO2), 2.83 
(2 H, t, J 7.8, CH2CH2CO2), 2.61 (2 H, t, J 7.8, CH2CH2CO2), 2.49 (2 H, t, J 7.8, 
CH2CH2CO2), 1.41 (9 H, s, CMe3), 1.29 (3 H, t, J 7.0, CH2Me); ml, ý- (FAB) 83 3 
(NM+), 855 (MNa+) (Found: MH+, 833.3507. C441153 35 CIN401o requires MH+, 
833.3528); COSY spectra exhibited a good correlation with the proposed 
structure. 
3-[4- (2- ([4- (2-Chloro-4-nitrophenylazo) -phenyl]-ethylamino) -ethoxy) -phenyl]- 
propionic acid 2-12-(2-t2-[4-(2-tert-butoxycarbonylethyl)-phenoxy]-ethoxy)- 
ethoxy)-ethoxy]-ethyl ester, 70.55-57 
oý 
1N 
ýý 
NI- 
N 
cl 
N02 
To a solution of 53 (470 mg, 0.70 mmol), triphenylphosphine (275 mg, 1.05 
mmol, 1.5 eq) and diethyl azodicarboxylate (183 mg, 1.05 mmol, 1.5 eq) in 
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dichloromethane (5 ml) was added tert-butyl ester 62 (311 mg, 1.40 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 70 as a dark red oil, (291 
mg, 0.33 mmol, 47%). vn,, (Nujol)/cm-' 1728,1600,1513,1340; 81j(300 MHz; 
CDC13) 8.34 (1 H, d, J 2.5, ArCH), 8.10 (1 H, dd, J 8.9,2.5, ArCH), 7.92 (2 H, 
d, JAB 9.2, ArCH), 7.75 (1 H, d, J 8.9, ArCH), 7.11 (2 H, d, JAB 8.7, ArCH), 7.09 
(2 H, d, JAB 8.7, ArCH), 6.84-6.77 (6 H, in, ArCH), 4.21 (2 H, t, J 4.8, 
ArOCH2CH2), 4.15 (2 H, t, J 5.7, ArOCH2CH2), 4.08 (2 H, t, J 4.9, 
OCH2CH202Q, 3.85-3.80 (4 H, in, CHA 3.73-3.57 (12 H, in, CHA 2.88 (2 H, t, 
J 7.7, CH2CH2CO2), 2.83 (2 H, t, J 7.7, CH2CH2CO2). 2.61 (2 H, t,, J 7.7, 
CH2CH2CO2), 2.49 (2 H, t, J 7.7, CH2CH2CO2). 1.41 (9 H, s, CMe3), 1.28 (3 H, 
t, J 7.1, CH2N[e); mýZ (FAB) 877 (ME), 899 (MNa+) (Found: MH+, 877.3802. 
C46H57 35CIN4011 requires MH+, 877.3790); COSY spectra exhibited a good 
correlation with the proposed structure. 
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3-[4- (2- t[4-(2- Chloro-4-n itrophenylazo) -phenyl]-ethylam ino) -ethoxy) -phenyl]- 
propionic acid 2-(2-[2-(2-(2-[4-(2-tert-butoxycarbonylethyl)-phenoxy]-ethoxy)- 
55-57 
ethoxy)-ethoxy]-ethoxy)-ethyl ester, 71 . 
0 
0 
cl 
N02 
To a solution of 54 (420 mg, 0.59 mmol), triphenylphosphine (231 mg, 0.88 
mmol, 1.5 eq) and diethyl azodicarboxylate (154 mg, 0.89 mmol, 1.5 eq) in 
dichloromethane (5 ml) was added tert-butyl ester 62 (260 mg, 1.17 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol. -ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: hexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 71 as a dark red oil, (235 
mg, 0.26 mmol, 44%). vn-,,,, (Nujol)/cm-1 1727,1601,1513,1340; 8H(300 MHz; 
CDC13) 8.37 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.0,2.5, ArCH), 7.94 (2 H, 
d, JAB 9.2, ArCH), 7.77 (1 H, d, J 9.0, ArCH), 7.11 (2 H, d, JAB 8.7, ArCH), 7.09 
(2 H, d, JAB 8.7, ArCR), 6.84-6.79 (6 H, m, ArCH), 4.21 (2 H, t, J 4.8, 
ArOCH2CH2). 4.16 (2 H, t, J 5.7, ArOCH2CH2), 4.09 (2 H, t, J 4.9, 
OCH2CH202C), 3.86-3.81 (4 H, in, CHA 3.73-3.56 (16 H, in, CHA 2.89 (2 H, t, 
J 7.7, CH2CH2CO2), 2.83 (2 H, t, J 7.7, CH2CH2CO2), 2.61 (2 H, t, 17.7, 
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CH2CH2CO2), 2.49 (2 H, t, J 7.7, CH2CH2CO2), 1.41 (9 H, s, CMeA 1.29 (3 H, 
t, J 7.1, CH2Me); ml-- (FAB) 921 (MH), 943 (MNa+) (Found: MH+, 921.4048. 
C48H61 35CIN4012 requires NM+, 921.4053); COSY spectra exhibited a good 
correlation with the proposed structure. 
3-[4- (2- ([4-(2-Chloro-4-nilrophenylaz o) -phenyl]-ethylam ino) -elhoxy) -phenyll- 
propi . oni .c acid 2-(2-(2-[2-(2-(2-[4-(2-lert-butoxycarbonylethyl)-pheno. ýyl- 
ethoxy]-ethoxy)-ethoxy]-ethoxy)-ethoxy) -ethyl ester, 72.55-57 
0N 
N 
cl 
N02 
To a solution of 55 (767 mg, 1.01 mmol), triphenylphosphine (397 mg, 1.51 
rnmol, 1.5 eq) and diethyl azodicarboxylate (264 mg, 1.51 mmol, 1.5 eq) in 
dichloromethane (5 ml) was added iert-butyl ester 62 (448 mg, 2.02 mmol, 2.0 
eq). The reaction mixture was stirred at room temperature for 5 hours after 
which time TLC (methanol: ethyl acetate, 1: 9) indicated that the starting material 
had been consumed. The dichloromethane was removed under reduced pressure 
and the product isolated by gradient flash column chromatography (ethyl 
acetate: bexane, 4: 1; methanol: ethyl acetate, 1: 9) to give 72 as a dark red oil, (549 
mg, 0.57 mmol, 56%). v,,.,, (Nujol)/cm-1 1727,1601,1513,1340; 84300 MHz; 
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CDC13) 8.37 (1 H, d, J 2.5, ArCH), 8.13 (1 H, dd, J 9.0,2.5, ArCH), 7.94 (2 H, 
d, JAB 9.2, ArCH), 7.77 (1 H, d, J 9.0, ArCH), 7.11 (2 H, d, JAB 8.7, ArCH), 7.09 
(2 H, d, JAB 8.9, ArCH), 6.83-6.79 (6 H, m, ArCH), 4.21 (2 H, t, J 4.8, 
ArOCH2CH2), 4.16 (2 H, t, J 5.7, ArOCH2CH2), 4.09 (2 H, t, J 4.9, 
OCH2CH202Q, 3.86-3.81 (4 H, m, CHA 3.73 -3.56 (20 H3 M, CH2), 2.89 (2 H, t, 
J 7.7, CH2CH2CO2), 2.83 (2 H, t, 17.7, CH2CH2CO2), 2.61 (2 H, t, J 7.7, 
CH2CH2CO2), 2.49 (2 H, t, J 7.7, CH2CH2CO2). 1.31 (9 H, s, CMeA 1.29 (3 H, 
t, J 7.1, CH2Me); mIz (FAB) 965 (MH+), 987 (MNa+) (Found: MH+, 965.4323. 
C50H65 35CIN4013 requires M14+, 965.4315); COSY spectra exhibited a good 
correlation with the proposed structure. 
1 79 General procedure for deprotection of63-72 to give 73-84 respective Y. 
0 : %: " 10 N""'ý 
l:: x 04--ýOýn ý-ýZ 
HO 
7"2 N 
ci 
NO2 
To a solution of TIS: TFA, 1: 49 (10 ml) was added a solution of 63 (200 mg, 258 
pmol) in dichloromethane (1.5 ml). The reaction mixture was stirred at room 
temperature for 10 minutes after which time TLC (ethyl acetate: hexane, 3: 2) 
indicated that the starting material had been consumed. The reaction mixture 
was concentrated under reduced pressure and the product isolated via flash 
column chromatography to give 73 as a red oil (158 mg, 220 pmol, 85%). The 
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acid derivative was then coupled directly to the supported protected peptide 40 as 
descnbed below. 
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General preparation for attaching the ten dye-linkers to the terminal amino group 
of the peptide, followed by deprotection and partial cleavage of these systems 
from the polymer supported was: 
a) To a suspension of the peptide on Tentagel 40 (25 mg) in dimethylformamide 
ml) were added the dye-linker (20 mg, 21.0-27.9 pmol, excess), PyBOP (30 
mg, 57.7 gmol, excess), HOBt (30 mg, 222 pmol, excess) and DIPEA (3 drops, 
-30 mg, 233 ýtmol, excess) and gently mixed by bubbling nitrogen through at 
room temperature for 3 hours. The resin was then isolated by filtration and 
washed with dimethylformamide (2 x 10 ml), dichloromethane (2 x 10 ml), 
methanol (2 x 10 ml) and dried under reduced pressure to give the supported 
protected peptidyl dye-linker system (83-92) as a black resin (26 mg). 
b) The protected peptide dye-linker system (20 mg) was suspended in 
triisopropylamine: TFA, 1: 49 (3 ml) and gently mixed by bubbling nitrogen 
through at room temperature for 2 hours. The resin was isolated by filtration, 
washed with methanol (2 x 10 in]), dichloromethane (2 x 10 ml) and dried under 
reduced pressure to give the supported unprotected peptide dye-linker system 
(93-102) as a black resin (18 mg). The filtrate was dried under reduced pressure 
to give a red powder (2 mg). The result of cleavage of the 10% Rink linker. The 
peptide dye-linker systems were identified from their filtrates by low resolution 
electrospray mass spectrometry performed by the EPSRC Swansea Mass 
Spectrometry Service as summarised below. 
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93; mlz (ES) 795 (N4H3 
3+)e 119 1 (NU12 2+), fOr C107H, 5()CIN25035. 
94; nvýz (ES) 809 (N1H331,1214 (NM2 
2+), for CI()gH, 54C1N25036. 
95; m/z (ES) 824 (NM3 
3+), 1236 (Nffl2 2+), for Cil 1H158C1N25037. 
96; m.: (ES) 839 (MH3 
3+ ), 1258 (NM2 2+), fOr Cl ]3H162C1N25038. 
97, t? zlz (ES) 854 (N4H3 
3+ ), 1280 (N1H2 2+), for C, 15Hs6C1N25039. 
98; mlz (ES) 780 (NM3 
3+), , 199 (NM22+), for Cjo8H152C1N25035- 
99; mlz (ES) 814 (NM3 
3+), 1221 (N4H2 2+), for C1I0H156C1N25036. 
100; m-- (ES) 829 (Nffl3 
3+)j 1243 (Nffl22+), for Cl ]2H160C1N25037. 
101; mIz (ES) 844 (N4H3 
3+), 1265 (N1H2 2+ ), for C1 14H , 64C1N25038- 
3+ 2+ 102; mz (ES) 858 (NM3 ), 1287 (NM2 ), for CI 16H168C1N25039. 
3-[4-(tert-Butyldimethylsilanyloxy)-phenyl]-propionic acid tert-butyl ester, 
104.61 
Me 
I 
Nýt O-Si II Io 
Me 4o, rý 0 
To a solution of 62 (8.0 g, 36.0 mmol) in dichloromethane (100 in]) was added 
dimethylaminopyridine (1-2 crystals), triethylamine (7.80 ml, 54.1 mmol, 1.5 eq) 
and tert-butyldimethylsilyl chloride (5.95 g, 39.6 mmol, 1.1 eq). The reaction 
was stirred at room temperature for 8 hours after which time TLC (ethyl 
acetate: hexane, 1: 9, and PMA dip to visualise) indicated that the starting material 
had been consumed. The reaction mixture was washed with water (3 x 20 ml), 
dried (MgS04) and concentrated under reduced pressure. The product was 
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isolated with flash column chromatography (ethyl acetate: hexane, 1: 9) to give 
104 as a clear colourless oil (9.60 g, 28.2 mmol, 79%). v,,.,, ýujol)/cm- 1 173 1, 
1600,1511; 8H(300 MHz; CDC13) 7.06 (2 H, d, JAB 8.5, ArCH), 6.77 (2 H, d, JAB 
8.5, ArCH), 2.86 (2 H, t, J 7.7, ArCH2CH2), 2.52 (2 H, t, J 7.7, ArCH2CH2), 1.43 
(9 H, s, CMeAl. 00 (9 H, s, SiCiMe2), 0.20 (6 H, s, SiMe); 8c(75 MHz; CDC13) 
172.7 (C), 154.3 (C), 133.8 (C), 129.6 (2 CH), 120.3 (2 CH), 80.6 (C), 37.7 
(CH2), 30.8 (CH2)5 28.5 (CHA 26.1 (CHA18.6 (C), -4.0 (CHA m/ý (El) 336 
(M); (Cf) 354 (MW14+); (Found MNH4+, 354.2461. C19H3203Si requires 
MNI-14 , 354.2464); COSY spectra exhibited a good correlation %vith the 
proposed structure. 
3-[4-(tert-Butyldimethylsilanyloxy)-phenyll-2-methylpropionic acid lert-butyl 
ester, 5.99 
Me 
I 
O-si 
I+ 
Me 
0 
A solution of 104 (4.5 g, 13.4 mmol) In tetrahydrofuran (25 ml) was cooled to - 
78'C and stirred for 30 minutes. To this methyl iodide (8.2 ml, 132.4 mmol, 10 
eq), FIMPA (16.2 ml, 132.4 mmol, 10 eq) and LDA [2M solution in THF], (7.3 
ml, 14.6 mmol, 1.1 eq) were added and stirred at -78*C for 6 hours. The 
reaction mixture was then stirred at room temperature overnight after which time 
TLC (diethyl ether: hexane, 1: 9) indicated that the starting material had been 
consumed. The excess reagents and solvent were carefully removed under 
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reduced pressure and the product isolated via flash column chromatography 
(ethyl acetate: hexane, 1: 9) to give 105 as a clear colourless oil (2.8 g, 8.0 mmol, 
60%). v,,,.,, (Nujol)/cm-1 1729,1600,1510; M300 MHz; CDC13) 7.04 (2 H, d, 
JAB 8.4, ArCH), 6.76 (2 H, d, JAB 8.4, ArCH), 2.94-2.83 (1 H, in, ArCH2CH), 
2.64-2.49 (2 H, in, ArCH2CH), 1.39 (9 H, s, CMeA 1.12 (3 H, d, J 6.6, CHN[e), 
1.00 (9 H, s, SICMe3), 0.20 (6 H, s, SiMeA 8c(75 MHz; CDC13) 172.7 (C), 
154.3 (C), 133.8 (C), 129.6 (2 CH), 120.3 (2 CH), 80.6 (C), 42.9 (CH), 38.0 
(CH2), 28.5 (CHA 26.1 (CHA 16.5 (CHA 18.6 (C), 4.0 (CHA mz (EI) 350 
(M+); (CI) 368 (MNI-14+); (Found: NUqH4+, 368.2622. C2oH34O3Si requires 
MNH4+, 368.262 1). COSY spectra exhibited a good correlation with the 
proposed structure. 
61 3-(4-Hydroxyphenyl)-2-methylpropionic acid tert-butyl ester, 106 . 
OH 
0 
0 
A solution of 105 (1.5 g, 4.29 mmol) in tetrahydrofuran (20 ml) was cooled to - 
I O*C to which TBAF (1.34 g, 4.24 mmol) was quickly added. The reaction 
mixture was stirred at room temperature for 20 minutes after which time TLC 
(ethyl acetate: hexane, 1: 4, and PMA dip to visualise) indicated that the starting 
material had been consumed. The reaction mixture was diluted with diethyl 
ether (40 ml), washed with water (3 x 20 ml), dried (MgS04) and concentrated 
under reduced pressure. The product was isolated via flash column 
chromatography (ethyl acetate: hexane, 1: 4) to give 106 as a clear colourless oil 
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(830 mg, 3.52 mmol, 82%). v,,.,, (Nujol)/cm-1 3392,1728,1600,1516; 8H(300 
MHz; CDC13) 7.00 (2 H, d, JAB 8.5, ArCH), 6.72 (2 H, d, JAB 8.5, ArCH), 6.53 
(I H, s, ArOH), 2.89-2.80 (1 H, m, ArCH2CH), 2.64-2.49 (2 H, in, ArCH2CH), 
1.38 (9 H, s, CMe3), I. ll (3 H, d, J 6.6, CHMe); 8c(75 MHz; CDC13) 177.0 (C), 
154.3 (C), 132.6 (C), 131.5 (2 CH), 115.7 (2 CH), 81.0 (C), 43.2 (CH), 39.4 
(CH2), 28.5 (CH3). 17.4 (CHA iwz (EI) 236 (M); (Cl) 254 (MNH4+); (Found 
MNH4+, 254.1752. C14H2003 requires MNH4+, 354.1756); COSY spectra 
exhibited a good correlation vvith the proposed structure. 
3-[4- (2- [[4- (2-Chloro-4-nitrophenyla,: o) -phenyl]-ethylamino) -ethoxy) -phenyll- 
2-methylpropionic acid tert-butyl ester, 107.55-57 
+. 
lrý, 
Z 0"ýN'ý'ý 
0 
Ne 
N 
ci 
N02 
To a solution of 106 (660 mg, 2.80 mmol) in dichloromethane (10 ml) was added 
triphenylphosphine (734 mg, 2.80 mmol), diethyl azodicarboxylate (0.44 ml, 
2.80 mmol) and disperse red (974 mg, 2.80 mmol). The reaction mixture was 
stirred at room temperature for 3 hours after which time TLC (ethyl 
acetate: hexane, 1: 4) indicated that the starting material had been consumed. The 
dichloromethane was removed under reduced pressure and the product isolated 
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via flash column chrornatograph to give 107 as a dark red oil (514 mg, 0.91 
mmol, 33%). v,,,,, (Nujol)/Cm-', 1724,1601,1514,1337; 6H(300 MHz; CDCh) 
8.35 (1 H, d, J2.5, ArCH), 8.11 (1 H, -dd, J8.9,2.5, ArCH), 7.92 (2 H, d, JAB 
9.0, ArCH), 7.75 (1 H, d, J 8.9, ArCH), 7.08 (2 H, d, JAB 9.0, ArCH), 6.79 (4 H, 
d, JAB 9.0, ArCH), 4.16 (2 H, t, J 5.8, ATOCH2CH2), 3.84 (2 H, t, J 5.8, 
ArOCH2CH2), 3.61 (2 H, q, J 7.1, CH2Me), 2.94-2.80 (1 H, m, ArCH2CH), 2.63- 
2.47 (2 H, m, ArCH2CH), 1.41 (9 H, s, CMe3), 1.28 (3 H, t, J 7.1, CH2Me), 1.09 
(3 H, d, J 6.6, CHMe); 8c(75 MHz; CDC13) 176.0 (C), 157.3 (C), 153.5 (C), 
152.2 (C), 147.5 (C), 144.7 (C), 134.3 (C), 132.8 (C), 130.5 (2 CH), 127.4 (CH), 
126.4 (CH), 123.0 (CH), 118.4 (2 CH), 114.6 (2 CH), I 11.9 (2 CH), 81.5 (C), 
65.7 (CHA 50.4 (CH2), 46.7 (CH2), 42.9 (CH), 39.3 (CHA 28.4 (CHA 17.3 
(CH3), 12.7 (CHA m1z (EI) 566 (M+), 568 (M++2); (CI) 567 (MH+), 569 
(MW+2); (Found MH+, 567.2372. C30H35 35CIN405 requires MH+, 567.2374); 
COSY spectra exhibited a good correlation with the proposed structure. 
3-[4- (2- tl 4- (2-Chloro-4-n itrophenylazzo) -phenyl]-ethylam ino) -ethoxy) -phenyll- 
2-methylpropionic acid, 108.79 
HO YI-Z 
0 
cl 
N02 
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To a solution of TIS: TFA, 1: 49 (5 ml) was added a solution of 107 (354 mg, 0.63 
mmol) in dichloromethane (I ml). The reaction mixture was stirred at room 
temperature for 10 minutes after which time TLC (ethyl acetate: hexane, 2: 3) 
indicated that the starting material had been consumed. The reaction mixture 
was concentrated under reduced pressure and the product isolated via flash 
column chromatography to give 108 as a red oil (258 mg, 0.51 mmol, 81 %). 
vn, ax(NuJol)/cm-' 1707,1601,1515,1339; 8H(300 MHz; CDC13) 8.35 (1 H, d,. J 
2.5, ArCH), 8.11 (1 H, dd, J 8.9,2.5, ArCH), 7.92 (2 H, d, JAB 9.0, ArCH), 7.75 
(I H, d, J 8.9, ArCH), 7.08 (2 H, d, JAB 9.0, ArCH), 6.79 (4 H, d, JAB 9.0, 
ArCH), 4.16 (2 H, t, J 5.8, ArOCH2CH2), 3.85 (2 H, t, J 5.8, ArOCH2CH2), 3.61 
(2 H, q, J 7.1, CH2Me), 3.01-2.93 (1 H, m, ArCH2CH), 2.74-2.58 (2 H, m, 
ArCH2CH), 1.29 (3 H, t, J 7.1, CH2Me), 1.15 (3 H, d, J 6.6, CHMe); 8c(75 
MHz; CDC13) 176.0 (C), 157.3 (C), 153.5 (C), 152.2 (C), 147.5 (C), 144.7 (C), 
134.3 (C), 132.8 (C), 130.5 (2 CH), 127.4 (CH), 126.4 (CH), 123.0 (CH), 118.4 
(CH), 115.7 (CH), 114.7 (2CH), 111.9 (2CH), 65.7 (CH2), 50.3 (CH2), 46.7 
(CH2), 41.8 (CH), 38.9 (CHA 16.9 (CH302.7 (CHA m/z (EI) 5 10 (M+), 512 
(N4++2); (CI) 511 (M]H+), 513 (MH++2); (Found MH+, 511.175 1. C26H27 15CIN405 
requires MH+, 511.1748). COSY spectra exhibited a good correlation with the 
proposed structure. 
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3-[4-(2- [14- (2-Chloro-4-n itrophenylazo) -phenyl]-ethylamino) -ethoxy) -phenyll- 
2-methylpropionic acid 2-(2-[2-[2-(2-hydroxy-ethoxy)-ethoxyl-elhoxy)-ethoxy)- 
ethyl ester, 109.55-57 
0"ý 
DO 
N, Zý, 
N 
), ' C1 
N02 
To a solution of 108 (200 mg, 0.39 mmol) in dichloromethane (10 ml) was added 
triphenylphosphine (113 mg, 0.43 mmol, 1.1 eq), diethyl azodIcarboxylate (75 
mg, 0.43 mmol, 1.1 eq) and pentaglycol (0.11 ml, 0.51 mmol, 1.3 eq). The 
reaction mixture was stirred at room temperature for 4 hours after which time 
TLC indicated that the starting material had been consumed. The reaction 
mixture was diluted with further dichloromethane (20 ml), washed with water, (3 
x 20 ml), dried (MgS04) and concentrated under reduced pressure. The product 
was isolated via flash column chromatography to give 109 as a red oil ( 160 mg, 
0.22 mmol, 56%). vmx . 
(Nujol)/cm-1,1731,1600,1514,1337; 811(300 MHz, 
CDCIý3) 8.39 (1 H, d, J 2.4, ArCH), 8.15 (1 H, dd, J 8.9,2.4, ArCH), 7.95 (2 H, 
d, JkB 9.3, ArCH), 7.78 (1 H, d, J 8.9, ArCH), 7.08 (2 H, d, JAB 8.7, ArCH), 6.81 
(2 H, d, JAB 9.3, ArCH), 6.79 (2 H, d, JAB 8.7, ArCH), 4.244.15 (4 H, m, 
ArOCH2CH2), 3.86 (2 H, t, J 5.8, HOCH2CH2), 3.73-3.58 (20 H, In, CHA 2.99- 
2.93 (1 H, m, ArCH2CH), 2.75-2.58 (2 H, in, ArCH2CH), 1.30 (3 H, t, J 7.1, 
CH2Me), 1.13 (3 H, d, J 6.8, CHMe); Sc(75 NfHz; CDC13) 176.4 (C), 157.3 (C), 
153.5 (C), 152.1 (C), 147.5 (C), 144.7 (C), 134.3 (C), 132.4 (C), 130.5 (2CH), 
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127.4 (CH), 126.4 (CH), 123.0 (CH), 118.4 (2CH), 114.6 (2CH), 111.9 (2CH), 
72.9 (CHA 71.0 (4CH2)5 70.7 (2CH2), 69.5 (CHA 65.7 (CHA 63.8 (CHA 62.1 
(CHA 50.4 (CHA 46.7 (CH2), 41.9 (CH), 39.1 (CH2), 17.0 (CHA 12.7 (CH3); 
m, 'z (FAB) 753 (MNa+), 755 (MNaFf++2) (Found: MH+, 731.3053. 
C361447 35CIN401o requires MH+, 731.3059); COSY spectra exhibited a good 
correlation with the proposed structure. 
344- (2- ([4- (2- Chloro-4-n itrophenylazo) -phenyl]-ethylamino) -ethoxy) -phenyll- 
2-methylpropionic acid 2-(2-[2-(2-f2-[4-(2-tert-butoxycarbonylelhyl)-phenoxyl- 
etho)gý-ethoxy)-etho. )TI-ethoxy]-ethyl ester, 110.55-57 
0 
0 
50 
No 
N 
cl 
02 
To a solution of 109 (105 mg, 144 pmol) in dichloromethane was added 
triphenylphosphme (41.4 mg, 158 ptmol, 1.1 eq), djethyl azodicarboxylate (28 
mg, 158 4mol, 1.1 eq) and 62 (32 mg, 144 jimol). The reaction mixture was 
stirred at room temperature for 2 hours after which time TLC (ethyl 
acetate: hexane, 1: 4) indicated that the starting material had been consumed. The 
reaction mixture was concentrated under reduced pressure and the product 
isolated via flash column chromatography (ethyl acetate: hexane, 1: 4) to give 110 
196 
Experimental 
(79 mg, 85 gmol, 59%); 8H(300 MEz; CDC13) 8.38 (1 H, d, J 2.5, ArCH), 8.14 
(I H, dd, J 9.0,2.5, ArCH), 7.95 (2 H, d, JAB 9.2, ArCH), 7.78 (1 H, d, J 9.0, 
ArCH), 7.09 (2 H, d, JAB 8.5, ArCH), 7.07 (2 H, d, JAB 8.7, ArCH), 6.82 (2 H, d, 
JAB 8.7, ArCH), 6.80 (2 H, d, JAB 9.2, ArCH), 7.68 (2 H, d, JAB 8.5, ArCH), 
4.24-4.14 (4 H, m, ArOCH-, CH-, ), 4.09 (2 H, t, J 4.9, HOCH2CH2), 3.87-3.81 (4 
H, m, CHA 3.76-3.59 (16 H, m, CHA 2.99-2.92 (1 H, m, ArCH2CH), 2.83 (2 H, 
t, J 7.8, ArCH2CH2), 2.75-2.57 (2 H, m, ArCH2CH), 2.49 (2 H, t, J 7.8, 
ArCH2CH2), 1.41 (9 H, s, CMeAl. 29 (3 H, t, 17.0, CH2Me), 1.13 (3 H, d3 J 
6.8, CHI%le); 6c(75 MHz; CDC13) 176.4 (C), 172.8 (C), 164.0 (C), 157.6 (C), 
157.3 (C), 153.5 (C), 152.1 (C), 147.5 (C), 144.7 (C), 134.3 (C), 133.5 (C), 132.4 
(C), 130.5 (2 CH), 129.6 (2 CH), 127.4 (CH), 126.4 (CH), 123.0 (CH), 118.4 (2 
CH), 114.9 (2 CH), 114.6 (2 CH), I 11.9 (2 CH), 80.7 (CHA 71.2 (CHA 7 1.0 
(3CH2), 70.2 (CHA 69.5 (CH2), 67.8 (CH2), 65.7 (CHA 63.8 (CHA 62.7 (CHA 
50.4 (CHA 46.7 (CHA 41.9 (CH), 39.1 (CHA 37.7 (CH2), 30.7 (CH2), 28.5 
(CH), 17.1 (CHA12.7 (CHA nil'-- (FAB) 957 (MNa), 959 (MNa++2) (Found: 
MH +, 935.4216. C491-163 35 CIN4012 requires MH+, 935.4209); COSY spectra 
exhibited a good correlation vvith the proposed structure. 
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3-[4-(2-([4-(2-Chloro-4-nitrophenylazo)-phenyll-ethylamino)-ethoxy)-phenyll- 
2-methylpropionic acid 2-(2-[2-(2-(2-[4-(2-carboxyethyl)-phenoxy]-ethoxy)- 
ethoxy)-ethoxyl-ethoxy)-ethyl ester, 111.79 
0 
50 
N 
N 
cl 
02 
To a solution of TISTFA, 1: 49 (3 ml) was added a solution of 110 (20 mg, 21 
pmol) in dichloromethane (0.5 ml). The reaction mixture was stiffed at room 
temperature for 10 minutes after which time TLC (ethyl acetate: hexane, 2: 3) 
indicated that the starting material had been consumed. The reaction mixture 
was concentrated under reduced pressure and the product isolated via flash 
column chromatography to give 111 as a red oil (14.5 mg, 16.5 pmol, 79%); 
8H(300 Nfflz; CDC13) 8.3 8 (1 IL d, J 2.5, ArCH), 8.14 (1 H, dd, J 9.0,2.5, 
ArCH), 7.95 (2 K d, JAB 9.2, ArCH), 7.78 (1 H, d, J 9.0, ArCH), 7.09 (2 H, d, 
J, kB 8.5, ArCH), 7.07 (2 K d, JAB 8.7, ArCH), 6.82 (2 H, d, JAB 8.7, ArCII), 6.80 
(2 I-L d, JAB 9.2, ArCH), 7.68 (2 FL d, JAB 8.5, ArCH), 4.244.14 (4 H, m, 
ArOCH2CH2), 4.09 (2 IL t, J 4.9, HOCH2CH2), 3.87-3.81 (4 H, m, CH2), 3.76- 
3.59 (16 H, m, CH2), 2.99-2.92 (I I-L m, ArCH2CH), 2.83 (2 H, t, J 7.8, 
ArCH2CH2), 2.75-2.57 (2 H, m, AxCH2CH), 2.49 (2 H, t, J 7.8, AxCH2CH2)* 
1.29 (3 H, t, J 7.0, CH2Me), 1.11 (3 FL d, J 6.8, CIHMe); Sc(75 MHz; CDC13) 
176.4 (C), 172.8 (C), 157.6 (C), 157.3 (C), 153.5 (C), 152.1 (C), 147.5 (C), 144.7 
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(C), 134.3 (C), 133.5 (C), 132.4 (C), 130.5 (2 CH), 129.6 (2 CH), 127.4 (CH), 
126.4 (CH), 123.0 (CH), 118.4 (2 CH), 114.9 (2 CH), 114.6 (2 CH), 111.9 (2 
CM, 80.7 (CH2), 71.2 (CH2), 71.0 (3CH2), 70.2 (CH2), 69.5 (CH2), 67.8 (CH2), 
65.7 (CH2), 63.8 (CH2), 62.7 (CH2), 50.4 (CH2), 46.7 (CH2), 41.9 (CH), 3 9.1 
(CH2), 37.7 (CH2), 30.7 (CH2), 17.1 (CH3), 12.7 (CH3); nilz (FAB) 901 (MNa+), 
903 (MNe+2) (Found: NUI+, 879.8577. C45H5535CIN4012 requires M[f +9 
879.3583); COSY spectra exhibited a good correlation with the proposed 
structure. 
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Preparation for the attaching the chiral dye-linker to the terminal arnino group of 
the peptide, followed by deprotection and partial cleavage of the system from the 
polymer supported was: 
a) To a suspension of the peptide on Tentagel 40 (10 mg) in dimethylformamide 
(I ml) was added the dye-linker 111 (10 mg, 11.4 pLmol, excess), PyBOP (30 mg, 
57.7 gmol, excess), HOBt (30 mg, 222 pmol, excess) and DIPEA (3 drops, -30 
mg, 233 pmol, excess), and gently mixed by bubbling nitrogen through at room 
temperature for 3 hours. The resin was then isolated by filtration and washed 
with dimethylformamide (2 x 10 ml), dichloromethane (2 x 10 ml), methanol (2 
x 10 ml) and dried under reduced pressure to give a black resin 112 (11 mg). 
b) The peptidyl dye-linker system 112 (9 mg) was suspended in 
triisopropylamine: TFA, 1: 49 (3 ml) and gently mixed by bubbling nitrogen 
through at room temperature for 2 hours. The resin was isolated by filtration, 
washed with methanol (2 x 10 in]), dichloromethane (2 x 10 ml) and dried under 
reduced pressure to give the supported unprotected peptide chiral dye-linker 
system 113 as a black resin (7 mg). The filtrate was dried under reduced 
pressure to give a red powder (I mg), the result of cleavage of the 10% Rink 
resin. 
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Phenylacelic acid 4-nitrophenyl ester, 103.55-57 
0- 
0- 
N0 'I \I 
To a solution of phenyl acetic acid (300 mg, 2.21 mmol), triphenylphosphine 
(578 mg, 2.21 mmol) and diethyl azodicarboxylate (0.35 ml, 2.21 mmol) in 
toluene (20 ml) was added p-nitrophenol (307 mg, 2.21 mmol). The reaction 
mixture was stirred for 12 hours at room temperature after which TLC (ethyl 
acetate: hexane, 1: 4) indicated that the phenyl acetic acid had been consumed. 
The toluene was removed at 50"C under reduced pressure to give a pale yellow 
oil which was redissolved in ether, washed with NaHC03 (3 x 30 ml), HCI (2 M 
3x 30 ml), water (3 x 30 ml), dried (MgSO4) and concentrated in vacuo. The 
product was eluted by flash column chromatography (ethyl acetate: hexane, 1: 9) 
to give 103 as a clear very pale yellow oil, (352 mg, 1.37 mmol, 62%). 
vma, (NujolYcm", 1764,1614,1524,1347; SIK300 MHz; CDC13) 8.21 (2 H, d4 
JAB 9.0, ArCH), 7.3 8-7.28 (5 I-L m ArCH), 7.24 (2 FL d, JAB 9.0, ArCH), 3.89 (2 
K s, ArCH2); 5c(75 NIHz; CDC13) 169.5 (C), 155.8 (C), 145.7 (C), 133.1 (C), 
129.7 (2 CH), 129.3 (2 CH), 128.1 (CH), 125.6 (2 CH), 122.8 (2 CH), 41.7 
(CH2); m/z (EI) 257 (M); (CI) 275 (MNH4+) (Found: We, 258.0766, MNH4+, 
275.1033. C14HIIN04 requires MW, 258.0766, MNI14+, 275.1032); 
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Toluene-4-suý'onic acid 2-(2-hydroxyethoxy) -ethyl ester, 119.45 
HO------'----ý0-S" -0- 11 0 
To a solution of diethylene glycol (15 ml, 158.0 mmol, 5 eq) in dichloromethane 
(150 ml) triethylamine (13.1 ml, 94.8 mmol, 3 eq) and a catalytic amount Of 
dimethylaminopyridine (1-2 crystals), p-toluenesulfonyl chloride (6.03 g, 31.6 
mmol, I eq) was carefully added at 01'C. The reaction mixture was allowed to 
warm to room temperature and stiffed for 8 hours after which TLC (ethyl 
acetate: hexane, 4: 1) indicated that the p-toluenesulfonyl chloride had been 
consumed. The dichloromethane was removed under vacuo to give a pale yellow 
solid which was redissolved in diethyl ether. This was washed with water (3 x 
30 ml) dried (MgS04) and concentrated in vacuo. The product was eluted by 
flash column chromatography (ethyl acetate: hexane, 2: 3) to give 119 as a clear 
colourless oil, (3.56 g, 13.7 mmol, 43%). v.,, (Nujol)/cm" 3401,1597; 8IK300 
NIHz; CDC13) 7.80 (2 K dý JAB 8.3, ArCH), 7.3 6 (2 I-L d, JAi3 8.3, ArCII), 4.19 
(2 IL t, J 4.6, CHzCH2OTs), 3.69 (2 H, t, J 4.6, CH2CH2OTs), 3.67 (2 H, t, J 3.7, 
HOCH2CH2), 3.53 (2 IL t, 13.7, HOCH2CH2), 2.45 (3 H, s, ArMe); Sc(75 MHz; 
CDC13) 145.4 (C), 133.3 (C), 130.3 (2 CH), 128.3 (2 CH), 72.9 (CH2), 69.6 
(CH2), 68.9 (CH2), 62.0 (CH2), 22.0 (CH3); ntlz (CI) 261 (MH), 278 (MNI-4) 
(Found: MIr, 261.0797. CIIH1605S requires NUI+, 261.0795); COSY spectra 
exhibited a good correlation with the proposed structure. 
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Toluene-4-suý'onic acid 2-[2-(2-hydroxyethoxy)-ethoxyl-ethyI ester, 120.45 
0 
114 '*ýO-s 
11 0 
To a solution of triethylene glycol (2 1.1 ml, 15 8.0 mmol, 5 eq) in 
dichloromethane (150 ml), triethylamine (13.1 ml, 94.8 mmol, 3 eq) and a 
catalytic amount of dimethylaminopyridine (1-2 crystals), p-toluenesulfonYl 
chloride (6.03 g, 31.6 mmol) was carefully added at 01'C. The reaction mixture 
Was allowed to wann to room temperature and stirred for 8 hours after which 
TLC (ethyl acetate: hexane, 4: 1) indicated that the p-toluenesulfonyl chloride had 
been consumed. The dichloromethane was removed under vacuo to give a pale 
yellow solid which was redissolved in diethyl ether. This was washed with water 
(3 x 30 ml) dried (N4gSO4) and concentrated in vacuo. The product was eluted 
by flash column chromatography (ethyl acetate: hexane, 3: 2) to give 120 as a 
clear colourless oil, (3.70 g, 12.2 mmol, 39%). v.. (Nujolycm"l 3417,1597; 
8ji(300 NIHz; CDC13) 7.80 (2 K d, JAB 8.4, ArCH), 7.35 (2 H, d, JAB 8.4, ArCII), 
4.17 (2 K t, J4.8, CH2CH2OTs), 3.73-3.69 (4 IL m, CH2), 3.61-3.56 (6 I-L m, 
C1112), 2.67 (1 I-L s, HOCH2CH2), 2.45 (3 H, s, ArMe); Sc(75 MH4 CDC13) 
145.3 (C), 133.3 (C), 130.2 (2 CH), 128.3 (2 CH), 72.9 (CH2), 71.1 (CH2), 70.6 
(CH2), 69.6 (CH2), 69.1 (CH2), 62.1 (CH2), 22.0 (CH3); m1z (CI) 305 (MH), 322 
(NM) (Found: MNW, 322.1321. C13H2oO6S requires NR*L+, 322.1324); 
COSY spectra exhibited a good correlation with the proposed structure. 
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Toluene-4-su6ronic acid 2-(2-[2-(2-hydroxyethoxy)-ethoxyl-etha'ty)-ethyI ester, 
121.45 
S-0- 
0 
To a solution of tetraethylene glycol (27.3 ml, 158.0 mmol, 5 eq) in 
dichloromethane (150 ml), triethylamine (13.1 ml, 94.8 mmol, 3 eq) and a 
catalytic amount of dimethylaminopyridine (1 -2 crystals), p-toluenesulfonyl 
chloride (6.03 g, 31.6 mmol) was carefully added at O*C. The reaction mixture 
was allowed to warm. to room temperature and stiffed for 8 hours after which 
TLC (ethyl acetate: hexane, 4: 1) indicated that the p-toluenesulfonyl chloride had 
been consumed. The dichloromethane was removed under vacuo to give a pale 
yellow solid which was redissolved in diethyl ether. This was washed with water 
(3 x 30 ml) dried (MgS04) and concentrated in vacuo. The product was eluted 
by flash column chromatography (ethyl acetate: hexane, 4: 1) to give 121 as a 
clear colourless oil, (4.38 g, 12.6 mmol, 40%). v. (Nujol)/cm"3426,1556; 
8H(300 MlIz; CDC13) 7.80 (2 H, d, JAB 8.4, AXCH), 7.35 (2 IL d, JAB 8.4, ArCH), 
4.16 (2 H, t, J 4.7, CH2CH2OTs), 3.72-3.57 (14 H, m, CH2), 3.37 (1 IL s, 
HOCH2CHA2.45 (3 K s, ArMe); BC(75 MHz; CDC13) 144.6 (C), 132.6 (C), 
129.6 (2 CH), 127.2 (2 CH), 72.2 (CH2), 70.4 (CH2), 70.3 (CH2), 69.9 (CH2), 
69.6 (CH2), 69.1 (CH2), 68.4 (CH2), 61.3 (CH2), 21.2 (CH3); m1z (EI) 348 (M), 
349(NlH); (CI) 366 (MNI-14); (Found MNIL+, 366.1591. C15H2407S requires 
MNIL+, 366.1586); COSY spectra exhibited a good correlation with the 
proposed structure. 
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2-[2-(2-Hydroxyethoxy)-ethyll-isoindole-1,3-dione, 122.1()o 
0- 
\/ 
N 
0 
To a solution of diethylene glycol tosylate 119 (3.5 g, 13.5 mmol) in 
dimethylformamide (50 ml) potassium phthalimide (2.74 g, 14.8 mmol, 1.1 eq) 
was added. The reaction mixture was stirred at 600C for 12 hours after which 
time TLC (80% ethyl acetate in hexane, and PMA dip to visualise) indicated that 
the starting material had been consumed. The reaction mixture was allowed to 
cool down to room temperature and 40 ml of water was added. The product was 
extracted with ether (5 x 20 ml) and the organic fraction combined and washed 
with water (20 ml). This was then dried (MgS04) and concentrated in vacuo to 
give a clear pale yellow oiL The product was isolated by flash column 
chromatography (ethyl acetate: hexane, 3: 2) to give 122 as a clear colourless oil, 
(2.54 g, 10.8 mmol, 80%). v.. (N-ujolycm-1 3467,1774,1772,1614; 81j(300 
Nffh; CDC13) 7.89-7.82 (2 I-L m, ArCH), 7.76-7.70 (2 IL m, ArCH), 3.92 (2 It t, 
J 5.5, PhthNCH2CH2), 3.75 (2 K t, J 5.5, PhNCH2CH2), 3.69 (2 I-L t, J 4.8, 
CH2CHzOH), 3.61 (2 IL t, J 4.8, CH2CH20H), 2.42 (1 H, brs, CH2CH20H); 
8c(75 Nffh; CDC13) 168.9 (2 Ci), 134.5 (2 CH), 132.4 (2 Ci), 123.7 (2 CH), 72.6 
(CH2), 68.8 (CH2), 62.1 (CH2), 3 8.0 (CH2); nVz (CI) 236 (MHý, 253 (MN114ý 
(Found: Nfll+, 236.0920. C121113NO4 requires MW, 236.0923); COSY spectra 
exhibited a good correlation with the proposed structure. 
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2-(2-[2-(2-Hydroxyethoxy)-ethoxyl-etW)-isoindole-1,3-dione, 123.100 
HO""ý 
To a solution of triethylene glycol tosylate 120 (3.5 g, 11.5 mmol) in 
dimethy1formamide (50 ml) was added potassium phthalimide (2.34 g, 12.7 
mmol, 1.1 eq). The reaction mixture was stirred at 60'C for 12 hours after which 
time TLC (ethyl acetate: hexane, 4: 1, and PMA dip to visualise) indicated that the 
starting material had been consumed. The reaction mixture was allowed to cool 
down to room temperature and 40 ml of water was added. The product was 
extracted with ether (5 x 20 ml) and the organic fraction combined and washed 
with water (20 ml). This was then dried (MgS04) and concentrated in vacuo to 
give a clear pale yellow oiL The product was isolated by flash column 
chromatography (ethyl acetate: hexane, 4: 1) to give 123 as a clear colourless oil, 
(2.44 g, 8.75 mmol, 76%). v,,. (Nujol)/cm" 3465,1770,1711,1614; 81j(300 
Nfflz; CDC13) 7.80-7.74 (2 11, m, ArCH), 7.68-7.61 (2 I-L m, ArCH), 3.83 (2 H, t, 
J5.6, PhthNCH2CH2), 3.68 (2 H, t, 15.6, PhthNCH2CH2), 3.60-3.51 (6 K m, 
CH2), 3.46 (2 H, t, J 4.3, CH2CH20H), 2.74 (1 H, t, J 6.0, CH2CH20H); 5c(75 
M11z; CDC13) 168.7 (2 0), 134.9 (2 CM, 134.4 (2 Ci), 123.7 (2 CM, 72.9 
(CH2), 70.7 (CH2), 70.3 (CH2), 68.3 (CH2), 62.1 (CH2), 37.6 (CH2); nz1z (CI) 280 
(WI), 297 (MNH4) (Found: NHI+, 280.1188. C14Hj7N05 requires Nfw, 
280.1185); COSY spectra exhibited a good correlation with the proposed 
structure. 
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2-[2-(2-Allyloxyethoxy)-ethyll-isoindole-1,3-dione, 125. 
0 
To a solution of diethylene glycol phthalimide 122 (2.0 g, 8.51 mmol) in 
tetrahydrofuran (25 ml), cesium carbonate (catalytic) and sodium hydride [50% 
w/W dispersion in mineral oil], (449 mg, 9.36 mmol, 1.1 eq) was carefully added 
at 0"C. Allyl bromide (1.08 ml, 12.8 mmol, 1.5 eq) was then quickly added at 
O"C, the reaction mixture allowed to warm to room temperature and stirred for 4 
hours after which time TLC (ethyl acetate: hexane, 4: 1, and PMA dip to visualise) 
indicated that the starting material had been consumed. This was then carefully 
quenched with water (2 ml), diluted with diethyl ether (30 ml), washed with 
water (3 x 30 ml), dried (MgSO4) and concentrated in vacuo. The product was 
isolated by flash column chromatography (ethyl acetate: hexane, 1: 4) to give 125 
as a clear colourless oil, (1.44 g, 5.20 mmol, 61%). v.,, (Nujol)/cm-1 1774,1713; 
SH(300 NlHz; CDC13) 7.88-7.82 (2 H, m, ArCH), 7.75-7.27 (2 H, m, ArCH), 5.84 
(I K ddt, J 17.1,10.4,5.7, CH2CHCH20), 5.22 (1 H, ddt, J 17.1,1.7,1.7, trans- 
CH2CHC1420). 5.13 (1 H, ddt, J 10.4,1.7,1.3, CiS-CH2CHCH20), 3.96 (2 H, dt, 
J 5.7,1.3, CH2CHCH20), 3.91 (2 IL t, J 5.9, PhthNCH2CH2), 3.76 (2 K t, J 5.9, 
PhthNCH2CH2), 3.68-3.62 (2 H, m, OCH2CH20allyl), 3.59-3.54 (2 H, m, 
OCH2CH20allyl); Sc(75 NfHz; CDC13) 168.7 (2 0), 135.1 (CH), 134.3 (2 CH), 
132.5 (2 0), 123.6 (2 CH), 117.4, (CH2), 72.6 (CH2), 70.5 (CH2), 69.8 (CH2), 
68.3 (CH2), 37.6 (CH2); nVz (CI) 276 (N*O, 293 (MNI-14) (Found: MH, 
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276.1240. CIH17NO4 requires Mr, 276.1236); COSY spectra exhibited a good 
correlation with the proposed structure. 
2-(2-[2-(2-Allyloxyethoxy)-ethax)]-ethyl)-isoindole-1,3-dione, 126. 
oQ 
O'O" 
N.. T 
0 
To a solution of triethylene glycol phthalimide 123 (2.0 g, 7.17 mmol) in 
tetrahydrofuran (40 ml), cesium carbonate (catalytic) and sodium hydride [50% 
w/w dispersion in mineral oil], (378 mg, 7.89 mmol, 1.1 eq) was carefully added 
at O*C. Allyl bromide (0.91 ml, 10.8 mmol, 1.5 eq) was then quickly added at 
O*C, the reaction mixture allowed to warni to room temperature and stiffed for 4 
hours after which time TLC (ethyl acetate: hexane, 4: 1, and PMA dip to visualise) 
indicated that the starting material had been consumed. This was then carefully 
quenched with water (2 ml), diluted with diethyl ether (30 ml), washed with 
water (3 x 30 ml), dried (MgSO4) and concentrated in vacuo. The product was 
isolated by flash column chromatography (ethyl acetate: hexane, 2: 3) to give 126 
as a clear colourless oil, (1.34 g, 4.17 mmol, 58%). v. (Nujol)/cm" 2869,1774, 
1713; Bji(300 Nffh; CDC13) 7.88-7.81 (2 H, m, ArCH), 7.75-7.69 (2 I-L m, 
ArCH), 5.89 (1 K ddt, 117.3,10.4,5.7, CH2CHCH20), 5.26 (1 H, ddt, J 17.1, 
1.7,1.7, trans-CH2CHCH20), 5.17 (I H, ddt, J 10.4,1.7,1.3, CiS-CH2CHCH20), 
3.99 (2 K dtý J 5.7,1.3, Cl-LCHC1120), 3.90 (2 K t, J 5.9, PhthNCH2CH2), 3.75 
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(2 t, J 5.9, PhthNCH2CH2), 3.68-3.64 (2 FL m, OCH2CH20allyl), 3.63-3.59 (4 
H, CH2), 3.55-3.51 (2 FL m, OCH2CH20allyl); Bc(75 Nfliz; CDC13) 168.6 (2 
Ci), 135.2 (CH), 134.3 (2 CH), 132.5 (2 Ci), 123.6 (2 CH), 117.5 (CH2), 72.6 
(CH2), 71.0 (CH2), 71.0 (CH2), 70.5 (CH2), 69.8 (CH2), 68.3 (CH2), 37.6 (CH2); 
m/z (CI) 320 (Nff-r), 337 (N4NI14) (Found: MH+, 320.1497. C17142IN05 requires 
NHI+, 320.1497); COSY spectra exhibited a good correlation with the proposed 
structure. 
2-(2-(2-[2-(2-Allyloxyethoxy)-ethoxy]-ethoxy)-ethyl)-isoindole-1,3-dione, 127. 
oý D/ 
To a solution of tetraethylene glycol tosylate 124 (3.5 g, 10.1 mmol) in 
dimethylforinamide (40 ml) was added potassium phthalimide (2.05 g, 11.1 
mmol, 1.1 eq). The reaction mixture was stirred at 60"C for 12 hours after which 
time TLC (ethyl acetate: hexane, 4: 1, and PMA dip to visualise) indicated that the 
starting material had been consumed. The reaction mixture was allowed to cool 
to room temperature and further then cooled to 0"C. Allyl bromide (1.28 ml, 
15.1 mmol, 1.5 eq), cesium carbonate (catalytic) and sodium hydride [50% w/w 
dispersion in mineral oil], (630 mg, 13.1 mmol, 1.3 eq) were carefully added and 
the reaction mixture was stirred at room temperature overnight after which TLC 
(ethyl acetate: hexane, 3: 2, and PMA dip to visualise) indicated that the 
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intermediate product had been consumed. This was then carefully quenched with 
water (40 ml) and the product extracted with ether (5 x 20 ml). The organic 
fractions were combined, washed with water (20 ml), dried (MgSO4) and 
concentrated in vacuo to give a clear pale yellow oil. The product was isolated 
by flash column chromatography (ethyl acetate: hexane, 2: 3) to give 127 as a 
clear colourless oil, (1.56 g, 4.27 mmol, 42%). v.,, (Nujol)/cm'1,1774,1713, 
1394; 84300 MHz, CDC13) 7.87-7.81 (2 H, m, ArCH), 7.75-7.69 (2 I-L m, 
ArCH), 5.92 (1 FL ddt, J 17.3,10.4,5.7, CH2CHCH20), 5.27 (1 H, ddý J 17.1, 
1.7,1.7, tranS-CH2CHCH20). 5.17 (1 H, ddt, J 10.4,1.7,1.3, cis-CH2CHCH20), 
4.02 (2 K dt, J 5.7,1.3, CH2CHCH20), 3.90 (2 H, t, J 5.8, PhthNCH2CH2), 3.75 
(2 I-L t, J 5.8, PhthNCH2CH2), 3.68-3.56 (12 H, m, CH2); Sc(75 Nffh; CDC13) 
168.6 (2 Ci), 135.1 (CH), 134.3 (2 CH), 132.5 (2 Ci), 123.6 (2 CH), 117.4 (CH2), 
72.5 (CH2), 70.9 (4 CH2), 70.4 (CH2), 69.7 (CH2), 68.2 (CH2), 37.6 (CH2); m1z 
(EI) 364 (MH); (CI) 381 (MNH4+); (Found MNH4+, 381.2027. C19H25NO6 
TequiresMNH4+, 381.2026). COSY spectra exhibited a good correlation with the 
proposed structure. 
2-(2-Allyloxyethoxy)-ethylamine, 128.100 
H2N-'ýON`ýO--'ý'ý 
To a solution of allyl diglycolphthalimide 125 (1.0 g, 3.64 mmol) in ethanol (50 
ml) hydrazine monohydrate was added dropwise (approximately 200 mg, 4.0 
mmol, excess) over a period of 30 minutes at which point TLC (ethyl 
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acetate: hexane, 2: 3 and permanganate dip to visualise) indicated that the starting 
material had been consumed. Concentrated hydrochloric acid (10 drops) was 
carefully added, the reaction mixture was refluxed for 2 hours and then cooled to 
room tempemture after which time TLC (methanol: dichloromethane, 1: 9 and 
ninhydrin dip to visualise) indicated the presence of the product. The reaction 
mixture was then concentrated in vacuo, diluted with ethyl acetate (10 ml) and 
the product extracted with dilute hydrochloric acid (I M, 2x5 ml). The aqueous 
extract was made basic with sodium hydroxide (4 M, 2x5 ml) and the product 
extracted with diethyl ether (4 x 10 ml). The organic fractions were combined 
and reduced under vacuo to give 128 as a clear pale yellow oil (380 mg, 2.62 
mmol, 72%). v. (NuJolycm713408,1652; 811(300 NIHz; CDC13) 5.93 (1 H, ddt, 
J 17.2,10.3,5.7, CH2CHCH20), 5.29 (1 H, ddt, J 17.2,1.6,1.6, trans- 
CH2CHCH20), 5.19 (I H, ddt, J 10.3,1.6,1.6, cis-CH2CHCH20), 4.04 (2 H, dt, 
J 5.7,1.6, CH2CHCH20), 3.67-3.57 (6 H, m, CH2), 3.52 (2 K t, J 5.3, CH2), 
2.90 (2 I-L br s, NH2); 8c(75 MHz; CDC13) 135.1 (2 CH), 117.6 (CH2), 72.7 
(CH2), 70.7 (CH2), 70.6 (CH2), 69.8 (CH2); m1z (CI) 146 (MR); COSY spectra 
exhibited a good correlation with the proposed structure. 
2-[2-(2-Allyloxyethoxy)-etha)(y7-etWamine, 12 . 
100 
To a solution of allyl triglycolphthalimide 126 (1.0 g, 3.13 mmol) in ethanol (50 
ml) hydrazine monohydrate, was added dropwise (approximately 200 mg, 4.0 
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mmol, excess) over a period of 30 minutes at which point TLC (ethyl 
acetate: hexane, 2: 3 and permanganate dip to visualise) indicated that the starting 
material had been consumed. Concentrated hydrochloric acid (10 drops) was 
carefully added, the reaction mixture was refluxed for 2 hours and then cooled to 
room temperature after which time TLC (methanol: dichloromethane, 1: 9 and 
ninhydrin dip to visualise) indicated the presence of the product. The reaction 
mixture was then concentrated in vacuo, diluted with ethyl acetate (10 ml) and 
the product extracted with dilute hydrochloric acid (I K2x5 ml). The aqueous 
extract was made basic with sodium hydroxide (4 K2x5 ml) and the product 
extracted with diethyl ether (4 x 10 ml). The organic fractions were combined 
and reduced under vacuo to give 129 as a clear pale yellow oil (444 mg, 2.35 
mmol, 75%). vr,, (Nujol)/cm" 3415,1652; U300 MHz; CDC13) 5.94 (1 H, ddt, 
J 17.3,10.4,5.8, CH2CHCH2O), 5.28 (1 H, ddt, J 17.3,1.3,1.3, trans- 
CH2CHCH20), 5.18 (1 K ddt, J 10.4,1.3,1.3, cis-CH2CHCH20), 4.04 (2 IL dt, 
J5.8,1.3, CH2CHCH20), 3.71-3.60 (12 H, m, CH2), 3.35 (2 H, br s, NH2); 8c(75 
Nffiz; CDC13) 135.1 (2 CM, 117.5 (CH2), 72.6 (CH2), 71.0 (3 CH2), 70.7 (CH2), 
69.9 (CH2); m1z (CI) 190 (MH); COSY spectra exhibited a good correlation 
with the proposed structure. 
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2-(2-[2-(2-Allyla-cyethoxy)-ethaxjl-ethaxy)-ethylamine, 130.100 
H2N°O°O 
To a solution of allyl tetraglycolphthalimide 127 (1.0 g, 2.75 mmol) in ethanol 
(50 ml) hydrazine monohydrate was added dropwise (approximately 200 mg, 4.0 
mmol, excess) over a period of 30 minutes at which point TLC (ethyl 
acetate: hexane, 2: 3 and permanganate dip to visualise) indicated that the starting 
material had been consumed. Concentrated hydrochloric acid (10 drops) was 
carefully added, the reaction mixture was refluxed for 2 hours and then cooled to 
room temperature after which time TLC (methanol: dichloromethane, 1: 9 and 
ninhydrin dip to visualise) indicated the presence of the product. 'Me reaction 
mixture was then concentrated in vacuo, diluted with ethyl acetate (10 ml) and 
the product extracted with dilute hydrochloric acid (I K2x5 ml). The aqueous 
extract was made basic with sodium hydroxide (4 K2x5 ml) and the product 
extracted with diethyl ether (4 x 10 ml). The organic fractions were combined 
and reduced under vacuo to give 130 as a clear pale yellow oil (43 6 mg, 1.87 
mmol, 68%). vx(Nujol)/cm"' 3401,1652; 51j(300 MHz; CDC13) 5.93 (1 I-L ddt, 
J 17.3,10.4,5.7, CH2CHCH20), 5.2 8 (1 H, ddt, J 17.3,1.5,1.5, trans- 
CH2CHCH20), 5.18 (I I-L ddt, J 10.4,1.5,1.5, cis-CH2CHCH20), 4.03 (2 K dt, 
J5.7,1.5, CH2CHCH2.0), 3.69-3.59 (16 H, m, CH2), 2.85 (2 H, br s, NH2); 8c(75 
MHz; CDC13) 135.1 (2 CH), 117.5 (CH2), 73.8 (CH2), 72.6 (CH2), 71.0 (4 CH2), 
70.7 (CH2), 69.8 (CH2); m1z (CI) 234 (MH+); (Found 1WI+, 234.1707. CI IH23NO4 
requires MW, 234.1705). COSY spectra exhibited a good correlation with the 
proposed structure. 
214 
Experimental 
Coupling 128 to vancomycin 
To a solution of vancomycin hydrochloride (50 mg, 33.6 pmol) in dimethyl 
sulfoxide was added allyl diethylglycolamine (20 mg, 138 pmol, excess), PyBOP 
(21 mg, 40.3 gmol, 1.2 eq), DEPEA (5.2 mg, 40.3 gmol, 1.2 eq), HOBt (5.4 mg, 
40.3 panol, 1.2 eq). The reaction mixture was stirred at room temperature for 4 
days after which time reverse phase BPLC indicated that the starting material 
had been consumed. The solution was concentrated under reduced pressure and 
the product isolated by preparative reverse phase BPLC to give 131 as a white 
powder (18 mg, 11.2 pmol, 33%). The mass spectrometry analysis is to follow. 
The reverse phase IHPLC chromatogram is shown below. The starting materials 
vancomycin, PyBOP and HOBt were found to co-run giving a broad peak with 
retention times of 2.09 minutes (analytical column; mobile phase 
acetonitrfle: water, 1: 3; flow rate, I ml/minute; 24"C) and 3.48 minutes 
(analytical column; mobile phase TFA: acetonitrile: water, 1: 24: 75; flow rate, I 
ml/minute; 24*C). 
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Analytical column; mobile phase TFA: acetonitrile: water, 1: 24: 75; flow rate, I 
ml/minute; 230C. 
Coupling 129 to vancomycin 
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To a solution of vancomycin hydrochloride (50 mg, 33.6 pmol) in dimethyl 
sulfoxide was added allyl triethylglycolamine (20 mg, 106 pmol, excess), 
PyBOP (21 mg, 40.3 pmol, 1.2 eq), DEPEA (5.2 mg, 40.3 gmol, 1.2 eq), HOBt 
(5.4 mg, 40.3 pmol, 1.2 eq). The reaction mixture was stirred at room 
temperature for 4 days after which time reverse phase BPLC indicated that the 
starting material had been consumed. The solution was concentrated under 
reduced pressure and the product isolated by preparative reverse phase BPLC to 
give 132 as a white powder (16 mg, 9.66 pmol, 29%); nVz (ES) 811 (MH22ý 
1621 (MH+). The reverse phase BPLC chromatograrn is shown below. 
I2 
Ist 
- 
ti 
4I 
1&I 
I 142 
71 
ID 
to 
120 
I 
0' 
P. 09! 4 
Analytical column; mobile phase TFA: acetonitrile: water, 1: 24: 75; flow rate, I 
ml/minute; 22"C; pressure 226 bar. 
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Coupling 130 to vancomycin 
OH 
0 
HO 
NH2 
ýo 0 
HOO,, 
ý! ý 00 
fro a. 
\H 
01 
HA ýN OH 
0 
H 
TRN 
HN 
ý\ý 
N lz H NH 
H H2 VH 0 
'ff H 
V, NH 0H 
0 
To a solution of vancomycin hydrochloride (50 mg, 33.6 pmol) in dimethyl 
sulfoxide was added allyl tetraethylglycolamine (20 mg, 86 ptmol, excess), 
PyBOP (21 mg, 40.3 gmol, 1.2 eq), DIPEA (5.2 mg, 40.3 gmol, 1.2 eq), HOBt 
(5.4 mg, 40.3 gmol, 1.2 eq). The reaction mixture was stirred at room 
temperature for 4 days after which time reverse phase BPLC indicated that the 
starting material had been consumed. The solution was concentrated under 
reduced pressure and the product isolated by preparative reverse phase IHPLC to 
give 133 as a white powder (19 mg, 11.4 gmol, 34Vo); Mlz (ES) 833 (MH22). 
The reverse phase IHPLC chromatograrn is shown below. 
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bei 
t 01 
2. IN 
IL Cd 
4. ag 
5 ix 
6. U 
709 
ton 
Be. L 
9 20- 2 
49 
Analytical column; mobile phase TFA: acetonitrile: water, 1: 24: 75; flow rate, I 
ml/minute; 24*C; pressure 205 bar. 
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Experimental 
The general procedure for the vancoMYCin dimerisation via metathesis to give 
134-136 was; 
Dichloromethane (100 ml) was frozen in liquid nitrogen and degassed under 
reduced pressure 4 times. Grubbs catalyst (12.4 mg, 15 gmol) was added to this 
and dissolved over 20 minutes via ultra-sonification to give a pale red brown 
solution. The vancomycin monomer (I mg, -0.6 gmol) was added to the 
solution of Grubbs catalyst in dichloromethane (I ml, 0.15 gmol, 25 mol%) and 
dissolved via ultra-sonification over a period of 20 minutes. The solution was 
frozen in liquid nitrogen and degass under reduced pressure 3 times then allowed 
to warm to room temperature. The reaction mixture was allowed to stir at room 
temperature for 2 days after which time analysis by reverse phase IHPLC was 
undertaken. The reverse phase HPLC chromatograms are shown below. 
136; m1z (ES) 1081 (MH 33+), 1621 (MIH22+) (Found: M+, 3237.1038. 
C150H184 3504N20052 requires M+, 3237.1123). 
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Experimental 
Analytical chromatogram of for 134. 
.1 
Ike 
120 
44.0 
14L 0 
two 
2ci a 
&to, L 
I& is, s 
702-2 
Analytical column; mobile phase TFA: acetonitrile: water, 1: 24: 75; flow rate, I 
ml/minute; 22*C; pressure 226 bar. 
Analytical chromatogram for 135. 
au. 
as- 
M 3*3 
V. S. 
me- 
nil 
I. ftl 
612 2 
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Experimental 
Analytical column; mobile phase TFA: acetonitrile: water, 1: 24: 75; flow rate, I 
ml/minute; 22*C; pressure 226 bar. 
Analytical chromatogram for 136. 
2, 
14.1 
194 
to I 
2MA 
Lrlkt 
11LUS 
IM2 
Analytical column; mobile phase TFA: acetonitrile: water, 1: 24: 75; flow rate, 1 
ml/minute; 25"C; pressure 184 bar. 
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